| ICD-10 | Descriptor |
| A02.1 |
Salmonella sepsis |
| A06.0 |
Acute amebic dysentery |
| A06.1 |
Chronic intestinal amebiasis |
| A06.2 |
Amebic nondysenteric colitis |
| A06.3 |
Ameboma of intestine |
| A06.4 |
Amebic liver abscess |
| A06.5 |
Amebic lung abscess |
| A06.6 |
Amebic brain abscess |
| A06.7 |
Cutaneous amebiasis |
| A06.81 |
Amebic cystitis |
| A06.82 |
Other amebic genitourinary infections |
| A06.89 |
Other amebic infections |
| A06.9 |
Amebiasis, unspecified |
| A17.83 |
Tuberculous neuritis |
| A17.9 |
Tuberculosis of nervous system, unspecified |
| A18.31 |
Tuberculous peritonitis |
| A18.32 |
Tuberculous enteritis |
| A18.39 |
Retroperitoneal tuberculosis |
| A18.82 |
Tuberculosis of other endocrine glands |
| A18.83 |
Tuberculosis of digestive tract organs, not elsewhere classified |
| A18.84 |
Tuberculosis of heart |
| A18.89 |
Tuberculosis of other sites |
| A19.9 |
Miliary tuberculosis, unspecified |
| A20.0 |
Bubonic plague |
| A20.1 |
Cellulocutaneous plague |
| A20.2 |
Pneumonic plague |
| A20.3 |
Plague meningitis |
| A20.7 |
Septicemic plague |
| A20.8 |
Other forms of plague |
| A20.9 |
Plague, unspecified |
| A22.7 |
Anthrax sepsis |
| A26.0 |
Cutaneous erysipeloid |
| A26.7 |
Erysipelothrix sepsis |
| A26.8 |
Other forms of erysipeloid |
| A26.9 |
Erysipeloid, unspecified |
| A27.0 |
Leptospirosis icterohemorrhagica |
| A30.1 |
Tuberculoid leprosy |
| A32.0 |
Cutaneous listeriosis |
| A32.11 |
Listerial meningitis |
| A32.12 |
Listerial meningoencephalitis |
| A32.7 |
Listerial sepsis |
| A32.81 |
Oculoglandular listeriosis |
| A32.82 |
Listerial endocarditis |
| A32.89 |
Other forms of listeriosis |
| A32.9 |
Listeriosis, unspecified |
| A36.89 |
Other diphtheritic complications |
| A39.2 |
Acute meningococcemia |
| A39.3 |
Chronic meningococcemia |
| A39.4 |
Meningococcemia, unspecified |
| A39.81 |
Meningococcal encephalitis |
| A40.0 |
Sepsis due to streptococcus, group A |
| A40.1 |
Sepsis due to streptococcus, group B |
| A40.3 |
Sepsis due to Streptococcus pneumoniae |
| A40.8 |
Other streptococcal sepsis |
| A40.9 |
Streptococcal sepsis, unspecified |
| A41.01 |
Sepsis due to Methicillin susceptible Staphylococcus aureus |
| A41.02 |
Sepsis due to Methicillin resistant Staphylococcus aureus |
| A41.1 |
Sepsis due to other specified staphylococcus |
| A41.2 |
Sepsis due to unspecified staphylococcus |
| A41.3 |
Sepsis due to Hemophilus influenzae |
| A41.4 |
Sepsis due to anaerobes |
| A41.50 |
Gram-negative sepsis, unspecified |
| A41.51 |
Sepsis due to Escherichia coli [E. coli] |
| A41.52 |
Sepsis due to Pseudomonas |
| A41.53 |
Sepsis due to Serratia |
| A41.54 |
Sepsis due to Acinetobacter baumannii |
| A41.59 |
Other Gram-negative sepsis |
| A41.81 |
Sepsis due to Enterococcus |
| A41.89 |
Other specified sepsis |
| A41.9 |
Sepsis, unspecified organism |
| A42.1 |
Abdominal actinomycosis |
| A42.7 |
Actinomycotic sepsis |
| A48.0 |
Gas gangrene |
| A51.45 |
Secondary syphilitic hepatitis |
| A52.74 |
Syphilis of liver and other viscera |
| A69.20 |
Lyme disease, unspecified |
| A69.21 |
Meningitis due to Lyme disease |
| A69.22 |
Other neurologic disorders in Lyme disease |
| A69.23 |
Arthritis due to Lyme disease |
| A69.29 |
Other conditions associated with Lyme disease |
| A70 |
Chlamydia psittaci infections |
| A77.0 |
Spotted fever due to Rickettsia rickettsii |
| A77.1 |
Spotted fever due to Rickettsia conorii |
| A77.2 |
Spotted fever due to Rickettsia siberica |
| A77.3 |
Spotted fever due to Rickettsia australis |
| A77.40 |
Ehrlichiosis, unspecified |
| A77.41 |
Ehrlichiosis chaffeensis [E. chaffeensis] |
| A77.49 |
Other ehrlichiosis |
| A77.8 |
Other spotted fevers |
| A77.9 |
Spotted fever, unspecified |
| A79.9 |
Rickettsiosis, unspecified |
| A95.0 |
Sylvatic yellow fever |
| A95.1 |
Urban yellow fever |
| B00.0 |
Eczema herpeticum |
| B00.7 |
Disseminated herpesviral disease |
| B15.0 |
Hepatitis A with hepatic coma |
| B15.9 |
Hepatitis A without hepatic coma |
| B16.0 |
Acute hepatitis B with delta-agent with hepatic coma |
| B16.1 |
Acute hepatitis B with delta-agent without hepatic coma |
| B16.2 |
Acute hepatitis B without delta-agent with hepatic coma |
| B16.9 |
Acute hepatitis B without delta-agent and without hepatic coma |
| B17.0 |
Acute delta-(super) infection of hepatitis B carrier |
| B17.10 |
Acute hepatitis C without hepatic coma |
| B17.11 |
Acute hepatitis C with hepatic coma |
| B17.2 |
Acute hepatitis E |
| B17.8 |
Other specified acute viral hepatitis |
| B17.9 |
Acute viral hepatitis, unspecified |
| B18.0 |
Chronic viral hepatitis B with delta-agent |
| B18.1 |
Chronic viral hepatitis B without delta-agent |
| B18.2 |
Chronic viral hepatitis C |
| B18.8 |
Other chronic viral hepatitis |
| B18.9 |
Chronic viral hepatitis, unspecified |
| B19.0 |
Unspecified viral hepatitis with hepatic coma |
| B19.10 |
Unspecified viral hepatitis B without hepatic coma |
| B19.11 |
Unspecified viral hepatitis B with hepatic coma |
| B19.20 |
Unspecified viral hepatitis C without hepatic coma |
| B19.21 |
Unspecified viral hepatitis C with hepatic coma |
| B19.9 |
Unspecified viral hepatitis without hepatic coma |
| B20 |
Human immunodeficiency virus [HIV] disease |
| B25.0 |
Cytomegaloviral pneumonitis |
| B25.1 |
Cytomegaloviral hepatitis |
| B25.2 |
Cytomegaloviral pancreatitis |
| B25.8 |
Other cytomegaloviral diseases |
| B25.9 |
Cytomegaloviral disease, unspecified |
| B26.81 |
Mumps hepatitis |
| B27.00 |
Gammaherpesviral mononucleosis without complication |
| B27.01 |
Gammaherpesviral mononucleosis with polyneuropathy |
| B27.02 |
Gammaherpesviral mononucleosis with meningitis |
| B27.09 |
Gammaherpesviral mononucleosis with other complications |
| B27.10 |
Cytomegaloviral mononucleosis without complications |
| B27.11 |
Cytomegaloviral mononucleosis with polyneuropathy |
| B27.12 |
Cytomegaloviral mononucleosis with meningitis |
| B27.19 |
Cytomegaloviral mononucleosis with other complication |
| B27.80 |
Other infectious mononucleosis without complication |
| B27.81 |
Other infectious mononucleosis with polyneuropathy |
| B27.82 |
Other infectious mononucleosis with meningitis |
| B27.89 |
Other infectious mononucleosis with other complication |
| B27.90 |
Infectious mononucleosis, unspecified without complication |
| B27.91 |
Infectious mononucleosis, unspecified with polyneuropathy |
| B27.92 |
Infectious mononucleosis, unspecified with meningitis |
| B27.99 |
Infectious mononucleosis, unspecified with other complication |
| B34.1 |
Enterovirus infection, unspecified |
| B37.7 |
Candidal sepsis |
| B39.4 |
Histoplasmosis capsulati, unspecified |
| B50.0 |
Plasmodium falciparum malaria with cerebral complications |
| B50.8 |
Other severe and complicated Plasmodium falciparum malaria |
| B51.0 |
Plasmodium vivax malaria with rupture of spleen |
| B51.8 |
Plasmodium vivax malaria with other complications |
| B52.0 |
Plasmodium malariae malaria with nephropathy |
| B52.8 |
Plasmodium malariae malaria with other complications |
| B57.30 |
Chagas' disease with digestive system involvement, unspecified |
| B57.31 |
Megaesophagus in Chagas' disease |
| B57.32 |
Megacolon in Chagas' disease |
| B57.39 |
Other digestive system involvement in Chagas' disease |
| B57.40 |
Chagas' disease with nervous system involvement, unspecified |
| B57.41 |
Meningitis in Chagas' disease |
| B57.42 |
Meningoencephalitis in Chagas' disease |
| B57.49 |
Other nervous system involvement in Chagas' disease |
| B57.5 |
Chagas' disease (chronic) with other organ involvement |
| B58.1 |
Toxoplasma hepatitis |
| B65.9 |
Schistosomiasis, unspecified |
| B66.1 |
Clonorchiasis |
| B66.3 |
Fascioliasis |
| B67.0 |
Echinococcus granulosus infection of liver |
| B67.5 |
Echinococcus multilocularis infection of liver |
| B67.8 |
Echinococcosis, unspecified, of liver |
| B67.90 |
Echinococcosis, unspecified |
| B67.99 |
Other echinococcosis |
| B97.10 |
Unspecified enterovirus as the cause of diseases classified elsewhere |
| B97.89 |
Other viral agents as the cause of diseases classified elsewhere |
| C15.3 |
Malignant neoplasm of upper third of esophagus |
| C15.4 |
Malignant neoplasm of middle third of esophagus |
| C15.5 |
Malignant neoplasm of lower third of esophagus |
| C15.8 |
Malignant neoplasm of overlapping sites of esophagus |
| C15.9 |
Malignant neoplasm of esophagus, unspecified |
| C16.0 |
Malignant neoplasm of cardia |
| C16.1 |
Malignant neoplasm of fundus of stomach |
| C16.2 |
Malignant neoplasm of body of stomach |
| C16.3 |
Malignant neoplasm of pyloric antrum |
| C16.4 |
Malignant neoplasm of pylorus |
| C16.5 |
Malignant neoplasm of lesser curvature of stomach, unspecified |
| C16.6 |
Malignant neoplasm of greater curvature of stomach, unspecified |
| C16.8 |
Malignant neoplasm of overlapping sites of stomach |
| C16.9 |
Malignant neoplasm of stomach, unspecified |
| C17.0 |
Malignant neoplasm of duodenum |
| C17.1 |
Malignant neoplasm of jejunum |
| C17.2 |
Malignant neoplasm of ileum |
| C17.3 |
Meckel's diverticulum, malignant |
| C17.8 |
Malignant neoplasm of overlapping sites of small intestine |
| C17.9 |
Malignant neoplasm of small intestine, unspecified |
| C18.0 |
Malignant neoplasm of cecum |
| C18.1 |
Malignant neoplasm of appendix |
| C18.2 |
Malignant neoplasm of ascending colon |
| C18.3 |
Malignant neoplasm of hepatic flexure |
| C18.4 |
Malignant neoplasm of transverse colon |
| C18.5 |
Malignant neoplasm of splenic flexure |
| C18.6 |
Malignant neoplasm of descending colon |
| C18.7 |
Malignant neoplasm of sigmoid colon |
| C18.8 |
Malignant neoplasm of overlapping sites of colon |
| C18.9 |
Malignant neoplasm of colon, unspecified |
| C19 |
Malignant neoplasm of rectosigmoid junction |
| C20 |
Malignant neoplasm of rectum |
| C21.0 |
Malignant neoplasm of anus, unspecified |
| C21.1 |
Malignant neoplasm of anal canal |
| C21.2 |
Malignant neoplasm of cloacogenic zone |
| C21.8 |
Malignant neoplasm of overlapping sites of rectum, anus and anal canal |
| C22.0 |
Liver cell carcinoma |
| C22.1 |
Intrahepatic bile duct carcinoma |
| C22.2 |
Hepatoblastoma |
| C22.3 |
Angiosarcoma of liver |
| C22.4 |
Other sarcomas of liver |
| C22.7 |
Other specified carcinomas of liver |
| C22.8 |
Malignant neoplasm of liver, primary, unspecified as to type |
| C22.9 |
Malignant neoplasm of liver, not specified as primary or secondary |
| C23 |
Malignant neoplasm of gallbladder |
| C24.0 |
Malignant neoplasm of extrahepatic bile duct |
| C24.1 |
Malignant neoplasm of ampulla of Vater |
| C24.8 |
Malignant neoplasm of overlapping sites of biliary tract |
| C24.9 |
Malignant neoplasm of biliary tract, unspecified |
| C25.0 |
Malignant neoplasm of head of pancreas |
| C25.1 |
Malignant neoplasm of body of pancreas |
| C25.2 |
Malignant neoplasm of tail of pancreas |
| C25.3 |
Malignant neoplasm of pancreatic duct |
| C25.4 |
Malignant neoplasm of endocrine pancreas |
| C25.7 |
Malignant neoplasm of other parts of pancreas |
| C25.8 |
Malignant neoplasm of overlapping sites of pancreas |
| C25.9 |
Malignant neoplasm of pancreas, unspecified |
| C26.0 |
Malignant neoplasm of intestinal tract, part unspecified |
| C26.1 |
Malignant neoplasm of spleen |
| C26.9 |
Malignant neoplasm of ill-defined sites within the digestive system |
| C30.0 |
Malignant neoplasm of nasal cavity |
| C30.1 |
Malignant neoplasm of middle ear |
| C31.0 |
Malignant neoplasm of maxillary sinus |
| C31.1 |
Malignant neoplasm of ethmoidal sinus |
| C31.2 |
Malignant neoplasm of frontal sinus |
| C31.3 |
Malignant neoplasm of sphenoid sinus |
| C31.8 |
Malignant neoplasm of overlapping sites of accessory sinuses |
| C31.9 |
Malignant neoplasm of accessory sinus, unspecified |
| C32.0 |
Malignant neoplasm of glottis |
| C32.1 |
Malignant neoplasm of supraglottis |
| C32.2 |
Malignant neoplasm of subglottis |
| C32.3 |
Malignant neoplasm of laryngeal cartilage |
| C32.8 |
Malignant neoplasm of overlapping sites of larynx |
| C32.9 |
Malignant neoplasm of larynx, unspecified |
| C33 |
Malignant neoplasm of trachea |
| C34.00 |
Malignant neoplasm of unspecified main bronchus |
| C34.01 |
Malignant neoplasm of right main bronchus |
| C34.02 |
Malignant neoplasm of left main bronchus |
| C34.10 |
Malignant neoplasm of upper lobe, unspecified bronchus or lung |
| C34.11 |
Malignant neoplasm of upper lobe, right bronchus or lung |
| C34.12 |
Malignant neoplasm of upper lobe, left bronchus or lung |
| C34.2 |
Malignant neoplasm of middle lobe, bronchus or lung |
| C34.30 |
Malignant neoplasm of lower lobe, unspecified bronchus or lung |
| C34.31 |
Malignant neoplasm of lower lobe, right bronchus or lung |
| C34.32 |
Malignant neoplasm of lower lobe, left bronchus or lung |
| C34.80 |
Malignant neoplasm of overlapping sites of unspecified bronchus and lung |
| C34.81 |
Malignant neoplasm of overlapping sites of right bronchus and lung |
| C34.82 |
Malignant neoplasm of overlapping sites of left bronchus and lung |
| C34.90 |
Malignant neoplasm of unspecified part of unspecified bronchus or lung |
| C34.91 |
Malignant neoplasm of unspecified part of right bronchus or lung |
| C34.92 |
Malignant neoplasm of unspecified part of left bronchus or lung |
| C37 |
Malignant neoplasm of thymus |
| C38.0 |
Malignant neoplasm of heart |
| C38.1 |
Malignant neoplasm of anterior mediastinum |
| C38.2 |
Malignant neoplasm of posterior mediastinum |
| C38.3 |
Malignant neoplasm of mediastinum, part unspecified |
| C38.4 |
Malignant neoplasm of pleura |
| C38.8 |
Malignant neoplasm of overlapping sites of heart, mediastinum and pleura |
| C39.0 |
Malignant neoplasm of upper respiratory tract, part unspecified |
| C39.9 |
Malignant neoplasm of lower respiratory tract, part unspecified |
| C40.00 |
Malignant neoplasm of scapula and long bones of unspecified upper limb |
| C40.01 |
Malignant neoplasm of scapula and long bones of right upper limb |
| C40.02 |
Malignant neoplasm of scapula and long bones of left upper limb |
| C40.10 |
Malignant neoplasm of short bones of unspecified upper limb |
| C40.11 |
Malignant neoplasm of short bones of right upper limb |
| C40.12 |
Malignant neoplasm of short bones of left upper limb |
| C40.20 |
Malignant neoplasm of long bones of unspecified lower limb |
| C40.21 |
Malignant neoplasm of long bones of right lower limb |
| C40.22 |
Malignant neoplasm of long bones of left lower limb |
| C40.30 |
Malignant neoplasm of short bones of unspecified lower limb |
| C40.31 |
Malignant neoplasm of short bones of right lower limb |
| C40.32 |
Malignant neoplasm of short bones of left lower limb |
| C40.80 |
Malignant neoplasm of overlapping sites of bone and articular cartilage of unspecified limb |
| C40.81 |
Malignant neoplasm of overlapping sites of bone and articular cartilage of right limb |
| C40.82 |
Malignant neoplasm of overlapping sites of bone and articular cartilage of left limb |
| C40.90 |
Malignant neoplasm of unspecified bones and articular cartilage of unspecified limb |
| C40.91 |
Malignant neoplasm of unspecified bones and articular cartilage of right limb |
| C40.92 |
Malignant neoplasm of unspecified bones and articular cartilage of left limb |
| C41.0 |
Malignant neoplasm of bones of skull and face |
| C41.1 |
Malignant neoplasm of mandible |
| C41.2 |
Malignant neoplasm of vertebral column |
| C41.3 |
Malignant neoplasm of ribs, sternum and clavicle |
| C41.4 |
Malignant neoplasm of pelvic bones, sacrum and coccyx |
| C41.9 |
Malignant neoplasm of bone and articular cartilage, unspecified |
| C43.0 |
Malignant melanoma of lip |
| C43.10 |
Malignant melanoma of unspecified eyelid, including canthus |
| C43.111 |
Malignant melanoma of right upper eyelid, including canthus |
| C43.112 |
Malignant melanoma of right lower eyelid, including canthus |
| C43.121 |
Malignant melanoma of left upper eyelid, including canthus |
| C43.122 |
Malignant melanoma of left lower eyelid, including canthus |
| C43.20 |
Malignant melanoma of unspecified ear and external auricular canal |
| C43.21 |
Malignant melanoma of right ear and external auricular canal |
| C43.22 |
Malignant melanoma of left ear and external auricular canal |
| C43.30 |
Malignant melanoma of unspecified part of face |
| C43.31 |
Malignant melanoma of nose |
| C43.39 |
Malignant melanoma of other parts of face |
| C43.4 |
Malignant melanoma of scalp and neck |
| C43.51 |
Malignant melanoma of anal skin |
| C43.52 |
Malignant melanoma of skin of breast |
| C43.59 |
Malignant melanoma of other part of trunk |
| C43.60 |
Malignant melanoma of unspecified upper limb, including shoulder |
| C43.61 |
Malignant melanoma of right upper limb, including shoulder |
| C43.62 |
Malignant melanoma of left upper limb, including shoulder |
| C43.70 |
Malignant melanoma of unspecified lower limb, including hip |
| C43.71 |
Malignant melanoma of right lower limb, including hip |
| C43.72 |
Malignant melanoma of left lower limb, including hip |
| C43.8 |
Malignant melanoma of overlapping sites of skin |
| C43.9 |
Malignant melanoma of skin, unspecified |
| C44.00 |
Unspecified malignant neoplasm of skin of lip |
| C44.01 |
Basal cell carcinoma of skin of lip |
| C44.02 |
Squamous cell carcinoma of skin of lip |
| C44.09 |
Other specified malignant neoplasm of skin of lip |
| C44.101 |
Unspecified malignant neoplasm of skin of unspecified eyelid, including canthus |
| C44.1021 |
Unspecified malignant neoplasm of skin of right upper eyelid, including canthus |
| C44.1022 |
Unspecified malignant neoplasm of skin of right lower eyelid, including canthus |
| C44.1091 |
Unspecified malignant neoplasm of skin of left upper eyelid, including canthus |
| C44.1092 |
Unspecified malignant neoplasm of skin of left lower eyelid, including canthus |
| C44.111 |
Basal cell carcinoma of skin of unspecified eyelid, including canthus |
| C44.1121 |
Basal cell carcinoma of skin of right upper eyelid, including canthus |
| C44.1122 |
Basal cell carcinoma of skin of right lower eyelid, including canthus |
| C44.1191 |
Basal cell carcinoma of skin of left upper eyelid, including canthus |
| C44.1192 |
Basal cell carcinoma of skin of left lower eyelid, including canthus |
| C44.121 |
Squamous cell carcinoma of skin of unspecified eyelid, including canthus |
| C44.1221 |
Squamous cell carcinoma of skin of right upper eyelid, including canthus |
| C44.1222 |
Squamous cell carcinoma of skin of right lower eyelid, including canthus |
| C44.1291 |
Squamous cell carcinoma of skin of left upper eyelid, including canthus |
| C44.1292 |
Squamous cell carcinoma of skin of left lower eyelid, including canthus |
| C44.1321 |
Sebaceous cell carcinoma of skin of right upper eyelid, including canthus |
| C44.1322 |
Sebaceous cell carcinoma of skin of right lower eyelid, including canthus |
| C44.1391 |
Sebaceous cell carcinoma of skin of left upper eyelid, including canthus |
| C44.1392 |
Sebaceous cell carcinoma of skin of left lower eyelid, including canthus |
| C44.191 |
Other specified malignant neoplasm of skin of unspecified eyelid, including canthus |
| C44.1921 |
Other specified malignant neoplasm of skin of right upper eyelid, including canthus |
| C44.1922 |
Other specified malignant neoplasm of skin of right lower eyelid, including canthus |
| C44.1991 |
Other specified malignant neoplasm of skin of left upper eyelid, including canthus |
| C44.1992 |
Other specified malignant neoplasm of skin of left lower eyelid, including canthus |
| C44.201 |
Unspecified malignant neoplasm of skin of unspecified ear and external auricular canal |
| C44.202 |
Unspecified malignant neoplasm of skin of right ear and external auricular canal |
| C44.209 |
Unspecified malignant neoplasm of skin of left ear and external auricular canal |
| C44.211 |
Basal cell carcinoma of skin of unspecified ear and external auricular canal |
| C44.212 |
Basal cell carcinoma of skin of right ear and external auricular canal |
| C44.219 |
Basal cell carcinoma of skin of left ear and external auricular canal |
| C44.221 |
Squamous cell carcinoma of skin of unspecified ear and external auricular canal |
| C44.222 |
Squamous cell carcinoma of skin of right ear and external auricular canal |
| C44.229 |
Squamous cell carcinoma of skin of left ear and external auricular canal |
| C44.291 |
Other specified malignant neoplasm of skin of unspecified ear and external auricular canal |
| C44.292 |
Other specified malignant neoplasm of skin of right ear and external auricular canal |
| C44.299 |
Other specified malignant neoplasm of skin of left ear and external auricular canal |
| C44.300 |
Unspecified malignant neoplasm of skin of unspecified part of face |
| C44.301 |
Unspecified malignant neoplasm of skin of nose |
| C44.309 |
Unspecified malignant neoplasm of skin of other parts of face |
| C44.310 |
Basal cell carcinoma of skin of unspecified parts of face |
| C44.311 |
Basal cell carcinoma of skin of nose |
| C44.319 |
Basal cell carcinoma of skin of other parts of face |
| C44.320 |
Squamous cell carcinoma of skin of unspecified parts of face |
| C44.321 |
Squamous cell carcinoma of skin of nose |
| C44.329 |
Squamous cell carcinoma of skin of other parts of face |
| C44.390 |
Other specified malignant neoplasm of skin of unspecified parts of face |
| C44.391 |
Other specified malignant neoplasm of skin of nose |
| C44.399 |
Other specified malignant neoplasm of skin of other parts of face |
| C44.40 |
Unspecified malignant neoplasm of skin of scalp and neck |
| C44.41 |
Basal cell carcinoma of skin of scalp and neck |
| C44.42 |
Squamous cell carcinoma of skin of scalp and neck |
| C44.49 |
Other specified malignant neoplasm of skin of scalp and neck |
| C44.500 |
Unspecified malignant neoplasm of anal skin |
| C44.501 |
Unspecified malignant neoplasm of skin of breast |
| C44.509 |
Unspecified malignant neoplasm of skin of other part of trunk |
| C44.510 |
Basal cell carcinoma of anal skin |
| C44.511 |
Basal cell carcinoma of skin of breast |
| C44.519 |
Basal cell carcinoma of skin of other part of trunk |
| C44.520 |
Squamous cell carcinoma of anal skin |
| C44.521 |
Squamous cell carcinoma of skin of breast |
| C44.529 |
Squamous cell carcinoma of skin of other part of trunk |
| C44.590 |
Other specified malignant neoplasm of anal skin |
| C44.591 |
Other specified malignant neoplasm of skin of breast |
| C44.599 |
Other specified malignant neoplasm of skin of other part of trunk |
| C44.601 |
Unspecified malignant neoplasm of skin of unspecified upper limb, including shoulder |
| C44.602 |
Unspecified malignant neoplasm of skin of right upper limb, including shoulder |
| C44.609 |
Unspecified malignant neoplasm of skin of left upper limb, including shoulder |
| C44.611 |
Basal cell carcinoma of skin of unspecified upper limb, including shoulder |
| C44.612 |
Basal cell carcinoma of skin of right upper limb, including shoulder |
| C44.619 |
Basal cell carcinoma of skin of left upper limb, including shoulder |
| C44.621 |
Squamous cell carcinoma of skin of unspecified upper limb, including shoulder |
| C44.622 |
Squamous cell carcinoma of skin of right upper limb, including shoulder |
| C44.629 |
Squamous cell carcinoma of skin of left upper limb, including shoulder |
| C44.691 |
Other specified malignant neoplasm of skin of unspecified upper limb, including shoulder |
| C44.692 |
Other specified malignant neoplasm of skin of right upper limb, including shoulder |
| C44.699 |
Other specified malignant neoplasm of skin of left upper limb, including shoulder |
| C44.701 |
Unspecified malignant neoplasm of skin of unspecified lower limb, including hip |
| C44.702 |
Unspecified malignant neoplasm of skin of right lower limb, including hip |
| C44.709 |
Unspecified malignant neoplasm of skin of left lower limb, including hip |
| C44.711 |
Basal cell carcinoma of skin of unspecified lower limb, including hip |
| C44.712 |
Basal cell carcinoma of skin of right lower limb, including hip |
| C44.719 |
Basal cell carcinoma of skin of left lower limb, including hip |
| C44.721 |
Squamous cell carcinoma of skin of unspecified lower limb, including hip |
| C44.722 |
Squamous cell carcinoma of skin of right lower limb, including hip |
| C44.729 |
Squamous cell carcinoma of skin of left lower limb, including hip |
| C44.791 |
Other specified malignant neoplasm of skin of unspecified lower limb, including hip |
| C44.792 |
Other specified malignant neoplasm of skin of right lower limb, including hip |
| C44.799 |
Other specified malignant neoplasm of skin of left lower limb, including hip |
| C44.80 |
Unspecified malignant neoplasm of overlapping sites of skin |
| C44.81 |
Basal cell carcinoma of overlapping sites of skin |
| C44.82 |
Squamous cell carcinoma of overlapping sites of skin |
| C44.89 |
Other specified malignant neoplasm of overlapping sites of skin |
| C44.90 |
Unspecified malignant neoplasm of skin, unspecified |
| C44.91 |
Basal cell carcinoma of skin, unspecified |
| C44.92 |
Squamous cell carcinoma of skin, unspecified |
| C44.99 |
Other specified malignant neoplasm of skin, unspecified |
| C45.0 |
Mesothelioma of pleura |
| C45.1 |
Mesothelioma of peritoneum |
| C45.2 |
Mesothelioma of pericardium |
| C46.0 |
Kaposi's sarcoma of skin |
| C46.1 |
Kaposi's sarcoma of soft tissue |
| C46.2 |
Kaposi's sarcoma of palate |
| C46.3 |
Kaposi's sarcoma of lymph nodes |
| C46.4 |
Kaposi's sarcoma of gastrointestinal sites |
| C46.50 |
Kaposi's sarcoma of unspecified lung |
| C46.51 |
Kaposi's sarcoma of right lung |
| C46.52 |
Kaposi's sarcoma of left lung |
| C46.7 |
Kaposi's sarcoma of other sites |
| C46.9 |
Kaposi's sarcoma, unspecified |
| C47.0 |
Malignant neoplasm of peripheral nerves of head, face and neck |
| C47.10 |
Malignant neoplasm of peripheral nerves of unspecified upper limb, including shoulder |
| C47.11 |
Malignant neoplasm of peripheral nerves of right upper limb, including shoulder |
| C47.12 |
Malignant neoplasm of peripheral nerves of left upper limb, including shoulder |
| C47.20 |
Malignant neoplasm of peripheral nerves of unspecified lower limb, including hip |
| C47.21 |
Malignant neoplasm of peripheral nerves of right lower limb, including hip |
| C47.22 |
Malignant neoplasm of peripheral nerves of left lower limb, including hip |
| C47.3 |
Malignant neoplasm of peripheral nerves of thorax |
| C47.4 |
Malignant neoplasm of peripheral nerves of abdomen |
| C47.5 |
Malignant neoplasm of peripheral nerves of pelvis |
| C47.6 |
Malignant neoplasm of peripheral nerves of trunk, unspecified |
| C47.8 |
Malignant neoplasm of overlapping sites of peripheral nerves and autonomic nervous system |
| C47.9 |
Malignant neoplasm of peripheral nerves and autonomic nervous system, unspecified |
| C48.0 |
Malignant neoplasm of retroperitoneum |
| C48.1 |
Malignant neoplasm of specified parts of peritoneum |
| C48.2 |
Malignant neoplasm of peritoneum, unspecified |
| C48.8 |
Malignant neoplasm of overlapping sites of retroperitoneum and peritoneum |
| C49.0 |
Malignant neoplasm of connective and soft tissue of head, face and neck |
| C49.10 |
Malignant neoplasm of connective and soft tissue of unspecified upper limb, including shoulder |
| C49.11 |
Malignant neoplasm of connective and soft tissue of right upper limb, including shoulder |
| C49.12 |
Malignant neoplasm of connective and soft tissue of left upper limb, including shoulder |
| C49.20 |
Malignant neoplasm of connective and soft tissue of unspecified lower limb, including hip |
| C49.21 |
Malignant neoplasm of connective and soft tissue of right lower limb, including hip |
| C49.22 |
Malignant neoplasm of connective and soft tissue of left lower limb, including hip |
| C49.3 |
Malignant neoplasm of connective and soft tissue of thorax |
| C49.4 |
Malignant neoplasm of connective and soft tissue of abdomen |
| C49.5 |
Malignant neoplasm of connective and soft tissue of pelvis |
| C49.6 |
Malignant neoplasm of connective and soft tissue of trunk, unspecified |
| C49.8 |
Malignant neoplasm of overlapping sites of connective and soft tissue |
| C49.9 |
Malignant neoplasm of connective and soft tissue, unspecified |
| C49.A0 |
Gastrointestinal stromal tumor, unspecified site |
| C49.A1 |
Gastrointestinal stromal tumor of esophagus |
| C49.A2 |
Gastrointestinal stromal tumor of stomach |
| C49.A3 |
Gastrointestinal stromal tumor of small intestine |
| C49.A4 |
Gastrointestinal stromal tumor of large intestine |
| C49.A5 |
Gastrointestinal stromal tumor of rectum |
| C49.A9 |
Gastrointestinal stromal tumor of other sites |
| C50.011 |
Malignant neoplasm of nipple and areola, right female breast |
| C50.012 |
Malignant neoplasm of nipple and areola, left female breast |
| C50.019 |
Malignant neoplasm of nipple and areola, unspecified female breast |
| C50.021 |
Malignant neoplasm of nipple and areola, right male breast |
| C50.022 |
Malignant neoplasm of nipple and areola, left male breast |
| C50.029 |
Malignant neoplasm of nipple and areola, unspecified male breast |
| C50.111 |
Malignant neoplasm of central portion of right female breast |
| C50.112 |
Malignant neoplasm of central portion of left female breast |
| C50.119 |
Malignant neoplasm of central portion of unspecified female breast |
| C50.121 |
Malignant neoplasm of central portion of right male breast |
| C50.122 |
Malignant neoplasm of central portion of left male breast |
| C50.129 |
Malignant neoplasm of central portion of unspecified male breast |
| C50.211 |
Malignant neoplasm of upper-inner quadrant of right female breast |
| C50.212 |
Malignant neoplasm of upper-inner quadrant of left female breast |
| C50.219 |
Malignant neoplasm of upper-inner quadrant of unspecified female breast |
| C50.221 |
Malignant neoplasm of upper-inner quadrant of right male breast |
| C50.222 |
Malignant neoplasm of upper-inner quadrant of left male breast |
| C50.229 |
Malignant neoplasm of upper-inner quadrant of unspecified male breast |
| C50.311 |
Malignant neoplasm of lower-inner quadrant of right female breast |
| C50.312 |
Malignant neoplasm of lower-inner quadrant of left female breast |
| C50.319 |
Malignant neoplasm of lower-inner quadrant of unspecified female breast |
| C50.321 |
Malignant neoplasm of lower-inner quadrant of right male breast |
| C50.322 |
Malignant neoplasm of lower-inner quadrant of left male breast |
| C50.329 |
Malignant neoplasm of lower-inner quadrant of unspecified male breast |
| C50.411 |
Malignant neoplasm of upper-outer quadrant of right female breast |
| C50.412 |
Malignant neoplasm of upper-outer quadrant of left female breast |
| C50.419 |
Malignant neoplasm of upper-outer quadrant of unspecified female breast |
| C50.421 |
Malignant neoplasm of upper-outer quadrant of right male breast |
| C50.422 |
Malignant neoplasm of upper-outer quadrant of left male breast |
| C50.429 |
Malignant neoplasm of upper-outer quadrant of unspecified male breast |
| C50.511 |
Malignant neoplasm of lower-outer quadrant of right female breast |
| C50.512 |
Malignant neoplasm of lower-outer quadrant of left female breast |
| C50.519 |
Malignant neoplasm of lower-outer quadrant of unspecified female breast |
| C50.521 |
Malignant neoplasm of lower-outer quadrant of right male breast |
| C50.522 |
Malignant neoplasm of lower-outer quadrant of left male breast |
| C50.529 |
Malignant neoplasm of lower-outer quadrant of unspecified male breast |
| C50.611 |
Malignant neoplasm of axillary tail of right female breast |
| C50.612 |
Malignant neoplasm of axillary tail of left female breast |
| C50.619 |
Malignant neoplasm of axillary tail of unspecified female breast |
| C50.621 |
Malignant neoplasm of axillary tail of right male breast |
| C50.622 |
Malignant neoplasm of axillary tail of left male breast |
| C50.629 |
Malignant neoplasm of axillary tail of unspecified male breast |
| C50.811 |
Malignant neoplasm of overlapping sites of right female breast |
| C50.812 |
Malignant neoplasm of overlapping sites of left female breast |
| C50.819 |
Malignant neoplasm of overlapping sites of unspecified female breast |
| C50.821 |
Malignant neoplasm of overlapping sites of right male breast |
| C50.822 |
Malignant neoplasm of overlapping sites of left male breast |
| C50.829 |
Malignant neoplasm of overlapping sites of unspecified male breast |
| C50.911 |
Malignant neoplasm of unspecified site of right female breast |
| C50.912 |
Malignant neoplasm of unspecified site of left female breast |
| C50.919 |
Malignant neoplasm of unspecified site of unspecified female breast |
| C50.921 |
Malignant neoplasm of unspecified site of right male breast |
| C50.922 |
Malignant neoplasm of unspecified site of left male breast |
| C50.929 |
Malignant neoplasm of unspecified site of unspecified male breast |
| C51.0 |
Malignant neoplasm of labium majus |
| C51.1 |
Malignant neoplasm of labium minus |
| C51.2 |
Malignant neoplasm of clitoris |
| C51.8 |
Malignant neoplasm of overlapping sites of vulva |
| C51.9 |
Malignant neoplasm of vulva, unspecified |
| C52 |
Malignant neoplasm of vagina |
| C53.0 |
Malignant neoplasm of endocervix |
| C53.1 |
Malignant neoplasm of exocervix |
| C53.8 |
Malignant neoplasm of overlapping sites of cervix uteri |
| C53.9 |
Malignant neoplasm of cervix uteri, unspecified |
| C54.0 |
Malignant neoplasm of isthmus uteri |
| C54.1 |
Malignant neoplasm of endometrium |
| C54.2 |
Malignant neoplasm of myometrium |
| C54.3 |
Malignant neoplasm of fundus uteri |
| C54.8 |
Malignant neoplasm of overlapping sites of corpus uteri |
| C54.9 |
Malignant neoplasm of corpus uteri, unspecified |
| C55 |
Malignant neoplasm of uterus, part unspecified |
| C56.1 |
Malignant neoplasm of right ovary |
| C56.2 |
Malignant neoplasm of left ovary |
| C56.9 |
Malignant neoplasm of unspecified ovary |
| C57.00 |
Malignant neoplasm of unspecified fallopian tube |
| C57.01 |
Malignant neoplasm of right fallopian tube |
| C57.02 |
Malignant neoplasm of left fallopian tube |
| C57.10 |
Malignant neoplasm of unspecified broad ligament |
| C57.11 |
Malignant neoplasm of right broad ligament |
| C57.12 |
Malignant neoplasm of left broad ligament |
| C57.20 |
Malignant neoplasm of unspecified round ligament |
| C57.21 |
Malignant neoplasm of right round ligament |
| C57.22 |
Malignant neoplasm of left round ligament |
| C57.3 |
Malignant neoplasm of parametrium |
| C57.4 |
Malignant neoplasm of uterine adnexa, unspecified |
| C57.7 |
Malignant neoplasm of other specified female genital organs |
| C57.8 |
Malignant neoplasm of overlapping sites of female genital organs |
| C57.9 |
Malignant neoplasm of female genital organ, unspecified |
| C58 |
Malignant neoplasm of placenta |
| C60.0 |
Malignant neoplasm of prepuce |
| C60.1 |
Malignant neoplasm of glans penis |
| C60.2 |
Malignant neoplasm of body of penis |
| C60.8 |
Malignant neoplasm of overlapping sites of penis |
| C60.9 |
Malignant neoplasm of penis, unspecified |
| C61 |
Malignant neoplasm of prostate |
| C62.00 |
Malignant neoplasm of unspecified undescended testis |
| C62.01 |
Malignant neoplasm of undescended right testis |
| C62.02 |
Malignant neoplasm of undescended left testis |
| C62.10 |
Malignant neoplasm of unspecified descended testis |
| C62.11 |
Malignant neoplasm of descended right testis |
| C62.12 |
Malignant neoplasm of descended left testis |
| C62.90 |
Malignant neoplasm of unspecified testis, unspecified whether descended or undescended |
| C62.91 |
Malignant neoplasm of right testis, unspecified whether descended or undescended |
| C62.92 |
Malignant neoplasm of left testis, unspecified whether descended or undescended |
| C63.00 |
Malignant neoplasm of unspecified epididymis |
| C63.01 |
Malignant neoplasm of right epididymis |
| C63.02 |
Malignant neoplasm of left epididymis |
| C63.10 |
Malignant neoplasm of unspecified spermatic cord |
| C63.11 |
Malignant neoplasm of right spermatic cord |
| C63.12 |
Malignant neoplasm of left spermatic cord |
| C63.2 |
Malignant neoplasm of scrotum |
| C63.7 |
Malignant neoplasm of other specified male genital organs |
| C63.8 |
Malignant neoplasm of overlapping sites of male genital organs |
| C63.9 |
Malignant neoplasm of male genital organ, unspecified |
| C64.1 |
Malignant neoplasm of right kidney, except renal pelvis |
| C64.2 |
Malignant neoplasm of left kidney, except renal pelvis |
| C64.9 |
Malignant neoplasm of unspecified kidney, except renal pelvis |
| C65.1 |
Malignant neoplasm of right renal pelvis |
| C65.2 |
Malignant neoplasm of left renal pelvis |
| C65.9 |
Malignant neoplasm of unspecified renal pelvis |
| C66.1 |
Malignant neoplasm of right ureter |
| C66.2 |
Malignant neoplasm of left ureter |
| C66.9 |
Malignant neoplasm of unspecified ureter |
| C67.0 |
Malignant neoplasm of trigone of bladder |
| C67.1 |
Malignant neoplasm of dome of bladder |
| C67.2 |
Malignant neoplasm of lateral wall of bladder |
| C67.3 |
Malignant neoplasm of anterior wall of bladder |
| C67.4 |
Malignant neoplasm of posterior wall of bladder |
| C67.5 |
Malignant neoplasm of bladder neck |
| C67.6 |
Malignant neoplasm of ureteric orifice |
| C67.7 |
Malignant neoplasm of urachus |
| C67.8 |
Malignant neoplasm of overlapping sites of bladder |
| C67.9 |
Malignant neoplasm of bladder, unspecified |
| C68.0 |
Malignant neoplasm of urethra |
| C68.1 |
Malignant neoplasm of paraurethral glands |
| C68.8 |
Malignant neoplasm of overlapping sites of urinary organs |
| C68.9 |
Malignant neoplasm of urinary organ, unspecified |
| C7A.00 |
Malignant carcinoid tumor of unspecified site |
| C7A.090 |
Malignant carcinoid tumor of the bronchus and lung |
| C7A.091 |
Malignant carcinoid tumor of the thymus |
| C7A.092 |
Malignant carcinoid tumor of the stomach |
| C7A.093 |
Malignant carcinoid tumor of the kidney |
| C7A.094 |
Malignant carcinoid tumor of the foregut, unspecified |
| C7A.095 |
Malignant carcinoid tumor of the midgut, unspecified |
| C7A.096 |
Malignant carcinoid tumor of the hindgut, unspecified |
| C7A.098 |
Malignant carcinoid tumors of other sites |
| C7B.00 |
Secondary carcinoid tumors, unspecified site |
| C7B.01 |
Secondary carcinoid tumors of distant lymph nodes |
| C7B.02 |
Secondary carcinoid tumors of liver |
| C7B.03 |
Secondary carcinoid tumors of bone |
| C7B.04 |
Secondary carcinoid tumors of peritoneum |
| C7B.09 |
Secondary carcinoid tumors of other sites |
| C7B.1 |
Secondary Merkel cell carcinoma |
| C7B.8 |
Other secondary neuroendocrine tumors |
| C81.00 |
Nodular lymphocyte predominant Hodgkin lymphoma, unspecified site |
| C81.01 |
Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of head, face, and neck |
| C81.02 |
Nodular lymphocyte predominant Hodgkin lymphoma, intrathoracic lymph nodes |
| C81.03 |
Nodular lymphocyte predominant Hodgkin lymphoma, intra-abdominal lymph nodes |
| C81.04 |
Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of axilla and upper limb |
| C81.05 |
Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of inguinal region and lower limb |
| C81.06 |
Nodular lymphocyte predominant Hodgkin lymphoma, intrapelvic lymph nodes |
| C81.07 |
Nodular lymphocyte predominant Hodgkin lymphoma, spleen |
| C81.08 |
Nodular lymphocyte predominant Hodgkin lymphoma, lymph nodes of multiple sites |
| C81.09 |
Nodular lymphocyte predominant Hodgkin lymphoma, extranodal and solid organ sites |
| C81.10 |
Nodular sclerosis Hodgkin lymphoma, unspecified site |
| C81.11 |
Nodular sclerosis Hodgkin lymphoma, lymph nodes of head, face, and neck |
| C81.12 |
Nodular sclerosis Hodgkin lymphoma, intrathoracic lymph nodes |
| C81.13 |
Nodular sclerosis Hodgkin lymphoma, intra-abdominal lymph nodes |
| C81.14 |
Nodular sclerosis Hodgkin lymphoma, lymph nodes of axilla and upper limb |
| C81.15 |
Nodular sclerosis Hodgkin lymphoma, lymph nodes of inguinal region and lower limb |
| C81.16 |
Nodular sclerosis Hodgkin lymphoma, intrapelvic lymph nodes |
| C81.17 |
Nodular sclerosis Hodgkin lymphoma, spleen |
| C81.18 |
Nodular sclerosis Hodgkin lymphoma, lymph nodes of multiple sites |
| C81.19 |
Nodular sclerosis Hodgkin lymphoma, extranodal and solid organ sites |
| C81.20 |
Mixed cellularity Hodgkin lymphoma, unspecified site |
| C81.21 |
Mixed cellularity Hodgkin lymphoma, lymph nodes of head, face, and neck |
| C81.22 |
Mixed cellularity Hodgkin lymphoma, intrathoracic lymph nodes |
| C81.23 |
Mixed cellularity Hodgkin lymphoma, intra-abdominal lymph nodes |
| C81.24 |
Mixed cellularity Hodgkin lymphoma, lymph nodes of axilla and upper limb |
| C81.25 |
Mixed cellularity Hodgkin lymphoma, lymph nodes of inguinal region and lower limb |
| C81.26 |
Mixed cellularity Hodgkin lymphoma, intrapelvic lymph nodes |
| C81.27 |
Mixed cellularity Hodgkin lymphoma, spleen |
| C81.28 |
Mixed cellularity Hodgkin lymphoma, lymph nodes of multiple sites |
| C81.29 |
Mixed cellularity Hodgkin lymphoma, extranodal and solid organ sites |
| C81.30 |
Lymphocyte depleted Hodgkin lymphoma, unspecified site |
| C81.31 |
Lymphocyte depleted Hodgkin lymphoma, lymph nodes of head, face, and neck |
| C81.32 |
Lymphocyte depleted Hodgkin lymphoma, intrathoracic lymph nodes |
| C81.33 |
Lymphocyte depleted Hodgkin lymphoma, intra-abdominal lymph nodes |
| C81.34 |
Lymphocyte depleted Hodgkin lymphoma, lymph nodes of axilla and upper limb |
| C81.35 |
Lymphocyte depleted Hodgkin lymphoma, lymph nodes of inguinal region and lower limb |
| C81.36 |
Lymphocyte depleted Hodgkin lymphoma, intrapelvic lymph nodes |
| C81.37 |
Lymphocyte depleted Hodgkin lymphoma, spleen |
| C81.38 |
Lymphocyte depleted Hodgkin lymphoma, lymph nodes of multiple sites |
| C81.39 |
Lymphocyte depleted Hodgkin lymphoma, extranodal and solid organ sites |
| C81.40 |
Lymphocyte-rich Hodgkin lymphoma, unspecified site |
| C81.41 |
Lymphocyte-rich Hodgkin lymphoma, lymph nodes of head, face, and neck |
| C81.42 |
Lymphocyte-rich Hodgkin lymphoma, intrathoracic lymph nodes |
| C81.43 |
Lymphocyte-rich Hodgkin lymphoma, intra-abdominal lymph nodes |
| C81.44 |
Lymphocyte-rich Hodgkin lymphoma, lymph nodes of axilla and upper limb |
| C81.45 |
Lymphocyte-rich Hodgkin lymphoma, lymph nodes of inguinal region and lower limb |
| C81.46 |
Lymphocyte-rich Hodgkin lymphoma, intrapelvic lymph nodes |
| C81.47 |
Lymphocyte-rich Hodgkin lymphoma, spleen |
| C81.48 |
Lymphocyte-rich Hodgkin lymphoma, lymph nodes of multiple sites |
| C81.49 |
Lymphocyte-rich Hodgkin lymphoma, extranodal and solid organ sites |
| C81.70 |
Other Hodgkin lymphoma, unspecified site |
| C81.71 |
Other Hodgkin lymphoma, lymph nodes of head, face, and neck |
| C81.72 |
Other Hodgkin lymphoma, intrathoracic lymph nodes |
| C81.73 |
Other Hodgkin lymphoma, intra-abdominal lymph nodes |
| C81.74 |
Other Hodgkin lymphoma, lymph nodes of axilla and upper limb |
| C81.75 |
Other Hodgkin lymphoma, lymph nodes of inguinal region and lower limb |
| C81.76 |
Other Hodgkin lymphoma, intrapelvic lymph nodes |
| C81.77 |
Other Hodgkin lymphoma, spleen |
| C81.78 |
Other Hodgkin lymphoma, lymph nodes of multiple sites |
| C81.79 |
Other Hodgkin lymphoma, extranodal and solid organ sites |
| C81.90 |
Hodgkin lymphoma, unspecified, unspecified site |
| C81.91 |
Hodgkin lymphoma, unspecified, lymph nodes of head, face, and neck |
| C81.92 |
Hodgkin lymphoma, unspecified, intrathoracic lymph nodes |
| C81.93 |
Hodgkin lymphoma, unspecified, intra-abdominal lymph nodes |
| C81.94 |
Hodgkin lymphoma, unspecified, lymph nodes of axilla and upper limb |
| C81.95 |
Hodgkin lymphoma, unspecified, lymph nodes of inguinal region and lower limb |
| C81.96 |
Hodgkin lymphoma, unspecified, intrapelvic lymph nodes |
| C81.97 |
Hodgkin lymphoma, unspecified, spleen |
| C81.98 |
Hodgkin lymphoma, unspecified, lymph nodes of multiple sites |
| C81.99 |
Hodgkin lymphoma, unspecified, extranodal and solid organ sites |
| C82.00 |
Follicular lymphoma grade I, unspecified site |
| C82.01 |
Follicular lymphoma grade I, lymph nodes of head, face, and neck |
| C82.02 |
Follicular lymphoma grade I, intrathoracic lymph nodes |
| C82.03 |
Follicular lymphoma grade I, intra-abdominal lymph nodes |
| C82.04 |
Follicular lymphoma grade I, lymph nodes of axilla and upper limb |
| C82.05 |
Follicular lymphoma grade I, lymph nodes of inguinal region and lower limb |
| C82.06 |
Follicular lymphoma grade I, intrapelvic lymph nodes |
| C82.07 |
Follicular lymphoma grade I, spleen |
| C82.08 |
Follicular lymphoma grade I, lymph nodes of multiple sites |
| C82.09 |
Follicular lymphoma grade I, extranodal and solid organ sites |
| C82.10 |
Follicular lymphoma grade II, unspecified site |
| C82.11 |
Follicular lymphoma grade II, lymph nodes of head, face, and neck |
| C82.12 |
Follicular lymphoma grade II, intrathoracic lymph nodes |
| C82.13 |
Follicular lymphoma grade II, intra-abdominal lymph nodes |
| C82.14 |
Follicular lymphoma grade II, lymph nodes of axilla and upper limb |
| C82.15 |
Follicular lymphoma grade II, lymph nodes of inguinal region and lower limb |
| C82.16 |
Follicular lymphoma grade II, intrapelvic lymph nodes |
| C82.17 |
Follicular lymphoma grade II, spleen |
| C82.18 |
Follicular lymphoma grade II, lymph nodes of multiple sites |
| C82.19 |
Follicular lymphoma grade II, extranodal and solid organ sites |
| C82.20 |
Follicular lymphoma grade III, unspecified, unspecified site |
| C82.21 |
Follicular lymphoma grade III, unspecified, lymph nodes of head, face, and neck |
| C82.22 |
Follicular lymphoma grade III, unspecified, intrathoracic lymph nodes |
| C82.23 |
Follicular lymphoma grade III, unspecified, intra-abdominal lymph nodes |
| C82.24 |
Follicular lymphoma grade III, unspecified, lymph nodes of axilla and upper limb |
| C82.25 |
Follicular lymphoma grade III, unspecified, lymph nodes of inguinal region and lower limb |
| C82.26 |
Follicular lymphoma grade III, unspecified, intrapelvic lymph nodes |
| C82.27 |
Follicular lymphoma grade III, unspecified, spleen |
| C82.28 |
Follicular lymphoma grade III, unspecified, lymph nodes of multiple sites |
| C82.29 |
Follicular lymphoma grade III, unspecified, extranodal and solid organ sites |
| C82.30 |
Follicular lymphoma grade IIIa, unspecified site |
| C82.31 |
Follicular lymphoma grade IIIa, lymph nodes of head, face, and neck |
| C82.32 |
Follicular lymphoma grade IIIa, intrathoracic lymph nodes |
| C82.33 |
Follicular lymphoma grade IIIa, intra-abdominal lymph nodes |
| C82.34 |
Follicular lymphoma grade IIIa, lymph nodes of axilla and upper limb |
| C82.35 |
Follicular lymphoma grade IIIa, lymph nodes of inguinal region and lower limb |
| C82.36 |
Follicular lymphoma grade IIIa, intrapelvic lymph nodes |
| C82.37 |
Follicular lymphoma grade IIIa, spleen |
| C82.38 |
Follicular lymphoma grade IIIa, lymph nodes of multiple sites |
| C82.39 |
Follicular lymphoma grade IIIa, extranodal and solid organ sites |
| C82.40 |
Follicular lymphoma grade IIIb, unspecified site |
| C82.41 |
Follicular lymphoma grade IIIb, lymph nodes of head, face, and neck |
| C82.42 |
Follicular lymphoma grade IIIb, intrathoracic lymph nodes |
| C82.43 |
Follicular lymphoma grade IIIb, intra-abdominal lymph nodes |
| C82.44 |
Follicular lymphoma grade IIIb, lymph nodes of axilla and upper limb |
| C82.45 |
Follicular lymphoma grade IIIb, lymph nodes of inguinal region and lower limb |
| C82.46 |
Follicular lymphoma grade IIIb, intrapelvic lymph nodes |
| C82.47 |
Follicular lymphoma grade IIIb, spleen |
| C82.48 |
Follicular lymphoma grade IIIb, lymph nodes of multiple sites |
| C82.49 |
Follicular lymphoma grade IIIb, extranodal and solid organ sites |
| C82.50 |
Diffuse follicle center lymphoma, unspecified site |
| C82.51 |
Diffuse follicle center lymphoma, lymph nodes of head, face, and neck |
| C82.52 |
Diffuse follicle center lymphoma, intrathoracic lymph nodes |
| C82.53 |
Diffuse follicle center lymphoma, intra-abdominal lymph nodes |
| C82.54 |
Diffuse follicle center lymphoma, lymph nodes of axilla and upper limb |
| C82.55 |
Diffuse follicle center lymphoma, lymph nodes of inguinal region and lower limb |
| C82.56 |
Diffuse follicle center lymphoma, intrapelvic lymph nodes |
| C82.57 |
Diffuse follicle center lymphoma, spleen |
| C82.58 |
Diffuse follicle center lymphoma, lymph nodes of multiple sites |
| C82.59 |
Diffuse follicle center lymphoma, extranodal and solid organ sites |
| C82.60 |
Cutaneous follicle center lymphoma, unspecified site |
| C82.61 |
Cutaneous follicle center lymphoma, lymph nodes of head, face, and neck |
| C82.62 |
Cutaneous follicle center lymphoma, intrathoracic lymph nodes |
| C82.63 |
Cutaneous follicle center lymphoma, intra-abdominal lymph nodes |
| C82.64 |
Cutaneous follicle center lymphoma, lymph nodes of axilla and upper limb |
| C82.65 |
Cutaneous follicle center lymphoma, lymph nodes of inguinal region and lower limb |
| C82.66 |
Cutaneous follicle center lymphoma, intrapelvic lymph nodes |
| C82.67 |
Cutaneous follicle center lymphoma, spleen |
| C82.68 |
Cutaneous follicle center lymphoma, lymph nodes of multiple sites |
| C82.69 |
Cutaneous follicle center lymphoma, extranodal and solid organ sites |
| C82.80 |
Other types of follicular lymphoma, unspecified site |
| C82.81 |
Other types of follicular lymphoma, lymph nodes of head, face, and neck |
| C82.82 |
Other types of follicular lymphoma, intrathoracic lymph nodes |
| C82.83 |
Other types of follicular lymphoma, intra-abdominal lymph nodes |
| C82.84 |
Other types of follicular lymphoma, lymph nodes of axilla and upper limb |
| C82.85 |
Other types of follicular lymphoma, lymph nodes of inguinal region and lower limb |
| C82.86 |
Other types of follicular lymphoma, intrapelvic lymph nodes |
| C82.87 |
Other types of follicular lymphoma, spleen |
| C82.88 |
Other types of follicular lymphoma, lymph nodes of multiple sites |
| C82.89 |
Other types of follicular lymphoma, extranodal and solid organ sites |
| C82.90 |
Follicular lymphoma, unspecified, unspecified site |
| C82.91 |
Follicular lymphoma, unspecified, lymph nodes of head, face, and neck |
| C82.92 |
Follicular lymphoma, unspecified, intrathoracic lymph nodes |
| C82.93 |
Follicular lymphoma, unspecified, intra-abdominal lymph nodes |
| C82.94 |
Follicular lymphoma, unspecified, lymph nodes of axilla and upper limb |
| C82.95 |
Follicular lymphoma, unspecified, lymph nodes of inguinal region and lower limb |
| C82.96 |
Follicular lymphoma, unspecified, intrapelvic lymph nodes |
| C82.97 |
Follicular lymphoma, unspecified, spleen |
| C82.98 |
Follicular lymphoma, unspecified, lymph nodes of multiple sites |
| C82.99 |
Follicular lymphoma, unspecified, extranodal and solid organ sites |
| C83.00 |
Small cell B-cell lymphoma, unspecified site |
| C83.01 |
Small cell B-cell lymphoma, lymph nodes of head, face, and neck |
| C83.02 |
Small cell B-cell lymphoma, intrathoracic lymph nodes |
| C83.03 |
Small cell B-cell lymphoma, intra-abdominal lymph nodes |
| C83.04 |
Small cell B-cell lymphoma, lymph nodes of axilla and upper limb |
| C83.05 |
Small cell B-cell lymphoma, lymph nodes of inguinal region and lower limb |
| C83.06 |
Small cell B-cell lymphoma, intrapelvic lymph nodes |
| C83.07 |
Small cell B-cell lymphoma, spleen |
| C83.08 |
Small cell B-cell lymphoma, lymph nodes of multiple sites |
| C83.09 |
Small cell B-cell lymphoma, extranodal and solid organ sites |
| C83.10 |
Mantle cell lymphoma, unspecified site |
| C83.11 |
Mantle cell lymphoma, lymph nodes of head, face, and neck |
| C83.12 |
Mantle cell lymphoma, intrathoracic lymph nodes |
| C83.13 |
Mantle cell lymphoma, intra-abdominal lymph nodes |
| C83.14 |
Mantle cell lymphoma, lymph nodes of axilla and upper limb |
| C83.15 |
Mantle cell lymphoma, lymph nodes of inguinal region and lower limb |
| C83.16 |
Mantle cell lymphoma, intrapelvic lymph nodes |
| C83.17 |
Mantle cell lymphoma, spleen |
| C83.18 |
Mantle cell lymphoma, lymph nodes of multiple sites |
| C83.19 |
Mantle cell lymphoma, extranodal and solid organ sites |
| C83.30 |
Diffuse large B-cell lymphoma, unspecified site |
| C83.31 |
Diffuse large B-cell lymphoma, lymph nodes of head, face, and neck |
| C83.32 |
Diffuse large B-cell lymphoma, intrathoracic lymph nodes |
| C83.33 |
Diffuse large B-cell lymphoma, intra-abdominal lymph nodes |
| C83.34 |
Diffuse large B-cell lymphoma, lymph nodes of axilla and upper limb |
| C83.35 |
Diffuse large B-cell lymphoma, lymph nodes of inguinal region and lower limb |
| C83.36 |
Diffuse large B-cell lymphoma, intrapelvic lymph nodes |
| C83.37 |
Diffuse large B-cell lymphoma, spleen |
| C83.38 |
Diffuse large B-cell lymphoma, lymph nodes of multiple sites |
| C83.390 |
Primary central nervous system lymphoma |
| C83.398 |
Diffuse large B-cell lymphoma of other extranodal and solid organ sites |
| C83.50 |
Lymphoblastic (diffuse) lymphoma, unspecified site |
| C83.51 |
Lymphoblastic (diffuse) lymphoma, lymph nodes of head, face, and neck |
| C83.52 |
Lymphoblastic (diffuse) lymphoma, intrathoracic lymph nodes |
| C83.53 |
Lymphoblastic (diffuse) lymphoma, intra-abdominal lymph nodes |
| C83.54 |
Lymphoblastic (diffuse) lymphoma, lymph nodes of axilla and upper limb |
| C83.55 |
Lymphoblastic (diffuse) lymphoma, lymph nodes of inguinal region and lower limb |
| C83.56 |
Lymphoblastic (diffuse) lymphoma, intrapelvic lymph nodes |
| C83.57 |
Lymphoblastic (diffuse) lymphoma, spleen |
| C83.58 |
Lymphoblastic (diffuse) lymphoma, lymph nodes of multiple sites |
| C83.59 |
Lymphoblastic (diffuse) lymphoma, extranodal and solid organ sites |
| C83.70 |
Burkitt lymphoma, unspecified site |
| C83.71 |
Burkitt lymphoma, lymph nodes of head, face, and neck |
| C83.72 |
Burkitt lymphoma, intrathoracic lymph nodes |
| C83.73 |
Burkitt lymphoma, intra-abdominal lymph nodes |
| C83.74 |
Burkitt lymphoma, lymph nodes of axilla and upper limb |
| C83.75 |
Burkitt lymphoma, lymph nodes of inguinal region and lower limb |
| C83.76 |
Burkitt lymphoma, intrapelvic lymph nodes |
| C83.77 |
Burkitt lymphoma, spleen |
| C83.78 |
Burkitt lymphoma, lymph nodes of multiple sites |
| C83.79 |
Burkitt lymphoma, extranodal and solid organ sites |
| C83.80 |
Other non-follicular lymphoma, unspecified site |
| C83.81 |
Other non-follicular lymphoma, lymph nodes of head, face, and neck |
| C83.82 |
Other non-follicular lymphoma, intrathoracic lymph nodes |
| C83.83 |
Other non-follicular lymphoma, intra-abdominal lymph nodes |
| C83.84 |
Other non-follicular lymphoma, lymph nodes of axilla and upper limb |
| C83.85 |
Other non-follicular lymphoma, lymph nodes of inguinal region and lower limb |
| C83.86 |
Other non-follicular lymphoma, intrapelvic lymph nodes |
| C83.87 |
Other non-follicular lymphoma, spleen |
| C83.88 |
Other non-follicular lymphoma, lymph nodes of multiple sites |
| C83.89 |
Other non-follicular lymphoma, extranodal and solid organ sites |
| C83.90 |
Non-follicular (diffuse) lymphoma, unspecified, unspecified site |
| C83.91 |
Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of head, face, and neck |
| C83.92 |
Non-follicular (diffuse) lymphoma, unspecified, intrathoracic lymph nodes |
| C83.93 |
Non-follicular (diffuse) lymphoma, unspecified, intra-abdominal lymph nodes |
| C83.94 |
Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of axilla and upper limb |
| C83.95 |
Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of inguinal region and lower limb |
| C83.96 |
Non-follicular (diffuse) lymphoma, unspecified, intrapelvic lymph nodes |
| C83.97 |
Non-follicular (diffuse) lymphoma, unspecified, spleen |
| C83.98 |
Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of multiple sites |
| C83.99 |
Non-follicular (diffuse) lymphoma, unspecified, extranodal and solid organ sites |
| C84.00 |
Mycosis fungoides, unspecified site |
| C84.01 |
Mycosis fungoides, lymph nodes of head, face, and neck |
| C84.02 |
Mycosis fungoides, intrathoracic lymph nodes |
| C84.03 |
Mycosis fungoides, intra-abdominal lymph nodes |
| C84.04 |
Mycosis fungoides, lymph nodes of axilla and upper limb |
| C84.05 |
Mycosis fungoides, lymph nodes of inguinal region and lower limb |
| C84.06 |
Mycosis fungoides, intrapelvic lymph nodes |
| C84.07 |
Mycosis fungoides, spleen |
| C84.08 |
Mycosis fungoides, lymph nodes of multiple sites |
| C84.09 |
Mycosis fungoides, extranodal and solid organ sites |
| C84.10 |
Sezary disease, unspecified site |
| C84.11 |
Sezary disease, lymph nodes of head, face, and neck |
| C84.12 |
Sezary disease, intrathoracic lymph nodes |
| C84.13 |
Sezary disease, intra-abdominal lymph nodes |
| C84.14 |
Sezary disease, lymph nodes of axilla and upper limb |
| C84.15 |
Sezary disease, lymph nodes of inguinal region and lower limb |
| C84.16 |
Sezary disease, intrapelvic lymph nodes |
| C84.17 |
Sezary disease, spleen |
| C84.18 |
Sezary disease, lymph nodes of multiple sites |
| C84.19 |
Sezary disease, extranodal and solid organ sites |
| C84.40 |
Peripheral T-cell lymphoma, not elsewhere classified, unspecified site |
| C84.41 |
Peripheral T-cell lymphoma, not elsewhere classified, lymph nodes of head, face, and neck |
| C84.42 |
Peripheral T-cell lymphoma, not elsewhere classified, intrathoracic lymph nodes |
| C84.43 |
Peripheral T-cell lymphoma, not elsewhere classified, intra-abdominal lymph nodes |
| C84.44 |
Peripheral T-cell lymphoma, not elsewhere classified, lymph nodes of axilla and upper limb |
| C84.45 |
Peripheral T-cell lymphoma, not elsewhere classified, lymph nodes of inguinal region and lower limb |
| C84.46 |
Peripheral T-cell lymphoma, not elsewhere classified, intrapelvic lymph nodes |
| C84.47 |
Peripheral T-cell lymphoma, not elsewhere classified, spleen |
| C84.48 |
Peripheral T-cell lymphoma, not elsewhere classified, lymph nodes of multiple sites |
| C84.49 |
Peripheral T-cell lymphoma, not elsewhere classified, extranodal and solid organ sites |
| C84.60 |
Anaplastic large cell lymphoma, ALK-positive, unspecified site |
| C84.61 |
Anaplastic large cell lymphoma, ALK-positive, lymph nodes of head, face, and neck |
| C84.62 |
Anaplastic large cell lymphoma, ALK-positive, intrathoracic lymph nodes |
| C84.63 |
Anaplastic large cell lymphoma, ALK-positive, intra-abdominal lymph nodes |
| C84.64 |
Anaplastic large cell lymphoma, ALK-positive, lymph nodes of axilla and upper limb |
| C84.65 |
Anaplastic large cell lymphoma, ALK-positive, lymph nodes of inguinal region and lower limb |
| C84.66 |
Anaplastic large cell lymphoma, ALK-positive, intrapelvic lymph nodes |
| C84.67 |
Anaplastic large cell lymphoma, ALK-positive, spleen |
| C84.68 |
Anaplastic large cell lymphoma, ALK-positive, lymph nodes of multiple sites |
| C84.69 |
Anaplastic large cell lymphoma, ALK-positive, extranodal and solid organ sites |
| C84.70 |
Anaplastic large cell lymphoma, ALK-negative, unspecified site |
| C84.71 |
Anaplastic large cell lymphoma, ALK-negative, lymph nodes of head, face, and neck |
| C84.72 |
Anaplastic large cell lymphoma, ALK-negative, intrathoracic lymph nodes |
| C84.73 |
Anaplastic large cell lymphoma, ALK-negative, intra-abdominal lymph nodes |
| C84.74 |
Anaplastic large cell lymphoma, ALK-negative, lymph nodes of axilla and upper limb |
| C84.75 |
Anaplastic large cell lymphoma, ALK-negative, lymph nodes of inguinal region and lower limb |
| C84.76 |
Anaplastic large cell lymphoma, ALK-negative, intrapelvic lymph nodes |
| C84.77 |
Anaplastic large cell lymphoma, ALK-negative, spleen |
| C84.78 |
Anaplastic large cell lymphoma, ALK-negative, lymph nodes of multiple sites |
| C84.79 |
Anaplastic large cell lymphoma, ALK-negative, extranodal and solid organ sites |
| C84.90 |
Mature T/NK-cell lymphomas, unspecified, unspecified site |
| C84.91 |
Mature T/NK-cell lymphomas, unspecified, lymph nodes of head, face, and neck |
| C84.92 |
Mature T/NK-cell lymphomas, unspecified, intrathoracic lymph nodes |
| C84.93 |
Mature T/NK-cell lymphomas, unspecified, intra-abdominal lymph nodes |
| C84.94 |
Mature T/NK-cell lymphomas, unspecified, lymph nodes of axilla and upper limb |
| C84.95 |
Mature T/NK-cell lymphomas, unspecified, lymph nodes of inguinal region and lower limb |
| C84.96 |
Mature T/NK-cell lymphomas, unspecified, intrapelvic lymph nodes |
| C84.97 |
Mature T/NK-cell lymphomas, unspecified, spleen |
| C84.98 |
Mature T/NK-cell lymphomas, unspecified, lymph nodes of multiple sites |
| C84.99 |
Mature T/NK-cell lymphomas, unspecified, extranodal and solid organ sites |
| C84.A0 |
Cutaneous T-cell lymphoma, unspecified, unspecified site |
| C84.A1 |
Cutaneous T-cell lymphoma, unspecified lymph nodes of head, face, and neck |
| C84.A2 |
Cutaneous T-cell lymphoma, unspecified, intrathoracic lymph nodes |
| C84.A3 |
Cutaneous T-cell lymphoma, unspecified, intra-abdominal lymph nodes |
| C84.A4 |
Cutaneous T-cell lymphoma, unspecified, lymph nodes of axilla and upper limb |
| C84.A5 |
Cutaneous T-cell lymphoma, unspecified, lymph nodes of inguinal region and lower limb |
| C84.A6 |
Cutaneous T-cell lymphoma, unspecified, intrapelvic lymph nodes |
| C84.A7 |
Cutaneous T-cell lymphoma, unspecified, spleen |
| C84.A8 |
Cutaneous T-cell lymphoma, unspecified, lymph nodes of multiple sites |
| C84.A9 |
Cutaneous T-cell lymphoma, unspecified, extranodal and solid organ sites |
| C84.Z0 |
Other mature T/NK-cell lymphomas, unspecified site |
| C84.Z1 |
Other mature T/NK-cell lymphomas, lymph nodes of head, face, and neck |
| C84.Z2 |
Other mature T/NK-cell lymphomas, intrathoracic lymph nodes |
| C84.Z3 |
Other mature T/NK-cell lymphomas, intra-abdominal lymph nodes |
| C84.Z4 |
Other mature T/NK-cell lymphomas, lymph nodes of axilla and upper limb |
| C84.Z5 |
Other mature T/NK-cell lymphomas, lymph nodes of inguinal region and lower limb |
| C84.Z6 |
Other mature T/NK-cell lymphomas, intrapelvic lymph nodes |
| C84.Z7 |
Other mature T/NK-cell lymphomas, spleen |
| C84.Z8 |
Other mature T/NK-cell lymphomas, lymph nodes of multiple sites |
| C84.Z9 |
Other mature T/NK-cell lymphomas, extranodal and solid organ sites |
| C85.10 |
Unspecified B-cell lymphoma, unspecified site |
| C85.11 |
Unspecified B-cell lymphoma, lymph nodes of head, face, and neck |
| C85.12 |
Unspecified B-cell lymphoma, intrathoracic lymph nodes |
| C85.13 |
Unspecified B-cell lymphoma, intra-abdominal lymph nodes |
| C85.14 |
Unspecified B-cell lymphoma, lymph nodes of axilla and upper limb |
| C85.15 |
Unspecified B-cell lymphoma, lymph nodes of inguinal region and lower limb |
| C85.16 |
Unspecified B-cell lymphoma, intrapelvic lymph nodes |
| C85.17 |
Unspecified B-cell lymphoma, spleen |
| C85.18 |
Unspecified B-cell lymphoma, lymph nodes of multiple sites |
| C85.19 |
Unspecified B-cell lymphoma, extranodal and solid organ sites |
| C85.20 |
Mediastinal (thymic) large B-cell lymphoma, unspecified site |
| C85.21 |
Mediastinal (thymic) large B-cell lymphoma, lymph nodes of head, face, and neck |
| C85.22 |
Mediastinal (thymic) large B-cell lymphoma, intrathoracic lymph nodes |
| C85.23 |
Mediastinal (thymic) large B-cell lymphoma, intra-abdominal lymph nodes |
| C85.24 |
Mediastinal (thymic) large B-cell lymphoma, lymph nodes of axilla and upper limb |
| C85.25 |
Mediastinal (thymic) large B-cell lymphoma, lymph nodes of inguinal region and lower limb |
| C85.26 |
Mediastinal (thymic) large B-cell lymphoma, intrapelvic lymph nodes |
| C85.27 |
Mediastinal (thymic) large B-cell lymphoma, spleen |
| C85.28 |
Mediastinal (thymic) large B-cell lymphoma, lymph nodes of multiple sites |
| C85.29 |
Mediastinal (thymic) large B-cell lymphoma, extranodal and solid organ sites |
| C85.80 |
Other specified types of non-Hodgkin lymphoma, unspecified site |
| C85.81 |
Other specified types of non-Hodgkin lymphoma, lymph nodes of head, face, and neck |
| C85.82 |
Other specified types of non-Hodgkin lymphoma, intrathoracic lymph nodes |
| C85.83 |
Other specified types of non-Hodgkin lymphoma, intra-abdominal lymph nodes |
| C85.84 |
Other specified types of non-Hodgkin lymphoma, lymph nodes of axilla and upper limb |
| C85.85 |
Other specified types of non-Hodgkin lymphoma, lymph nodes of inguinal region and lower limb |
| C85.86 |
Other specified types of non-Hodgkin lymphoma, intrapelvic lymph nodes |
| C85.87 |
Other specified types of non-Hodgkin lymphoma, spleen |
| C85.88 |
Other specified types of non-Hodgkin lymphoma, lymph nodes of multiple sites |
| C85.89 |
Other specified types of non-Hodgkin lymphoma, extranodal and solid organ sites |
| C85.90 |
Non-Hodgkin lymphoma, unspecified, unspecified site |
| C85.91 |
Non-Hodgkin lymphoma, unspecified, lymph nodes of head, face, and neck |
| C85.92 |
Non-Hodgkin lymphoma, unspecified, intrathoracic lymph nodes |
| C85.93 |
Non-Hodgkin lymphoma, unspecified, intra-abdominal lymph nodes |
| C85.94 |
Non-Hodgkin lymphoma, unspecified, lymph nodes of axilla and upper limb |
| C85.95 |
Non-Hodgkin lymphoma, unspecified, lymph nodes of inguinal region and lower limb |
| C85.96 |
Non-Hodgkin lymphoma, unspecified, intrapelvic lymph nodes |
| C85.97 |
Non-Hodgkin lymphoma, unspecified, spleen |
| C85.98 |
Non-Hodgkin lymphoma, unspecified, lymph nodes of multiple sites |
| C85.99 |
Non-Hodgkin lymphoma, unspecified, extranodal and solid organ sites |
| C86.00 |
Extranodal NK/T-cell lymphoma, nasal type not having achieved remission |
| C86.01 |
Extranodal NK/T-cell lymphoma, nasal type, in remission |
| C86.10 |
Hepatosplenic T-cell lymphoma not having achieved remission |
| C86.11 |
Hepatosplenic T-cell lymphoma, in remission |
| C86.20 |
Enteropathy-type (intestinal) T-cell lymphoma not having achieved remission |
| C86.21 |
Enteropathy-type (intestinal) T-cell lymphoma, in remission |
| C86.30 |
Subcutaneous panniculitis-like T-cell lymphoma not having achieved remission |
| C86.31 |
Subcutaneous panniculitis-like T-cell lymphoma, in remission |
| C86.40 |
Blastic NK-cell lymphoma not having achieved remission |
| C86.41 |
Blastic NK-cell lymphoma, in remission |
| C86.50 |
Angioimmunoblastic T-cell lymphoma not having achieved remission |
| C86.51 |
Angioimmunoblastic T-cell lymphoma, in remission |
| C86.60 |
Primary cutaneous CD30-positive T-cell proliferations not having achieved remission |
| C86.61 |
Primary cutaneous CD30-positive T-cell proliferations, in remission |
| C88.20 |
Heavy chain disease not having achieved remission |
| C88.21 |
Heavy chain disease, in remission |
| C88.30 |
Immunoproliferative small intestinal disease not having achieved remission |
| C88.31 |
Immunoproliferative small intestinal disease, in remission |
| C88.40 |
Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma] not having achieved remission |
| C88.41 |
Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma], in remission |
| C88.80 |
Other malignant immunoproliferative diseases not having achieved remission |
| C88.81 |
Other malignant immunoproliferative diseases, in remission |
| C88.90 |
Malignant immunoproliferative disease, unspecified not having achieved remission |
| C88.91 |
Malignant immunoproliferative disease, unspecified, in remission |
| C90.00 |
Multiple myeloma not having achieved remission |
| C90.01 |
Multiple myeloma in remission |
| C90.02 |
Multiple myeloma in relapse |
| C90.10 |
Plasma cell leukemia not having achieved remission |
| C90.11 |
Plasma cell leukemia in remission |
| C90.12 |
Plasma cell leukemia in relapse |
| C90.20 |
Extramedullary plasmacytoma not having achieved remission |
| C90.21 |
Extramedullary plasmacytoma in remission |
| C90.22 |
Extramedullary plasmacytoma in relapse |
| C90.30 |
Solitary plasmacytoma not having achieved remission |
| C90.31 |
Solitary plasmacytoma in remission |
| C90.32 |
Solitary plasmacytoma in relapse |
| C91.00 |
Acute lymphoblastic leukemia not having achieved remission |
| C91.01 |
Acute lymphoblastic leukemia, in remission |
| C91.02 |
Acute lymphoblastic leukemia, in relapse |
| C91.10 |
Chronic lymphocytic leukemia of B-cell type not having achieved remission |
| C91.11 |
Chronic lymphocytic leukemia of B-cell type in remission |
| C91.12 |
Chronic lymphocytic leukemia of B-cell type in relapse |
| C91.30 |
Prolymphocytic leukemia of B-cell type not having achieved remission |
| C91.31 |
Prolymphocytic leukemia of B-cell type, in remission |
| C91.32 |
Prolymphocytic leukemia of B-cell type, in relapse |
| C91.40 |
Hairy cell leukemia not having achieved remission |
| C91.41 |
Hairy cell leukemia, in remission |
| C91.42 |
Hairy cell leukemia, in relapse |
| C91.50 |
Adult T-cell lymphoma/leukemia (HTLV-1-associated) not having achieved remission |
| C91.51 |
Adult T-cell lymphoma/leukemia (HTLV-1-associated), in remission |
| C91.52 |
Adult T-cell lymphoma/leukemia (HTLV-1-associated), in relapse |
| C91.60 |
Prolymphocytic leukemia of T-cell type not having achieved remission |
| C91.61 |
Prolymphocytic leukemia of T-cell type, in remission |
| C91.62 |
Prolymphocytic leukemia of T-cell type, in relapse |
| C91.90 |
Lymphoid leukemia, unspecified not having achieved remission |
| C91.91 |
Lymphoid leukemia, unspecified, in remission |
| C91.92 |
Lymphoid leukemia, unspecified, in relapse |
| C91.A0 |
Mature B-cell leukemia Burkitt-type not having achieved remission |
| C91.A1 |
Mature B-cell leukemia Burkitt-type, in remission |
| C91.A2 |
Mature B-cell leukemia Burkitt-type, in relapse |
| C91.Z0 |
Other lymphoid leukemia not having achieved remission |
| C91.Z1 |
Other lymphoid leukemia, in remission |
| C91.Z2 |
Other lymphoid leukemia, in relapse |
| C92.00 |
Acute myeloblastic leukemia, not having achieved remission |
| C92.01 |
Acute myeloblastic leukemia, in remission |
| C92.02 |
Acute myeloblastic leukemia, in relapse |
| C92.10 |
Chronic myeloid leukemia, BCR/ABL-positive, not having achieved remission |
| C92.11 |
Chronic myeloid leukemia, BCR/ABL-positive, in remission |
| C92.12 |
Chronic myeloid leukemia, BCR/ABL-positive, in relapse |
| C92.20 |
Atypical chronic myeloid leukemia, BCR/ABL-negative, not having achieved remission |
| C92.21 |
Atypical chronic myeloid leukemia, BCR/ABL-negative, in remission |
| C92.22 |
Atypical chronic myeloid leukemia, BCR/ABL-negative, in relapse |
| C92.30 |
Myeloid sarcoma, not having achieved remission |
| C92.31 |
Myeloid sarcoma, in remission |
| C92.32 |
Myeloid sarcoma, in relapse |
| C92.40 |
Acute promyelocytic leukemia, not having achieved remission |
| C92.41 |
Acute promyelocytic leukemia, in remission |
| C92.42 |
Acute promyelocytic leukemia, in relapse |
| C92.50 |
Acute myelomonocytic leukemia, not having achieved remission |
| C92.51 |
Acute myelomonocytic leukemia, in remission |
| C92.52 |
Acute myelomonocytic leukemia, in relapse |
| C92.60 |
Acute myeloid leukemia with 11q23-abnormality not having achieved remission |
| C92.61 |
Acute myeloid leukemia with 11q23-abnormality in remission |
| C92.62 |
Acute myeloid leukemia with 11q23-abnormality in relapse |
| C92.90 |
Myeloid leukemia, unspecified, not having achieved remission |
| C92.91 |
Myeloid leukemia, unspecified in remission |
| C92.92 |
Myeloid leukemia, unspecified in relapse |
| C92.A0 |
Acute myeloid leukemia with multilineage dysplasia, not having achieved remission |
| C92.A1 |
Acute myeloid leukemia with multilineage dysplasia, in remission |
| C92.A2 |
Acute myeloid leukemia with multilineage dysplasia, in relapse |
| C92.Z0 |
Other myeloid leukemia not having achieved remission |
| C92.Z1 |
Other myeloid leukemia, in remission |
| C92.Z2 |
Other myeloid leukemia, in relapse |
| C93.00 |
Acute monoblastic/monocytic leukemia, not having achieved remission |
| C93.01 |
Acute monoblastic/monocytic leukemia, in remission |
| C93.02 |
Acute monoblastic/monocytic leukemia, in relapse |
| C93.10 |
Chronic myelomonocytic leukemia not having achieved remission |
| C93.11 |
Chronic myelomonocytic leukemia, in remission |
| C93.12 |
Chronic myelomonocytic leukemia, in relapse |
| C93.30 |
Juvenile myelomonocytic leukemia, not having achieved remission |
| C93.31 |
Juvenile myelomonocytic leukemia, in remission |
| C93.32 |
Juvenile myelomonocytic leukemia, in relapse |
| C93.90 |
Monocytic leukemia, unspecified, not having achieved remission |
| C93.91 |
Monocytic leukemia, unspecified in remission |
| C93.92 |
Monocytic leukemia, unspecified in relapse |
| C93.Z0 |
Other monocytic leukemia, not having achieved remission |
| C93.Z1 |
Other monocytic leukemia, in remission |
| C93.Z2 |
Other monocytic leukemia, in relapse |
| C94.00 |
Acute erythroid leukemia, not having achieved remission |
| C94.01 |
Acute erythroid leukemia, in remission |
| C94.02 |
Acute erythroid leukemia, in relapse |
| C94.20 |
Acute megakaryoblastic leukemia not having achieved remission |
| C94.21 |
Acute megakaryoblastic leukemia, in remission |
| C94.22 |
Acute megakaryoblastic leukemia, in relapse |
| C94.30 |
Mast cell leukemia not having achieved remission |
| C94.31 |
Mast cell leukemia, in remission |
| C94.32 |
Mast cell leukemia, in relapse |
| C94.40 |
Acute panmyelosis with myelofibrosis not having achieved remission |
| C94.41 |
Acute panmyelosis with myelofibrosis, in remission |
| C94.42 |
Acute panmyelosis with myelofibrosis, in relapse |
| C94.6 |
Myelodysplastic disease, not elsewhere classified |
| C94.80 |
Other specified leukemias not having achieved remission |
| C94.81 |
Other specified leukemias, in remission |
| C94.82 |
Other specified leukemias, in relapse |
| C95.00 |
Acute leukemia of unspecified cell type not having achieved remission |
| C95.01 |
Acute leukemia of unspecified cell type, in remission |
| C95.02 |
Acute leukemia of unspecified cell type, in relapse |
| C95.10 |
Chronic leukemia of unspecified cell type not having achieved remission |
| C95.11 |
Chronic leukemia of unspecified cell type, in remission |
| C95.12 |
Chronic leukemia of unspecified cell type, in relapse |
| C95.90 |
Leukemia, unspecified not having achieved remission |
| C95.91 |
Leukemia, unspecified, in remission |
| C95.92 |
Leukemia, unspecified, in relapse |
| C96.0 |
Multifocal and multisystemic (disseminated) Langerhans-cell histiocytosis |
| C96.4 |
Sarcoma of dendritic cells (accessory cells) |
| C96.9 |
Malignant neoplasm of lymphoid, hematopoietic and related tissue, unspecified |
| C96.A |
Histiocytic sarcoma |
| C96.Z |
Other specified malignant neoplasms of lymphoid, hematopoietic and related tissue |
| D01.40 |
Carcinoma in situ of unspecified part of intestine |
| D01.49 |
Carcinoma in situ of other parts of intestine |
| D01.5 |
Carcinoma in situ of liver, gallbladder and bile ducts |
| D01.7 |
Carcinoma in situ of other specified digestive organs |
| D01.9 |
Carcinoma in situ of digestive organ, unspecified |
| D03.0 |
Melanoma in situ of lip |
| D03.10 |
Melanoma in situ of unspecified eyelid, including canthus |
| D03.111 |
Melanoma in situ of right upper eyelid, including canthus |
| D03.112 |
Melanoma in situ of right lower eyelid, including canthus |
| D03.121 |
Melanoma in situ of left upper eyelid, including canthus |
| D03.122 |
Melanoma in situ of left lower eyelid, including canthus |
| D03.20 |
Melanoma in situ of unspecified ear and external auricular canal |
| D03.21 |
Melanoma in situ of right ear and external auricular canal |
| D03.22 |
Melanoma in situ of left ear and external auricular canal |
| D03.30 |
Melanoma in situ of unspecified part of face |
| D03.39 |
Melanoma in situ of other parts of face |
| D03.4 |
Melanoma in situ of scalp and neck |
| D03.51 |
Melanoma in situ of anal skin |
| D03.52 |
Melanoma in situ of breast (skin) (soft tissue) |
| D03.59 |
Melanoma in situ of other part of trunk |
| D03.60 |
Melanoma in situ of unspecified upper limb, including shoulder |
| D03.61 |
Melanoma in situ of right upper limb, including shoulder |
| D03.62 |
Melanoma in situ of left upper limb, including shoulder |
| D03.70 |
Melanoma in situ of unspecified lower limb, including hip |
| D03.71 |
Melanoma in situ of right lower limb, including hip |
| D03.72 |
Melanoma in situ of left lower limb, including hip |
| D03.8 |
Melanoma in situ of other sites |
| D03.9 |
Melanoma in situ, unspecified |
| D13.4 |
Benign neoplasm of liver |
| D13.5 |
Benign neoplasm of extrahepatic bile ducts |
| D13.6 |
Benign neoplasm of pancreas |
| D13.7 |
Benign neoplasm of endocrine pancreas |
| D18.03 |
Hemangioma of intra-abdominal structures |
| D37.01 |
Neoplasm of uncertain behavior of lip |
| D37.02 |
Neoplasm of uncertain behavior of tongue |
| D37.030 |
Neoplasm of uncertain behavior of the parotid salivary glands |
| D37.031 |
Neoplasm of uncertain behavior of the sublingual salivary glands |
| D37.032 |
Neoplasm of uncertain behavior of the submandibular salivary glands |
| D37.039 |
Neoplasm of uncertain behavior of the major salivary glands, unspecified |
| D37.04 |
Neoplasm of uncertain behavior of the minor salivary glands |
| D37.05 |
Neoplasm of uncertain behavior of pharynx |
| D37.09 |
Neoplasm of uncertain behavior of other specified sites of the oral cavity |
| D37.1 |
Neoplasm of uncertain behavior of stomach |
| D37.2 |
Neoplasm of uncertain behavior of small intestine |
| D37.3 |
Neoplasm of uncertain behavior of appendix |
| D37.4 |
Neoplasm of uncertain behavior of colon |
| D37.5 |
Neoplasm of uncertain behavior of rectum |
| D37.6 |
Neoplasm of uncertain behavior of liver, gallbladder and bile ducts |
| D37.8 |
Neoplasm of uncertain behavior of other specified digestive organs |
| D37.9 |
Neoplasm of uncertain behavior of digestive organ, unspecified |
| D38.0 |
Neoplasm of uncertain behavior of larynx |
| D38.1 |
Neoplasm of uncertain behavior of trachea, bronchus and lung |
| D38.2 |
Neoplasm of uncertain behavior of pleura |
| D38.3 |
Neoplasm of uncertain behavior of mediastinum |
| D38.4 |
Neoplasm of uncertain behavior of thymus |
| D38.5 |
Neoplasm of uncertain behavior of other respiratory organs |
| D38.6 |
Neoplasm of uncertain behavior of respiratory organ, unspecified |
| D39.0 |
Neoplasm of uncertain behavior of uterus |
| D39.10 |
Neoplasm of uncertain behavior of unspecified ovary |
| D39.11 |
Neoplasm of uncertain behavior of right ovary |
| D39.12 |
Neoplasm of uncertain behavior of left ovary |
| D39.2 |
Neoplasm of uncertain behavior of placenta |
| D39.8 |
Neoplasm of uncertain behavior of other specified female genital organs |
| D39.9 |
Neoplasm of uncertain behavior of female genital organ, unspecified |
| D40.0 |
Neoplasm of uncertain behavior of prostate |
| D40.10 |
Neoplasm of uncertain behavior of unspecified testis |
| D40.11 |
Neoplasm of uncertain behavior of right testis |
| D40.12 |
Neoplasm of uncertain behavior of left testis |
| D40.8 |
Neoplasm of uncertain behavior of other specified male genital organs |
| D40.9 |
Neoplasm of uncertain behavior of male genital organ, unspecified |
| D41.00 |
Neoplasm of uncertain behavior of unspecified kidney |
| D41.01 |
Neoplasm of uncertain behavior of right kidney |
| D41.02 |
Neoplasm of uncertain behavior of left kidney |
| D41.10 |
Neoplasm of uncertain behavior of unspecified renal pelvis |
| D41.11 |
Neoplasm of uncertain behavior of right renal pelvis |
| D41.12 |
Neoplasm of uncertain behavior of left renal pelvis |
| D41.20 |
Neoplasm of uncertain behavior of unspecified ureter |
| D41.21 |
Neoplasm of uncertain behavior of right ureter |
| D41.22 |
Neoplasm of uncertain behavior of left ureter |
| D41.3 |
Neoplasm of uncertain behavior of urethra |
| D41.4 |
Neoplasm of uncertain behavior of bladder |
| D41.8 |
Neoplasm of uncertain behavior of other specified urinary organs |
| D41.9 |
Neoplasm of uncertain behavior of unspecified urinary organ |
| D42.0 |
Neoplasm of uncertain behavior of cerebral meninges |
| D42.1 |
Neoplasm of uncertain behavior of spinal meninges |
| D42.9 |
Neoplasm of uncertain behavior of meninges, unspecified |
| D43.0 |
Neoplasm of uncertain behavior of brain, supratentorial |
| D43.1 |
Neoplasm of uncertain behavior of brain, infratentorial |
| D43.2 |
Neoplasm of uncertain behavior of brain, unspecified |
| D43.3 |
Neoplasm of uncertain behavior of cranial nerves |
| D43.4 |
Neoplasm of uncertain behavior of spinal cord |
| D43.8 |
Neoplasm of uncertain behavior of other specified parts of central nervous system |
| D43.9 |
Neoplasm of uncertain behavior of central nervous system, unspecified |
| D44.0 |
Neoplasm of uncertain behavior of thyroid gland |
| D44.10 |
Neoplasm of uncertain behavior of unspecified adrenal gland |
| D44.11 |
Neoplasm of uncertain behavior of right adrenal gland |
| D44.12 |
Neoplasm of uncertain behavior of left adrenal gland |
| D44.2 |
Neoplasm of uncertain behavior of parathyroid gland |
| D44.3 |
Neoplasm of uncertain behavior of pituitary gland |
| D44.4 |
Neoplasm of uncertain behavior of craniopharyngeal duct |
| D44.5 |
Neoplasm of uncertain behavior of pineal gland |
| D44.6 |
Neoplasm of uncertain behavior of carotid body |
| D44.7 |
Neoplasm of uncertain behavior of aortic body and other paraganglia |
| D44.9 |
Neoplasm of uncertain behavior of unspecified endocrine gland |
| D45 |
Polycythemia vera |
| D46.0 |
Refractory anemia without ring sideroblasts, so stated |
| D46.1 |
Refractory anemia with ring sideroblasts |
| D46.20 |
Refractory anemia with excess of blasts, unspecified |
| D46.21 |
Refractory anemia with excess of blasts 1 |
| D46.22 |
Refractory anemia with excess of blasts 2 |
| D46.4 |
Refractory anemia, unspecified |
| D46.9 |
Myelodysplastic syndrome, unspecified |
| D46.A |
Refractory cytopenia with multilineage dysplasia |
| D46.B |
Refractory cytopenia with multilineage dysplasia and ring sideroblasts |
| D46.C |
Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality |
| D46.Z |
Other myelodysplastic syndromes |
| D47.09 |
Other mast cell neoplasms of uncertain behavior |
| D47.1 |
Chronic myeloproliferative disease |
| D47.3 |
Essential (hemorrhagic) thrombocythemia |
| D47.9 |
Neoplasm of uncertain behavior of lymphoid, hematopoietic and related tissue, unspecified |
| D47.Z1 |
Post-transplant lymphoproliferative disorder (PTLD) |
| D47.Z2 |
Castleman disease |
| D47.Z9 |
Other specified neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue |
| D48.0 |
Neoplasm of uncertain behavior of bone and articular cartilage |
| D48.110 |
Desmoid tumor of head and neck |
| D48.111 |
Desmoid tumor of chest wall |
| D48.112 |
Desmoid tumor, intrathoracic |
| D48.113 |
Desmoid tumor of abdominal wall |
| D48.114 |
Desmoid tumor, intraabdominal |
| D48.115 |
Desmoid tumor of upper extremity and shoulder girdle |
| D48.116 |
Desmoid tumor of lower extremity and pelvic girdle |
| D48.117 |
Desmoid tumor of back |
| D48.118 |
Desmoid tumor of other site |
| D48.119 |
Desmoid tumor of unspecified site |
| D48.19 |
Other specified neoplasm of uncertain behavior of connective and other soft tissue |
| D48.2 |
Neoplasm of uncertain behavior of peripheral nerves and autonomic nervous system |
| D48.3 |
Neoplasm of uncertain behavior of retroperitoneum |
| D48.4 |
Neoplasm of uncertain behavior of peritoneum |
| D48.5 |
Neoplasm of uncertain behavior of skin |
| D48.60 |
Neoplasm of uncertain behavior of unspecified breast |
| D48.61 |
Neoplasm of uncertain behavior of right breast |
| D48.62 |
Neoplasm of uncertain behavior of left breast |
| D48.7 |
Neoplasm of uncertain behavior of other specified sites |
| D48.9 |
Neoplasm of uncertain behavior, unspecified |
| D49.0 |
Neoplasm of unspecified behavior of digestive system |
| D57.00 |
Hb-SS disease with crisis, unspecified |
| D57.01 |
Hb-SS disease with acute chest syndrome |
| D57.02 |
Hb-SS disease with splenic sequestration |
| D57.04 |
Hb-SS disease with dactylitis |
| D57.1 |
Sickle-cell disease without crisis |
| D57.20 |
Sickle-cell/Hb-C disease without crisis |
| D57.211 |
Sickle-cell/Hb-C disease with acute chest syndrome |
| D57.212 |
Sickle-cell/Hb-C disease with splenic sequestration |
| D57.214 |
Sickle-cell/Hb-C disease with dactylitis |
| D57.219 |
Sickle-cell/Hb-C disease with crisis, unspecified |
| D57.412 |
Sickle-cell thalassemia, unspecified, with splenic sequestration |
| D57.414 |
Sickle-cell thalassemia, unspecified, with dactylitis |
| D57.434 |
Sickle-cell thalassemia beta zero with dactylitis |
| D57.454 |
Sickle-cell thalassemia beta plus with dactylitis |
| D57.80 |
Other sickle-cell disorders without crisis |
| D57.811 |
Other sickle-cell disorders with acute chest syndrome |
| D57.812 |
Other sickle-cell disorders with splenic sequestration |
| D57.814 |
Other sickle-cell disorders with dactylitis |
| D57.819 |
Other sickle-cell disorders with crisis, unspecified |
| D65 |
Disseminated intravascular coagulation [defibrination syndrome] |
| D68.32 |
Hemorrhagic disorder due to extrinsic circulating anticoagulants |
| D68.4 |
Acquired coagulation factor deficiency |
| D73.1 |
Hypersplenism |
| D81.810 |
Biotinidase deficiency |
| D81.82 |
Activated Phosphoinositide 3-kinase Delta Syndrome [APDS] |
| D84.1 |
Defects in the complement system |
| D86.0 |
Sarcoidosis of lung |
| D86.1 |
Sarcoidosis of lymph nodes |
| D86.2 |
Sarcoidosis of lung with sarcoidosis of lymph nodes |
| D86.3 |
Sarcoidosis of skin |
| D86.81 |
Sarcoid meningitis |
| D86.82 |
Multiple cranial nerve palsies in sarcoidosis |
| D86.83 |
Sarcoid iridocyclitis |
| D86.84 |
Sarcoid pyelonephritis |
| D86.85 |
Sarcoid myocarditis |
| D86.86 |
Sarcoid arthropathy |
| D86.87 |
Sarcoid myositis |
| D86.89 |
Sarcoidosis of other sites |
| D86.9 |
Sarcoidosis, unspecified |
| E08.21 |
Diabetes mellitus due to underlying condition with diabetic nephropathy |
| E08.22 |
Diabetes mellitus due to underlying condition with diabetic chronic kidney disease |
| E08.29 |
Diabetes mellitus due to underlying condition with other diabetic kidney complication |
| E09.21 |
Drug or chemical induced diabetes mellitus with diabetic nephropathy |
| E09.22 |
Drug or chemical induced diabetes mellitus with diabetic chronic kidney disease |
| E09.29 |
Drug or chemical induced diabetes mellitus with other diabetic kidney complication |
| E10.10 |
Type 1 diabetes mellitus with ketoacidosis without coma |
| E10.11 |
Type 1 diabetes mellitus with ketoacidosis with coma |
| E10.21 |
Type 1 diabetes mellitus with diabetic nephropathy |
| E10.22 |
Type 1 diabetes mellitus with diabetic chronic kidney disease |
| E10.29 |
Type 1 diabetes mellitus with other diabetic kidney complication |
| E10.311 |
Type 1 diabetes mellitus with unspecified diabetic retinopathy with macular edema |
| E10.319 |
Type 1 diabetes mellitus with unspecified diabetic retinopathy without macular edema |
| E10.3211 |
Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, right eye |
| E10.3212 |
Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, left eye |
| E10.3213 |
Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, bilateral |
| E10.3219 |
Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, unspecified eye |
| E10.3291 |
Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, right eye |
| E10.3292 |
Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, left eye |
| E10.3293 |
Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, bilateral |
| E10.3299 |
Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, unspecified eye |
| E10.3311 |
Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, right eye |
| E10.3312 |
Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, left eye |
| E10.3313 |
Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, bilateral |
| E10.3319 |
Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, unspecified eye |
| E10.3391 |
Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, right eye |
| E10.3392 |
Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, left eye |
| E10.3393 |
Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral |
| E10.3399 |
Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, unspecified eye |
| E10.3411 |
Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye |
| E10.3412 |
Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, left eye |
| E10.3413 |
Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, bilateral |
| E10.3419 |
Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, unspecified eye |
| E10.3491 |
Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, right eye |
| E10.3492 |
Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, left eye |
| E10.3493 |
Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, bilateral |
| E10.3499 |
Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, unspecified eye |
| E10.3511 |
Type 1 diabetes mellitus with proliferative diabetic retinopathy with macular edema, right eye |
| E10.3512 |
Type 1 diabetes mellitus with proliferative diabetic retinopathy with macular edema, left eye |
| E10.3513 |
Type 1 diabetes mellitus with proliferative diabetic retinopathy with macular edema, bilateral |
| E10.3519 |
Type 1 diabetes mellitus with proliferative diabetic retinopathy with macular edema, unspecified eye |
| E10.3591 |
Type 1 diabetes mellitus with proliferative diabetic retinopathy without macular edema, right eye |
| E10.3592 |
Type 1 diabetes mellitus with proliferative diabetic retinopathy without macular edema, left eye |
| E10.3593 |
Type 1 diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral |
| E10.3599 |
Type 1 diabetes mellitus with proliferative diabetic retinopathy without macular edema, unspecified eye |
| E10.36 |
Type 1 diabetes mellitus with diabetic cataract |
| E10.39 |
Type 1 diabetes mellitus with other diabetic ophthalmic complication |
| E10.40 |
Type 1 diabetes mellitus with diabetic neuropathy, unspecified |
| E10.41 |
Type 1 diabetes mellitus with diabetic mononeuropathy |
| E10.42 |
Type 1 diabetes mellitus with diabetic polyneuropathy |
| E10.43 |
Type 1 diabetes mellitus with diabetic autonomic (poly)neuropathy |
| E10.44 |
Type 1 diabetes mellitus with diabetic amyotrophy |
| E10.49 |
Type 1 diabetes mellitus with other diabetic neurological complication |
| E10.51 |
Type 1 diabetes mellitus with diabetic peripheral angiopathy without gangrene |
| E10.52 |
Type 1 diabetes mellitus with diabetic peripheral angiopathy with gangrene |
| E10.59 |
Type 1 diabetes mellitus with other circulatory complications |
| E10.610 |
Type 1 diabetes mellitus with diabetic neuropathic arthropathy |
| E10.618 |
Type 1 diabetes mellitus with other diabetic arthropathy |
| E10.620 |
Type 1 diabetes mellitus with diabetic dermatitis |
| E10.621 |
Type 1 diabetes mellitus with foot ulcer |
| E10.622 |
Type 1 diabetes mellitus with other skin ulcer |
| E10.628 |
Type 1 diabetes mellitus with other skin complications |
| E10.630 |
Type 1 diabetes mellitus with periodontal disease |
| E10.638 |
Type 1 diabetes mellitus with other oral complications |
| E10.641 |
Type 1 diabetes mellitus with hypoglycemia with coma |
| E10.649 |
Type 1 diabetes mellitus with hypoglycemia without coma |
| E10.65 |
Type 1 diabetes mellitus with hyperglycemia |
| E10.69 |
Type 1 diabetes mellitus with other specified complication |
| E10.8 |
Type 1 diabetes mellitus with unspecified complications |
| E10.9 |
Type 1 diabetes mellitus without complications |
| E11.00 |
Type 2 diabetes mellitus with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC) |
| E11.01 |
Type 2 diabetes mellitus with hyperosmolarity with coma |
| E11.21 |
Type 2 diabetes mellitus with diabetic nephropathy |
| E11.22 |
Type 2 diabetes mellitus with diabetic chronic kidney disease |
| E11.29 |
Type 2 diabetes mellitus with other diabetic kidney complication |
| E11.311 |
Type 2 diabetes mellitus with unspecified diabetic retinopathy with macular edema |
| E11.319 |
Type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema |
| E11.3211 |
Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, right eye |
| E11.3212 |
Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, left eye |
| E11.3213 |
Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, bilateral |
| E11.3219 |
Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, unspecified eye |
| E11.3291 |
Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, right eye |
| E11.3292 |
Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, left eye |
| E11.3293 |
Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, bilateral |
| E11.3299 |
Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, unspecified eye |
| E11.3311 |
Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, right eye |
| E11.3312 |
Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, left eye |
| E11.3313 |
Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, bilateral |
| E11.3319 |
Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, unspecified eye |
| E11.3391 |
Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, right eye |
| E11.3392 |
Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, left eye |
| E11.3393 |
Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral |
| E11.3399 |
Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, unspecified eye |
| E11.3411 |
Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye |
| E11.3412 |
Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, left eye |
| E11.3413 |
Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, bilateral |
| E11.3419 |
Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, unspecified eye |
| E11.3491 |
Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, right eye |
| E11.3492 |
Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, left eye |
| E11.3493 |
Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, bilateral |
| E11.3499 |
Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, unspecified eye |
| E11.3511 |
Type 2 diabetes mellitus with proliferative diabetic retinopathy with macular edema, right eye |
| E11.3512 |
Type 2 diabetes mellitus with proliferative diabetic retinopathy with macular edema, left eye |
| E11.3513 |
Type 2 diabetes mellitus with proliferative diabetic retinopathy with macular edema, bilateral |
| E11.3519 |
Type 2 diabetes mellitus with proliferative diabetic retinopathy with macular edema, unspecified eye |
| E11.3591 |
Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, right eye |
| E11.3592 |
Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, left eye |
| E11.3593 |
Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral |
| E11.3599 |
Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, unspecified eye |
| E11.36 |
Type 2 diabetes mellitus with diabetic cataract |
| E11.39 |
Type 2 diabetes mellitus with other diabetic ophthalmic complication |
| E11.40 |
Type 2 diabetes mellitus with diabetic neuropathy, unspecified |
| E11.41 |
Type 2 diabetes mellitus with diabetic mononeuropathy |
| E11.42 |
Type 2 diabetes mellitus with diabetic polyneuropathy |
| E11.43 |
Type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy |
| E11.44 |
Type 2 diabetes mellitus with diabetic amyotrophy |
| E11.49 |
Type 2 diabetes mellitus with other diabetic neurological complication |
| E11.51 |
Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene |
| E11.52 |
Type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene |
| E11.59 |
Type 2 diabetes mellitus with other circulatory complications |
| E11.610 |
Type 2 diabetes mellitus with diabetic neuropathic arthropathy |
| E11.618 |
Type 2 diabetes mellitus with other diabetic arthropathy |
| E11.620 |
Type 2 diabetes mellitus with diabetic dermatitis |
| E11.621 |
Type 2 diabetes mellitus with foot ulcer |
| E11.622 |
Type 2 diabetes mellitus with other skin ulcer |
| E11.628 |
Type 2 diabetes mellitus with other skin complications |
| E11.630 |
Type 2 diabetes mellitus with periodontal disease |
| E11.638 |
Type 2 diabetes mellitus with other oral complications |
| E11.641 |
Type 2 diabetes mellitus with hypoglycemia with coma |
| E11.649 |
Type 2 diabetes mellitus with hypoglycemia without coma |
| E11.65 |
Type 2 diabetes mellitus with hyperglycemia |
| E11.69 |
Type 2 diabetes mellitus with other specified complication |
| E11.8 |
Type 2 diabetes mellitus with unspecified complications |
| E11.9 |
Type 2 diabetes mellitus without complications |
| E13.00 |
Other specified diabetes mellitus with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC) |
| E13.01 |
Other specified diabetes mellitus with hyperosmolarity with coma |
| E13.10 |
Other specified diabetes mellitus with ketoacidosis without coma |
| E13.11 |
Other specified diabetes mellitus with ketoacidosis with coma |
| E13.21 |
Other specified diabetes mellitus with diabetic nephropathy |
| E13.22 |
Other specified diabetes mellitus with diabetic chronic kidney disease |
| E13.29 |
Other specified diabetes mellitus with other diabetic kidney complication |
| E13.311 |
Other specified diabetes mellitus with unspecified diabetic retinopathy with macular edema |
| E13.319 |
Other specified diabetes mellitus with unspecified diabetic retinopathy without macular edema |
| E13.3211 |
Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, right eye |
| E13.3212 |
Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, left eye |
| E13.3213 |
Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, bilateral |
| E13.3219 |
Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, unspecified eye |
| E13.3291 |
Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, right eye |
| E13.3292 |
Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, left eye |
| E13.3293 |
Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, bilateral |
| E13.3299 |
Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, unspecified eye |
| E13.3311 |
Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, right eye |
| E13.3312 |
Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, left eye |
| E13.3313 |
Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, bilateral |
| E13.3319 |
Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, unspecified eye |
| E13.3391 |
Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, right eye |
| E13.3392 |
Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, left eye |
| E13.3393 |
Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral |
| E13.3399 |
Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, unspecified eye |
| E13.3411 |
Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye |
| E13.3412 |
Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, left eye |
| E13.3413 |
Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, bilateral |
| E13.3419 |
Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, unspecified eye |
| E13.3491 |
Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, right eye |
| E13.3492 |
Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, left eye |
| E13.3493 |
Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, bilateral |
| E13.3499 |
Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, unspecified eye |
| E13.3511 |
Other specified diabetes mellitus with proliferative diabetic retinopathy with macular edema, right eye |
| E13.3512 |
Other specified diabetes mellitus with proliferative diabetic retinopathy with macular edema, left eye |
| E13.3513 |
Other specified diabetes mellitus with proliferative diabetic retinopathy with macular edema, bilateral |
| E13.3519 |
Other specified diabetes mellitus with proliferative diabetic retinopathy with macular edema, unspecified eye |
| E13.3521 |
Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, right eye |
| E13.3522 |
Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, left eye |
| E13.3523 |
Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, bilateral |
| E13.3529 |
Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, unspecified eye |
| E13.3531 |
Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, right eye |
| E13.3532 |
Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, left eye |
| E13.3533 |
Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, bilateral |
| E13.3539 |
Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, unspecified eye |
| E13.3541 |
Other specified diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, right eye |
| E13.3542 |
Other specified diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, left eye |
| E13.3543 |
Other specified diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, bilateral |
| E13.3549 |
Other specified diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, unspecified eye |
| E13.3551 |
Other specified diabetes mellitus with stable proliferative diabetic retinopathy, right eye |
| E13.3552 |
Other specified diabetes mellitus with stable proliferative diabetic retinopathy, left eye |
| E13.3553 |
Other specified diabetes mellitus with stable proliferative diabetic retinopathy, bilateral |
| E13.3559 |
Other specified diabetes mellitus with stable proliferative diabetic retinopathy, unspecified eye |
| E13.3591 |
Other specified diabetes mellitus with proliferative diabetic retinopathy without macular edema, right eye |
| E13.3592 |
Other specified diabetes mellitus with proliferative diabetic retinopathy without macular edema, left eye |
| E13.3593 |
Other specified diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral |
| E13.3599 |
Other specified diabetes mellitus with proliferative diabetic retinopathy without macular edema, unspecified eye |
| E13.36 |
Other specified diabetes mellitus with diabetic cataract |
| E13.37X1 |
Other specified diabetes mellitus with diabetic macular edema, resolved following treatment, right eye |
| E13.37X2 |
Other specified diabetes mellitus with diabetic macular edema, resolved following treatment, left eye |
| E13.37X3 |
Other specified diabetes mellitus with diabetic macular edema, resolved following treatment, bilateral |
| E13.37X9 |
Other specified diabetes mellitus with diabetic macular edema, resolved following treatment, unspecified eye |
| E13.39 |
Other specified diabetes mellitus with other diabetic ophthalmic complication |
| E13.40 |
Other specified diabetes mellitus with diabetic neuropathy, unspecified |
| E13.41 |
Other specified diabetes mellitus with diabetic mononeuropathy |
| E13.42 |
Other specified diabetes mellitus with diabetic polyneuropathy |
| E13.43 |
Other specified diabetes mellitus with diabetic autonomic (poly)neuropathy |
| E13.44 |
Other specified diabetes mellitus with diabetic amyotrophy |
| E13.49 |
Other specified diabetes mellitus with other diabetic neurological complication |
| E13.51 |
Other specified diabetes mellitus with diabetic peripheral angiopathy without gangrene |
| E13.52 |
Other specified diabetes mellitus with diabetic peripheral angiopathy with gangrene |
| E13.59 |
Other specified diabetes mellitus with other circulatory complications |
| E13.610 |
Other specified diabetes mellitus with diabetic neuropathic arthropathy |
| E13.618 |
Other specified diabetes mellitus with other diabetic arthropathy |
| E13.620 |
Other specified diabetes mellitus with diabetic dermatitis |
| E13.621 |
Other specified diabetes mellitus with foot ulcer |
| E13.622 |
Other specified diabetes mellitus with other skin ulcer |
| E13.628 |
Other specified diabetes mellitus with other skin complications |
| E13.630 |
Other specified diabetes mellitus with periodontal disease |
| E13.638 |
Other specified diabetes mellitus with other oral complications |
| E13.641 |
Other specified diabetes mellitus with hypoglycemia with coma |
| E13.649 |
Other specified diabetes mellitus with hypoglycemia without coma |
| E13.65 |
Other specified diabetes mellitus with hyperglycemia |
| E13.69 |
Other specified diabetes mellitus with other specified complication |
| E13.8 |
Other specified diabetes mellitus with unspecified complications |
| E13.9 |
Other specified diabetes mellitus without complications |
| E20.1 |
Pseudohypoparathyroidism |
| E21.0 |
Primary hyperparathyroidism |
| E21.1 |
Secondary hyperparathyroidism, not elsewhere classified |
| E21.2 |
Other hyperparathyroidism |
| E21.3 |
Hyperparathyroidism, unspecified |
| E44.1 |
Mild protein-calorie malnutrition |
| E46 |
Unspecified protein-calorie malnutrition |
| E55.0 |
Rickets, active |
| E56.1 |
Deficiency of vitamin K |
| E64.0 |
Sequelae of protein-calorie malnutrition |
| E70.20 |
Disorder of tyrosine metabolism, unspecified |
| E70.21 |
Tyrosinemia |
| E70.29 |
Other disorders of tyrosine metabolism |
| E70.30 |
Albinism, unspecified |
| E70.310 |
X-linked ocular albinism |
| E70.311 |
Autosomal recessive ocular albinism |
| E70.318 |
Other ocular albinism |
| E70.319 |
Ocular albinism, unspecified |
| E70.320 |
Tyrosinase negative oculocutaneous albinism |
| E70.321 |
Tyrosinase positive oculocutaneous albinism |
| E70.328 |
Other oculocutaneous albinism |
| E70.329 |
Oculocutaneous albinism, unspecified |
| E70.330 |
Chediak-Higashi syndrome |
| E70.331 |
Hermansky-Pudlak syndrome |
| E70.338 |
Other albinism with hematologic abnormality |
| E70.339 |
Albinism with hematologic abnormality, unspecified |
| E70.39 |
Other specified albinism |
| E70.5 |
Disorders of tryptophan metabolism |
| E70.81 |
Aromatic L-amino acid decarboxylase deficiency |
| E70.89 |
Other disorders of aromatic amino-acid metabolism |
| E70.9 |
Disorder of aromatic amino-acid metabolism, unspecified |
| E72.9 |
Disorder of amino-acid metabolism, unspecified |
| E74.00 |
Glycogen storage disease, unspecified |
| E74.01 |
von Gierke disease |
| E74.02 |
Pompe disease |
| E74.03 |
Cori disease |
| E74.04 |
McArdle disease |
| E74.05 |
Lysosome-associated membrane protein 2 [LAMP2] deficiency |
| E74.09 |
Other glycogen storage disease |
| E74.4 |
Disorders of pyruvate metabolism and gluconeogenesis |
| E75.21 |
Fabry (-Anderson) disease |
| E75.22 |
Gaucher disease |
| E75.240 |
Niemann-Pick disease type A |
| E75.241 |
Niemann-Pick disease type B |
| E75.242 |
Niemann-Pick disease type C |
| E75.243 |
Niemann-Pick disease type D |
| E75.248 |
Other Niemann-Pick disease |
| E75.249 |
Niemann-Pick disease, unspecified |
| E75.26 |
Sulfatase deficiency |
| E75.27 |
Pelizaeus-Merzbacher disease |
| E75.28 |
Canavan disease |
| E75.3 |
Sphingolipidosis, unspecified |
| E75.6 |
Lipid storage disorder, unspecified |
| E77.0 |
Defects in post-translational modification of lysosomal enzymes |
| E77.1 |
Defects in glycoprotein degradation |
| E77.8 |
Other disorders of glycoprotein metabolism |
| E77.9 |
Disorder of glycoprotein metabolism, unspecified |
| E78.00 |
Pure hypercholesterolemia, unspecified |
| E78.01 |
Familial hypercholesterolemia |
| E78.1 |
Pure hyperglyceridemia |
| E78.2 |
Mixed hyperlipidemia |
| E78.41 |
Elevated Lipoprotein(a) |
| E78.49 |
Other hyperlipidemia |
| E78.5 |
Hyperlipidemia, unspecified |
| E78.70 |
Disorder of bile acid and cholesterol metabolism, unspecified |
| E78.9 |
Disorder of lipoprotein metabolism, unspecified |
| E80.0 |
Hereditary erythropoietic porphyria |
| E80.1 |
Porphyria cutanea tarda |
| E80.20 |
Unspecified porphyria |
| E80.21 |
Acute intermittent (hepatic) porphyria |
| E80.29 |
Other porphyria |
| E80.4 |
Gilbert syndrome |
| E80.5 |
Crigler-Najjar syndrome |
| E80.6 |
Other disorders of bilirubin metabolism |
| E80.7 |
Disorder of bilirubin metabolism, unspecified |
| E83.00 |
Disorder of copper metabolism, unspecified |
| E83.01 |
Wilson's disease |
| E83.09 |
Other disorders of copper metabolism |
| E83.10 |
Disorder of iron metabolism, unspecified |
| E83.110 |
Hereditary hemochromatosis |
| E83.111 |
Hemochromatosis due to repeated red blood cell transfusions |
| E83.118 |
Other hemochromatosis |
| E83.119 |
Hemochromatosis, unspecified |
| E83.19 |
Other disorders of iron metabolism |
| E83.30 |
Disorder of phosphorus metabolism, unspecified |
| E83.31 |
Familial hypophosphatemia |
| E83.32 |
Hereditary vitamin D-dependent rickets (type 1) (type 2) |
| E83.39 |
Other disorders of phosphorus metabolism |
| E83.40 |
Disorders of magnesium metabolism, unspecified |
| E83.41 |
Hypermagnesemia |
| E83.42 |
Hypomagnesemia |
| E83.49 |
Other disorders of magnesium metabolism |
| E83.50 |
Unspecified disorder of calcium metabolism |
| E83.51 |
Hypocalcemia |
| E83.52 |
Hypercalcemia |
| E83.59 |
Other disorders of calcium metabolism |
| E83.81 |
Hungry bone syndrome |
| E85.0 |
Non-neuropathic heredofamilial amyloidosis |
| E85.1 |
Neuropathic heredofamilial amyloidosis |
| E85.2 |
Heredofamilial amyloidosis, unspecified |
| E85.3 |
Secondary systemic amyloidosis |
| E85.4 |
Organ-limited amyloidosis |
| E85.82 |
Wild-type transthyretin-related (ATTR) amyloidosis |
| E85.89 |
Other amyloidosis |
| E85.9 |
Amyloidosis, unspecified |
| E88.01 |
Alpha-1-antitrypsin deficiency |
| E88.02 |
Plasminogen deficiency |
| F10.10 |
Alcohol abuse, uncomplicated |
| F10.11 |
Alcohol abuse, in remission |
| F10.120 |
Alcohol abuse with intoxication, uncomplicated |
| F10.121 |
Alcohol abuse with intoxication delirium |
| F10.129 |
Alcohol abuse with intoxication, unspecified |
| F10.14 |
Alcohol abuse with alcohol-induced mood disorder |
| F10.150 |
Alcohol abuse with alcohol-induced psychotic disorder with delusions |
| F10.151 |
Alcohol abuse with alcohol-induced psychotic disorder with hallucinations |
| F10.159 |
Alcohol abuse with alcohol-induced psychotic disorder, unspecified |
| F10.180 |
Alcohol abuse with alcohol-induced anxiety disorder |
| F10.181 |
Alcohol abuse with alcohol-induced sexual dysfunction |
| F10.182 |
Alcohol abuse with alcohol-induced sleep disorder |
| F10.188 |
Alcohol abuse with other alcohol-induced disorder |
| F10.19 |
Alcohol abuse with unspecified alcohol-induced disorder |
| F10.20 |
Alcohol dependence, uncomplicated |
| F10.21 |
Alcohol dependence, in remission |
| F10.220 |
Alcohol dependence with intoxication, uncomplicated |
| F10.221 |
Alcohol dependence with intoxication delirium |
| F10.229 |
Alcohol dependence with intoxication, unspecified |
| F10.230 |
Alcohol dependence with withdrawal, uncomplicated |
| F10.231 |
Alcohol dependence with withdrawal delirium |
| F10.232 |
Alcohol dependence with withdrawal with perceptual disturbance |
| F10.239 |
Alcohol dependence with withdrawal, unspecified |
| F10.24 |
Alcohol dependence with alcohol-induced mood disorder |
| F10.250 |
Alcohol dependence with alcohol-induced psychotic disorder with delusions |
| F10.251 |
Alcohol dependence with alcohol-induced psychotic disorder with hallucinations |
| F10.259 |
Alcohol dependence with alcohol-induced psychotic disorder, unspecified |
| F10.26 |
Alcohol dependence with alcohol-induced persisting amnestic disorder |
| F10.27 |
Alcohol dependence with alcohol-induced persisting dementia |
| F10.280 |
Alcohol dependence with alcohol-induced anxiety disorder |
| F10.281 |
Alcohol dependence with alcohol-induced sexual dysfunction |
| F10.282 |
Alcohol dependence with alcohol-induced sleep disorder |
| F10.288 |
Alcohol dependence with other alcohol-induced disorder |
| F10.29 |
Alcohol dependence with unspecified alcohol-induced disorder |
| F10.90 |
Alcohol use, unspecified, uncomplicated |
| F10.91 |
Alcohol use, unspecified, in remission |
| F10.920 |
Alcohol use, unspecified with intoxication, uncomplicated |
| F10.921 |
Alcohol use, unspecified with intoxication delirium |
| F10.929 |
Alcohol use, unspecified with intoxication, unspecified |
| F10.94 |
Alcohol use, unspecified with alcohol-induced mood disorder |
| F10.950 |
Alcohol use, unspecified with alcohol-induced psychotic disorder with delusions |
| F10.951 |
Alcohol use, unspecified with alcohol-induced psychotic disorder with hallucinations |
| F10.959 |
Alcohol use, unspecified with alcohol-induced psychotic disorder, unspecified |
| F10.96 |
Alcohol use, unspecified with alcohol-induced persisting amnestic disorder |
| F10.97 |
Alcohol use, unspecified with alcohol-induced persisting dementia |
| F10.980 |
Alcohol use, unspecified with alcohol-induced anxiety disorder |
| F10.981 |
Alcohol use, unspecified with alcohol-induced sexual dysfunction |
| F10.982 |
Alcohol use, unspecified with alcohol-induced sleep disorder |
| F10.988 |
Alcohol use, unspecified with other alcohol-induced disorder |
| F10.99 |
Alcohol use, unspecified with unspecified alcohol-induced disorder |
| F11.10 |
Opioid abuse, uncomplicated |
| F11.120 |
Opioid abuse with intoxication, uncomplicated |
| F11.129 |
Opioid abuse with intoxication, unspecified |
| F11.20 |
Opioid dependence, uncomplicated |
| F11.21 |
Opioid dependence, in remission |
| F11.220 |
Opioid dependence with intoxication, uncomplicated |
| F11.221 |
Opioid dependence with intoxication delirium |
| F11.222 |
Opioid dependence with intoxication with perceptual disturbance |
| F11.229 |
Opioid dependence with intoxication, unspecified |
| F11.23 |
Opioid dependence with withdrawal |
| F11.24 |
Opioid dependence with opioid-induced mood disorder |
| F11.250 |
Opioid dependence with opioid-induced psychotic disorder with delusions |
| F11.251 |
Opioid dependence with opioid-induced psychotic disorder with hallucinations |
| F11.259 |
Opioid dependence with opioid-induced psychotic disorder, unspecified |
| F11.281 |
Opioid dependence with opioid-induced sexual dysfunction |
| F11.282 |
Opioid dependence with opioid-induced sleep disorder |
| F11.288 |
Opioid dependence with other opioid-induced disorder |
| F11.29 |
Opioid dependence with unspecified opioid-induced disorder |
| F11.90 |
Opioid use, unspecified, uncomplicated |
| F11.91 |
Opioid use, unspecified, in remission |
| F12.10 |
Cannabis abuse, uncomplicated |
| F12.11 |
Cannabis abuse, in remission |
| F12.20 |
Cannabis dependence, uncomplicated |
| F12.21 |
Cannabis dependence, in remission |
| F12.220 |
Cannabis dependence with intoxication, uncomplicated |
| F12.221 |
Cannabis dependence with intoxication delirium |
| F12.222 |
Cannabis dependence with intoxication with perceptual disturbance |
| F12.229 |
Cannabis dependence with intoxication, unspecified |
| F12.23 |
Cannabis dependence with withdrawal |
| F12.250 |
Cannabis dependence with psychotic disorder with delusions |
| F12.251 |
Cannabis dependence with psychotic disorder with hallucinations |
| F12.259 |
Cannabis dependence with psychotic disorder, unspecified |
| F12.280 |
Cannabis dependence with cannabis-induced anxiety disorder |
| F12.288 |
Cannabis dependence with other cannabis-induced disorder |
| F12.29 |
Cannabis dependence with unspecified cannabis-induced disorder |
| F12.90 |
Cannabis use, unspecified, uncomplicated |
| F12.91 |
Cannabis use, unspecified, in remission |
| F12.93 |
Cannabis use, unspecified with withdrawal |
| F13.10 |
Sedative, hypnotic or anxiolytic abuse, uncomplicated |
| F13.11 |
Sedative, hypnotic or anxiolytic abuse, in remission |
| F13.120 |
Sedative, hypnotic or anxiolytic abuse with intoxication, uncomplicated |
| F13.20 |
Sedative, hypnotic or anxiolytic dependence, uncomplicated |
| F13.21 |
Sedative, hypnotic or anxiolytic dependence, in remission |
| F13.220 |
Sedative, hypnotic or anxiolytic dependence with intoxication, uncomplicated |
| F13.221 |
Sedative, hypnotic or anxiolytic dependence with intoxication delirium |
| F13.229 |
Sedative, hypnotic or anxiolytic dependence with intoxication, unspecified |
| F13.230 |
Sedative, hypnotic or anxiolytic dependence with withdrawal, uncomplicated |
| F13.231 |
Sedative, hypnotic or anxiolytic dependence with withdrawal delirium |
| F13.232 |
Sedative, hypnotic or anxiolytic dependence with withdrawal with perceptual disturbance |
| F13.239 |
Sedative, hypnotic or anxiolytic dependence with withdrawal, unspecified |
| F13.24 |
Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced mood disorder |
| F13.250 |
Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced psychotic disorder with delusions |
| F13.251 |
Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced psychotic disorder with hallucinations |
| F13.259 |
Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced psychotic disorder, unspecified |
| F13.26 |
Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced persisting amnestic disorder |
| F13.27 |
Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced persisting dementia |
| F13.280 |
Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced anxiety disorder |
| F13.281 |
Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced sexual dysfunction |
| F13.282 |
Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced sleep disorder |
| F13.288 |
Sedative, hypnotic or anxiolytic dependence with other sedative, hypnotic or anxiolytic-induced disorder |
| F13.29 |
Sedative, hypnotic or anxiolytic dependence with unspecified sedative, hypnotic or anxiolytic-induced disorder |
| F13.90 |
Sedative, hypnotic, or anxiolytic use, unspecified, uncomplicated |
| F13.91 |
Sedative, hypnotic or anxiolytic use, unspecified, in remission |
| F14.10 |
Cocaine abuse, uncomplicated |
| F14.120 |
Cocaine abuse with intoxication, uncomplicated |
| F14.20 |
Cocaine dependence, uncomplicated |
| F14.21 |
Cocaine dependence, in remission |
| F14.220 |
Cocaine dependence with intoxication, uncomplicated |
| F14.221 |
Cocaine dependence with intoxication delirium |
| F14.222 |
Cocaine dependence with intoxication with perceptual disturbance |
| F14.229 |
Cocaine dependence with intoxication, unspecified |
| F14.23 |
Cocaine dependence with withdrawal |
| F14.24 |
Cocaine dependence with cocaine-induced mood disorder |
| F14.250 |
Cocaine dependence with cocaine-induced psychotic disorder with delusions |
| F14.251 |
Cocaine dependence with cocaine-induced psychotic disorder with hallucinations |
| F14.259 |
Cocaine dependence with cocaine-induced psychotic disorder, unspecified |
| F14.280 |
Cocaine dependence with cocaine-induced anxiety disorder |
| F14.281 |
Cocaine dependence with cocaine-induced sexual dysfunction |
| F14.282 |
Cocaine dependence with cocaine-induced sleep disorder |
| F14.288 |
Cocaine dependence with other cocaine-induced disorder |
| F14.29 |
Cocaine dependence with unspecified cocaine-induced disorder |
| F14.90 |
Cocaine use, unspecified, uncomplicated |
| F14.91 |
Cocaine use, unspecified, in remission |
| F15.10 |
Other stimulant abuse, uncomplicated |
| F15.120 |
Other stimulant abuse with intoxication, uncomplicated |
| F15.20 |
Other stimulant dependence, uncomplicated |
| F15.21 |
Other stimulant dependence, in remission |
| F15.220 |
Other stimulant dependence with intoxication, uncomplicated |
| F15.221 |
Other stimulant dependence with intoxication delirium |
| F15.222 |
Other stimulant dependence with intoxication with perceptual disturbance |
| F15.229 |
Other stimulant dependence with intoxication, unspecified |
| F15.23 |
Other stimulant dependence with withdrawal |
| F15.24 |
Other stimulant dependence with stimulant-induced mood disorder |
| F15.250 |
Other stimulant dependence with stimulant-induced psychotic disorder with delusions |
| F15.251 |
Other stimulant dependence with stimulant-induced psychotic disorder with hallucinations |
| F15.259 |
Other stimulant dependence with stimulant-induced psychotic disorder, unspecified |
| F15.280 |
Other stimulant dependence with stimulant-induced anxiety disorder |
| F15.281 |
Other stimulant dependence with stimulant-induced sexual dysfunction |
| F15.282 |
Other stimulant dependence with stimulant-induced sleep disorder |
| F15.288 |
Other stimulant dependence with other stimulant-induced disorder |
| F15.29 |
Other stimulant dependence with unspecified stimulant-induced disorder |
| F15.90 |
Other stimulant use, unspecified, uncomplicated |
| F15.91 |
Other stimulant use, unspecified, in remission |
| F16.10 |
Hallucinogen abuse, uncomplicated |
| F16.11 |
Hallucinogen abuse, in remission |
| F16.120 |
Hallucinogen abuse with intoxication, uncomplicated |
| F16.20 |
Hallucinogen dependence, uncomplicated |
| F16.21 |
Hallucinogen dependence, in remission |
| F16.220 |
Hallucinogen dependence with intoxication, uncomplicated |
| F16.221 |
Hallucinogen dependence with intoxication with delirium |
| F16.229 |
Hallucinogen dependence with intoxication, unspecified |
| F16.24 |
Hallucinogen dependence with hallucinogen-induced mood disorder |
| F16.250 |
Hallucinogen dependence with hallucinogen-induced psychotic disorder with delusions |
| F16.251 |
Hallucinogen dependence with hallucinogen-induced psychotic disorder with hallucinations |
| F16.259 |
Hallucinogen dependence with hallucinogen-induced psychotic disorder, unspecified |
| F16.280 |
Hallucinogen dependence with hallucinogen-induced anxiety disorder |
| F16.283 |
Hallucinogen dependence with hallucinogen persisting perception disorder (flashbacks) |
| F16.288 |
Hallucinogen dependence with other hallucinogen-induced disorder |
| F16.29 |
Hallucinogen dependence with unspecified hallucinogen-induced disorder |
| F16.90 |
Hallucinogen use, unspecified, uncomplicated |
| F16.91 |
Hallucinogen use, unspecified, in remission |
| F17.200 |
Nicotine dependence, unspecified, uncomplicated |
| F17.201 |
Nicotine dependence, unspecified, in remission |
| F17.210 |
Nicotine dependence, cigarettes, uncomplicated |
| F17.211 |
Nicotine dependence, cigarettes, in remission |
| F17.220 |
Nicotine dependence, chewing tobacco, uncomplicated |
| F17.221 |
Nicotine dependence, chewing tobacco, in remission |
| F17.290 |
Nicotine dependence, other tobacco product, uncomplicated |
| F17.291 |
Nicotine dependence, other tobacco product, in remission |
| F18.10 |
Inhalant abuse, uncomplicated |
| F18.11 |
Inhalant abuse, in remission |
| F18.120 |
Inhalant abuse with intoxication, uncomplicated |
| F18.20 |
Inhalant dependence, uncomplicated |
| F18.21 |
Inhalant dependence, in remission |
| F18.220 |
Inhalant dependence with intoxication, uncomplicated |
| F18.221 |
Inhalant dependence with intoxication delirium |
| F18.229 |
Inhalant dependence with intoxication, unspecified |
| F18.24 |
Inhalant dependence with inhalant-induced mood disorder |
| F18.250 |
Inhalant dependence with inhalant-induced psychotic disorder with delusions |
| F18.251 |
Inhalant dependence with inhalant-induced psychotic disorder with hallucinations |
| F18.259 |
Inhalant dependence with inhalant-induced psychotic disorder, unspecified |
| F18.27 |
Inhalant dependence with inhalant-induced dementia |
| F18.280 |
Inhalant dependence with inhalant-induced anxiety disorder |
| F18.288 |
Inhalant dependence with other inhalant-induced disorder |
| F18.29 |
Inhalant dependence with unspecified inhalant-induced disorder |
| F18.90 |
Inhalant use, unspecified, uncomplicated |
| F18.91 |
Inhalant use, unspecified, in remission |
| F19.10 |
Other psychoactive substance abuse, uncomplicated |
| F19.11 |
Other psychoactive substance abuse, in remission |
| F19.120 |
Other psychoactive substance abuse with intoxication, uncomplicated |
| F19.20 |
Other psychoactive substance dependence, uncomplicated |
| F19.21 |
Other psychoactive substance dependence, in remission |
| F19.220 |
Other psychoactive substance dependence with intoxication, uncomplicated |
| F19.221 |
Other psychoactive substance dependence with intoxication delirium |
| F19.222 |
Other psychoactive substance dependence with intoxication with perceptual disturbance |
| F19.229 |
Other psychoactive substance dependence with intoxication, unspecified |
| F19.230 |
Other psychoactive substance dependence with withdrawal, uncomplicated |
| F19.231 |
Other psychoactive substance dependence with withdrawal delirium |
| F19.232 |
Other psychoactive substance dependence with withdrawal with perceptual disturbance |
| F19.239 |
Other psychoactive substance dependence with withdrawal, unspecified |
| F19.24 |
Other psychoactive substance dependence with psychoactive substance-induced mood disorder |
| F19.250 |
Other psychoactive substance dependence with psychoactive substance-induced psychotic disorder with delusions |
| F19.251 |
Other psychoactive substance dependence with psychoactive substance-induced psychotic disorder with hallucinations |
| F19.259 |
Other psychoactive substance dependence with psychoactive substance-induced psychotic disorder, unspecified |
| F19.26 |
Other psychoactive substance dependence with psychoactive substance-induced persisting amnestic disorder |
| F19.27 |
Other psychoactive substance dependence with psychoactive substance-induced persisting dementia |
| F19.280 |
Other psychoactive substance dependence with psychoactive substance-induced anxiety disorder |
| F19.281 |
Other psychoactive substance dependence with psychoactive substance-induced sexual dysfunction |
| F19.282 |
Other psychoactive substance dependence with psychoactive substance-induced sleep disorder |
| F19.288 |
Other psychoactive substance dependence with other psychoactive substance-induced disorder |
| F19.29 |
Other psychoactive substance dependence with unspecified psychoactive substance-induced disorder |
| F19.90 |
Other psychoactive substance use, unspecified, uncomplicated |
| F19.91 |
Other psychoactive substance use, unspecified, in remission |
| F50.82 |
Avoidant/restrictive food intake disorder |
| F55.0 |
Abuse of antacids |
| F55.1 |
Abuse of herbal or folk remedies |
| F55.2 |
Abuse of laxatives |
| F55.3 |
Abuse of steroids or hormones |
| F55.4 |
Abuse of vitamins |
| F55.8 |
Abuse of other non-psychoactive substances |
| G62.1 |
Alcoholic polyneuropathy |
| G71.11 |
Myotonic muscular dystrophy |
| G71.12 |
Myotonia congenita |
| G71.13 |
Myotonic chondrodystrophy |
| G71.14 |
Drug induced myotonia |
| G71.19 |
Other specified myotonic disorders |
| I27.83 |
Eisenmenger's syndrome |
| I50.810 |
Right heart failure, unspecified |
| I50.811 |
Acute right heart failure |
| I50.812 |
Chronic right heart failure |
| I50.813 |
Acute on chronic right heart failure |
| I50.814 |
Right heart failure due to left heart failure |
| I50.82 |
Biventricular heart failure |
| I50.83 |
High output heart failure |
| I50.84 |
End stage heart failure |
| I50.89 |
Other heart failure |
| I80.241 |
Phlebitis and thrombophlebitis of right peroneal vein |
| I80.242 |
Phlebitis and thrombophlebitis of left peroneal vein |
| I80.243 |
Phlebitis and thrombophlebitis of peroneal vein, bilateral |
| I80.251 |
Phlebitis and thrombophlebitis of right calf muscular vein |
| I80.252 |
Phlebitis and thrombophlebitis of left calf muscular vein |
| I80.253 |
Phlebitis and thrombophlebitis of calf muscular vein, bilateral |
| I81 |
Portal vein thrombosis |
| I82.0 |
Budd-Chiari syndrome |
| I82.1 |
Thrombophlebitis migrans |
| I82.210 |
Acute embolism and thrombosis of superior vena cava |
| I82.211 |
Chronic embolism and thrombosis of superior vena cava |
| I82.220 |
Acute embolism and thrombosis of inferior vena cava |
| I82.221 |
Chronic embolism and thrombosis of inferior vena cava |
| I82.290 |
Acute embolism and thrombosis of other thoracic veins |
| I82.291 |
Chronic embolism and thrombosis of other thoracic veins |
| I82.3 |
Embolism and thrombosis of renal vein |
| I82.401 |
Acute embolism and thrombosis of unspecified deep veins of right lower extremity |
| I82.402 |
Acute embolism and thrombosis of unspecified deep veins of left lower extremity |
| I82.403 |
Acute embolism and thrombosis of unspecified deep veins of lower extremity, bilateral |
| I82.409 |
Acute embolism and thrombosis of unspecified deep veins of unspecified lower extremity |
| I82.411 |
Acute embolism and thrombosis of right femoral vein |
| I82.412 |
Acute embolism and thrombosis of left femoral vein |
| I82.413 |
Acute embolism and thrombosis of femoral vein, bilateral |
| I82.419 |
Acute embolism and thrombosis of unspecified femoral vein |
| I82.421 |
Acute embolism and thrombosis of right iliac vein |
| I82.422 |
Acute embolism and thrombosis of left iliac vein |
| I82.423 |
Acute embolism and thrombosis of iliac vein, bilateral |
| I82.429 |
Acute embolism and thrombosis of unspecified iliac vein |
| I82.431 |
Acute embolism and thrombosis of right popliteal vein |
| I82.432 |
Acute embolism and thrombosis of left popliteal vein |
| I82.433 |
Acute embolism and thrombosis of popliteal vein, bilateral |
| I82.439 |
Acute embolism and thrombosis of unspecified popliteal vein |
| I82.441 |
Acute embolism and thrombosis of right tibial vein |
| I82.442 |
Acute embolism and thrombosis of left tibial vein |
| I82.443 |
Acute embolism and thrombosis of tibial vein, bilateral |
| I82.449 |
Acute embolism and thrombosis of unspecified tibial vein |
| I82.451 |
Acute embolism and thrombosis of right peroneal vein |
| I82.452 |
Acute embolism and thrombosis of left peroneal vein |
| I82.453 |
Acute embolism and thrombosis of peroneal vein, bilateral |
| I82.461 |
Acute embolism and thrombosis of right calf muscular vein |
| I82.462 |
Acute embolism and thrombosis of left calf muscular vein |
| I82.463 |
Acute embolism and thrombosis of calf muscular vein, bilateral |
| I82.491 |
Acute embolism and thrombosis of other specified deep vein of right lower extremity |
| I82.492 |
Acute embolism and thrombosis of other specified deep vein of left lower extremity |
| I82.493 |
Acute embolism and thrombosis of other specified deep vein of lower extremity, bilateral |
| I82.499 |
Acute embolism and thrombosis of other specified deep vein of unspecified lower extremity |
| I82.4Y1 |
Acute embolism and thrombosis of unspecified deep veins of right proximal lower extremity |
| I82.4Y2 |
Acute embolism and thrombosis of unspecified deep veins of left proximal lower extremity |
| I82.4Y3 |
Acute embolism and thrombosis of unspecified deep veins of proximal lower extremity, bilateral |
| I82.4Y9 |
Acute embolism and thrombosis of unspecified deep veins of unspecified proximal lower extremity |
| I82.4Z1 |
Acute embolism and thrombosis of unspecified deep veins of right distal lower extremity |
| I82.4Z2 |
Acute embolism and thrombosis of unspecified deep veins of left distal lower extremity |
| I82.4Z3 |
Acute embolism and thrombosis of unspecified deep veins of distal lower extremity, bilateral |
| I82.4Z9 |
Acute embolism and thrombosis of unspecified deep veins of unspecified distal lower extremity |
| I82.501 |
Chronic embolism and thrombosis of unspecified deep veins of right lower extremity |
| I82.502 |
Chronic embolism and thrombosis of unspecified deep veins of left lower extremity |
| I82.503 |
Chronic embolism and thrombosis of unspecified deep veins of lower extremity, bilateral |
| I82.509 |
Chronic embolism and thrombosis of unspecified deep veins of unspecified lower extremity |
| I82.511 |
Chronic embolism and thrombosis of right femoral vein |
| I82.512 |
Chronic embolism and thrombosis of left femoral vein |
| I82.513 |
Chronic embolism and thrombosis of femoral vein, bilateral |
| I82.519 |
Chronic embolism and thrombosis of unspecified femoral vein |
| I82.521 |
Chronic embolism and thrombosis of right iliac vein |
| I82.522 |
Chronic embolism and thrombosis of left iliac vein |
| I82.523 |
Chronic embolism and thrombosis of iliac vein, bilateral |
| I82.529 |
Chronic embolism and thrombosis of unspecified iliac vein |
| I82.531 |
Chronic embolism and thrombosis of right popliteal vein |
| I82.532 |
Chronic embolism and thrombosis of left popliteal vein |
| I82.533 |
Chronic embolism and thrombosis of popliteal vein, bilateral |
| I82.539 |
Chronic embolism and thrombosis of unspecified popliteal vein |
| I82.541 |
Chronic embolism and thrombosis of right tibial vein |
| I82.542 |
Chronic embolism and thrombosis of left tibial vein |
| I82.543 |
Chronic embolism and thrombosis of tibial vein, bilateral |
| I82.549 |
Chronic embolism and thrombosis of unspecified tibial vein |
| I82.551 |
Chronic embolism and thrombosis of right peroneal vein |
| I82.552 |
Chronic embolism and thrombosis of left peroneal vein |
| I82.553 |
Chronic embolism and thrombosis of peroneal vein, bilateral |
| I82.561 |
Chronic embolism and thrombosis of right calf muscular vein |
| I82.562 |
Chronic embolism and thrombosis of left calf muscular vein |
| I82.563 |
Chronic embolism and thrombosis of calf muscular vein, bilateral |
| I82.591 |
Chronic embolism and thrombosis of other specified deep vein of right lower extremity |
| I82.592 |
Chronic embolism and thrombosis of other specified deep vein of left lower extremity |
| I82.593 |
Chronic embolism and thrombosis of other specified deep vein of lower extremity, bilateral |
| I82.599 |
Chronic embolism and thrombosis of other specified deep vein of unspecified lower extremity |
| I82.5Y1 |
Chronic embolism and thrombosis of unspecified deep veins of right proximal lower extremity |
| I82.5Y2 |
Chronic embolism and thrombosis of unspecified deep veins of left proximal lower extremity |
| I82.5Y3 |
Chronic embolism and thrombosis of unspecified deep veins of proximal lower extremity, bilateral |
| I82.5Y9 |
Chronic embolism and thrombosis of unspecified deep veins of unspecified proximal lower extremity |
| I82.5Z1 |
Chronic embolism and thrombosis of unspecified deep veins of right distal lower extremity |
| I82.5Z2 |
Chronic embolism and thrombosis of unspecified deep veins of left distal lower extremity |
| I82.5Z3 |
Chronic embolism and thrombosis of unspecified deep veins of distal lower extremity, bilateral |
| I82.5Z9 |
Chronic embolism and thrombosis of unspecified deep veins of unspecified distal lower extremity |
| I82.601 |
Acute embolism and thrombosis of unspecified veins of right upper extremity |
| I82.602 |
Acute embolism and thrombosis of unspecified veins of left upper extremity |
| I82.603 |
Acute embolism and thrombosis of unspecified veins of upper extremity, bilateral |
| I82.609 |
Acute embolism and thrombosis of unspecified veins of unspecified upper extremity |
| I82.611 |
Acute embolism and thrombosis of superficial veins of right upper extremity |
| I82.612 |
Acute embolism and thrombosis of superficial veins of left upper extremity |
| I82.613 |
Acute embolism and thrombosis of superficial veins of upper extremity, bilateral |
| I82.619 |
Acute embolism and thrombosis of superficial veins of unspecified upper extremity |
| I82.621 |
Acute embolism and thrombosis of deep veins of right upper extremity |
| I82.622 |
Acute embolism and thrombosis of deep veins of left upper extremity |
| I82.623 |
Acute embolism and thrombosis of deep veins of upper extremity, bilateral |
| I82.629 |
Acute embolism and thrombosis of deep veins of unspecified upper extremity |
| I82.701 |
Chronic embolism and thrombosis of unspecified veins of right upper extremity |
| I82.702 |
Chronic embolism and thrombosis of unspecified veins of left upper extremity |
| I82.703 |
Chronic embolism and thrombosis of unspecified veins of upper extremity, bilateral |
| I82.709 |
Chronic embolism and thrombosis of unspecified veins of unspecified upper extremity |
| I82.711 |
Chronic embolism and thrombosis of superficial veins of right upper extremity |
| I82.712 |
Chronic embolism and thrombosis of superficial veins of left upper extremity |
| I82.713 |
Chronic embolism and thrombosis of superficial veins of upper extremity, bilateral |
| I82.719 |
Chronic embolism and thrombosis of superficial veins of unspecified upper extremity |
| I82.721 |
Chronic embolism and thrombosis of deep veins of right upper extremity |
| I82.722 |
Chronic embolism and thrombosis of deep veins of left upper extremity |
| I82.723 |
Chronic embolism and thrombosis of deep veins of upper extremity, bilateral |
| I82.729 |
Chronic embolism and thrombosis of deep veins of unspecified upper extremity |
| I82.811 |
Embolism and thrombosis of superficial veins of right lower extremity |
| I82.812 |
Embolism and thrombosis of superficial veins of left lower extremity |
| I82.813 |
Embolism and thrombosis of superficial veins of lower extremities, bilateral |
| I82.819 |
Embolism and thrombosis of superficial veins of unspecified lower extremity |
| I82.890 |
Acute embolism and thrombosis of other specified veins |
| I82.891 |
Chronic embolism and thrombosis of other specified veins |
| I82.90 |
Acute embolism and thrombosis of unspecified vein |
| I82.91 |
Chronic embolism and thrombosis of unspecified vein |
| I82.A11 |
Acute embolism and thrombosis of right axillary vein |
| I82.A12 |
Acute embolism and thrombosis of left axillary vein |
| I82.A13 |
Acute embolism and thrombosis of axillary vein, bilateral |
| I82.A19 |
Acute embolism and thrombosis of unspecified axillary vein |
| I82.A21 |
Chronic embolism and thrombosis of right axillary vein |
| I82.A22 |
Chronic embolism and thrombosis of left axillary vein |
| I82.A23 |
Chronic embolism and thrombosis of axillary vein, bilateral |
| I82.A29 |
Chronic embolism and thrombosis of unspecified axillary vein |
| I82.B11 |
Acute embolism and thrombosis of right subclavian vein |
| I82.B12 |
Acute embolism and thrombosis of left subclavian vein |
| I82.B13 |
Acute embolism and thrombosis of subclavian vein, bilateral |
| I82.B19 |
Acute embolism and thrombosis of unspecified subclavian vein |
| I82.B21 |
Chronic embolism and thrombosis of right subclavian vein |
| I82.B22 |
Chronic embolism and thrombosis of left subclavian vein |
| I82.B23 |
Chronic embolism and thrombosis of subclavian vein, bilateral |
| I82.B29 |
Chronic embolism and thrombosis of unspecified subclavian vein |
| I82.C11 |
Acute embolism and thrombosis of right internal jugular vein |
| I82.C12 |
Acute embolism and thrombosis of left internal jugular vein |
| I82.C13 |
Acute embolism and thrombosis of internal jugular vein, bilateral |
| I82.C19 |
Acute embolism and thrombosis of unspecified internal jugular vein |
| I82.C21 |
Chronic embolism and thrombosis of right internal jugular vein |
| I82.C22 |
Chronic embolism and thrombosis of left internal jugular vein |
| I82.C23 |
Chronic embolism and thrombosis of internal jugular vein, bilateral |
| I82.C29 |
Chronic embolism and thrombosis of unspecified internal jugular vein |
| I85.00 |
Esophageal varices without bleeding |
| I85.01 |
Esophageal varices with bleeding |
| I85.10 |
Secondary esophageal varices without bleeding |
| I85.11 |
Secondary esophageal varices with bleeding |
| J17 |
Pneumonia in diseases classified elsewhere |
| K50.00 |
Crohn's disease of small intestine without complications |
| K50.011 |
Crohn's disease of small intestine with rectal bleeding |
| K50.012 |
Crohn's disease of small intestine with intestinal obstruction |
| K50.013 |
Crohn's disease of small intestine with fistula |
| K50.014 |
Crohn's disease of small intestine with abscess |
| K50.018 |
Crohn's disease of small intestine with other complication |
| K50.019 |
Crohn's disease of small intestine with unspecified complications |
| K50.10 |
Crohn's disease of large intestine without complications |
| K50.111 |
Crohn's disease of large intestine with rectal bleeding |
| K50.112 |
Crohn's disease of large intestine with intestinal obstruction |
| K50.113 |
Crohn's disease of large intestine with fistula |
| K50.114 |
Crohn's disease of large intestine with abscess |
| K50.118 |
Crohn's disease of large intestine with other complication |
| K50.119 |
Crohn's disease of large intestine with unspecified complications |
| K50.80 |
Crohn's disease of both small and large intestine without complications |
| K50.811 |
Crohn's disease of both small and large intestine with rectal bleeding |
| K50.812 |
Crohn's disease of both small and large intestine with intestinal obstruction |
| K50.813 |
Crohn's disease of both small and large intestine with fistula |
| K50.814 |
Crohn's disease of both small and large intestine with abscess |
| K50.818 |
Crohn's disease of both small and large intestine with other complication |
| K50.819 |
Crohn's disease of both small and large intestine with unspecified complications |
| K50.90 |
Crohn's disease, unspecified, without complications |
| K50.911 |
Crohn's disease, unspecified, with rectal bleeding |
| K50.912 |
Crohn's disease, unspecified, with intestinal obstruction |
| K50.913 |
Crohn's disease, unspecified, with fistula |
| K50.914 |
Crohn's disease, unspecified, with abscess |
| K50.918 |
Crohn's disease, unspecified, with other complication |
| K50.919 |
Crohn's disease, unspecified, with unspecified complications |
| K51.00 |
Ulcerative (chronic) pancolitis without complications |
| K51.011 |
Ulcerative (chronic) pancolitis with rectal bleeding |
| K51.012 |
Ulcerative (chronic) pancolitis with intestinal obstruction |
| K51.013 |
Ulcerative (chronic) pancolitis with fistula |
| K51.014 |
Ulcerative (chronic) pancolitis with abscess |
| K51.018 |
Ulcerative (chronic) pancolitis with other complication |
| K51.019 |
Ulcerative (chronic) pancolitis with unspecified complications |
| K51.20 |
Ulcerative (chronic) proctitis without complications |
| K51.211 |
Ulcerative (chronic) proctitis with rectal bleeding |
| K51.212 |
Ulcerative (chronic) proctitis with intestinal obstruction |
| K51.213 |
Ulcerative (chronic) proctitis with fistula |
| K51.214 |
Ulcerative (chronic) proctitis with abscess |
| K51.218 |
Ulcerative (chronic) proctitis with other complication |
| K51.219 |
Ulcerative (chronic) proctitis with unspecified complications |
| K51.30 |
Ulcerative (chronic) rectosigmoiditis without complications |
| K51.311 |
Ulcerative (chronic) rectosigmoiditis with rectal bleeding |
| K51.312 |
Ulcerative (chronic) rectosigmoiditis with intestinal obstruction |
| K51.313 |
Ulcerative (chronic) rectosigmoiditis with fistula |
| K51.314 |
Ulcerative (chronic) rectosigmoiditis with abscess |
| K51.318 |
Ulcerative (chronic) rectosigmoiditis with other complication |
| K51.319 |
Ulcerative (chronic) rectosigmoiditis with unspecified complications |
| K51.40 |
Inflammatory polyps of colon without complications |
| K51.411 |
Inflammatory polyps of colon with rectal bleeding |
| K51.412 |
Inflammatory polyps of colon with intestinal obstruction |
| K51.413 |
Inflammatory polyps of colon with fistula |
| K51.414 |
Inflammatory polyps of colon with abscess |
| K51.418 |
Inflammatory polyps of colon with other complication |
| K51.419 |
Inflammatory polyps of colon with unspecified complications |
| K51.50 |
Left sided colitis without complications |
| K51.511 |
Left sided colitis with rectal bleeding |
| K51.512 |
Left sided colitis with intestinal obstruction |
| K51.513 |
Left sided colitis with fistula |
| K51.514 |
Left sided colitis with abscess |
| K51.518 |
Left sided colitis with other complication |
| K51.519 |
Left sided colitis with unspecified complications |
| K51.80 |
Other ulcerative colitis without complications |
| K51.811 |
Other ulcerative colitis with rectal bleeding |
| K51.812 |
Other ulcerative colitis with intestinal obstruction |
| K51.813 |
Other ulcerative colitis with fistula |
| K51.814 |
Other ulcerative colitis with abscess |
| K51.818 |
Other ulcerative colitis with other complication |
| K51.819 |
Other ulcerative colitis with unspecified complications |
| K51.90 |
Ulcerative colitis, unspecified, without complications |
| K51.911 |
Ulcerative colitis, unspecified with rectal bleeding |
| K51.912 |
Ulcerative colitis, unspecified with intestinal obstruction |
| K51.913 |
Ulcerative colitis, unspecified with fistula |
| K51.914 |
Ulcerative colitis, unspecified with abscess |
| K51.918 |
Ulcerative colitis, unspecified with other complication |
| K51.919 |
Ulcerative colitis, unspecified with unspecified complications |
| K52.0 |
Gastroenteritis and colitis due to radiation |
| K52.1 |
Toxic gastroenteritis and colitis |
| K52.21 |
Food protein-induced enterocolitis syndrome |
| K52.22 |
Food protein-induced enteropathy |
| K52.29 |
Other allergic and dietetic gastroenteritis and colitis |
| K52.3 |
Indeterminate colitis |
| K52.81 |
Eosinophilic gastritis or gastroenteritis |
| K52.82 |
Eosinophilic colitis |
| K52.831 |
Collagenous colitis |
| K52.832 |
Lymphocytic colitis |
| K52.838 |
Other microscopic colitis |
| K52.839 |
Microscopic colitis, unspecified |
| K52.89 |
Other specified noninfective gastroenteritis and colitis |
| K52.9 |
Noninfective gastroenteritis and colitis, unspecified |
| K55.011 |
Focal (segmental) acute (reversible) ischemia of small intestine |
| K55.012 |
Diffuse acute (reversible) ischemia of small intestine |
| K55.019 |
Acute (reversible) ischemia of small intestine, extent unspecified |
| K55.021 |
Focal (segmental) acute infarction of small intestine |
| K55.022 |
Diffuse acute infarction of small intestine |
| K55.029 |
Acute infarction of small intestine, extent unspecified |
| K55.031 |
Focal (segmental) acute (reversible) ischemia of large intestine |
| K55.032 |
Diffuse acute (reversible) ischemia of large intestine |
| K55.039 |
Acute (reversible) ischemia of large intestine, extent unspecified |
| K55.041 |
Focal (segmental) acute infarction of large intestine |
| K55.042 |
Diffuse acute infarction of large intestine |
| K55.049 |
Acute infarction of large intestine, extent unspecified |
| K55.051 |
Focal (segmental) acute (reversible) ischemia of intestine, part unspecified |
| K55.052 |
Diffuse acute (reversible) ischemia of intestine, part unspecified |
| K55.059 |
Acute (reversible) ischemia of intestine, part and extent unspecified |
| K55.061 |
Focal (segmental) acute infarction of intestine, part unspecified |
| K55.062 |
Diffuse acute infarction of intestine, part unspecified |
| K55.069 |
Acute infarction of intestine, part and extent unspecified |
| K55.30 |
Necrotizing enterocolitis, unspecified |
| K55.31 |
Stage 1 necrotizing enterocolitis |
| K55.32 |
Stage 2 necrotizing enterocolitis |
| K55.33 |
Stage 3 necrotizing enterocolitis |
| K56.0 |
Paralytic ileus |
| K56.1 |
Intussusception |
| K56.2 |
Volvulus |
| K56.3 |
Gallstone ileus |
| K56.41 |
Fecal impaction |
| K56.49 |
Other impaction of intestine |
| K56.50 |
Intestinal adhesions [bands], unspecified as to partial versus complete obstruction |
| K56.51 |
Intestinal adhesions [bands], with partial obstruction |
| K56.52 |
Intestinal adhesions [bands] with complete obstruction |
| K56.600 |
Partial intestinal obstruction, unspecified as to cause |
| K56.601 |
Complete intestinal obstruction, unspecified as to cause |
| K56.609 |
Unspecified intestinal obstruction, unspecified as to partial versus complete obstruction |
| K56.690 |
Other partial intestinal obstruction |
| K56.691 |
Other complete intestinal obstruction |
| K56.699 |
Other intestinal obstruction unspecified as to partial versus complete obstruction |
| K56.7 |
Ileus, unspecified |
| K57.00 |
Diverticulitis of small intestine with perforation and abscess without bleeding |
| K57.01 |
Diverticulitis of small intestine with perforation and abscess with bleeding |
| K57.12 |
Diverticulitis of small intestine without perforation or abscess without bleeding |
| K57.13 |
Diverticulitis of small intestine without perforation or abscess with bleeding |
| K57.20 |
Diverticulitis of large intestine with perforation and abscess without bleeding |
| K57.21 |
Diverticulitis of large intestine with perforation and abscess with bleeding |
| K57.32 |
Diverticulitis of large intestine without perforation or abscess without bleeding |
| K57.33 |
Diverticulitis of large intestine without perforation or abscess with bleeding |
| K57.40 |
Diverticulitis of both small and large intestine with perforation and abscess without bleeding |
| K57.41 |
Diverticulitis of both small and large intestine with perforation and abscess with bleeding |
| K57.52 |
Diverticulitis of both small and large intestine without perforation or abscess without bleeding |
| K57.53 |
Diverticulitis of both small and large intestine without perforation or abscess with bleeding |
| K57.80 |
Diverticulitis of intestine, part unspecified, with perforation and abscess without bleeding |
| K57.81 |
Diverticulitis of intestine, part unspecified, with perforation and abscess with bleeding |
| K57.92 |
Diverticulitis of intestine, part unspecified, without perforation or abscess without bleeding |
| K57.93 |
Diverticulitis of intestine, part unspecified, without perforation or abscess with bleeding |
| K59.31 |
Toxic megacolon |
| K63.1 |
Perforation of intestine (nontraumatic) |
| K65.0 |
Generalized (acute) peritonitis |
| K65.1 |
Peritoneal abscess |
| K65.2 |
Spontaneous bacterial peritonitis |
| K65.3 |
Choleperitonitis |
| K65.4 |
Sclerosing mesenteritis |
| K65.8 |
Other peritonitis |
| K65.9 |
Peritonitis, unspecified |
| K67 |
Disorders of peritoneum in infectious diseases classified elsewhere |
| K68.19 |
Other retroperitoneal abscess |
| K68.9 |
Other disorders of retroperitoneum |
| K70.0 |
Alcoholic fatty liver |
| K70.10 |
Alcoholic hepatitis without ascites |
| K70.11 |
Alcoholic hepatitis with ascites |
| K70.2 |
Alcoholic fibrosis and sclerosis of liver |
| K70.30 |
Alcoholic cirrhosis of liver without ascites |
| K70.31 |
Alcoholic cirrhosis of liver with ascites |
| K70.40 |
Alcoholic hepatic failure without coma |
| K70.41 |
Alcoholic hepatic failure with coma |
| K70.9 |
Alcoholic liver disease, unspecified |
| K71.0 |
Toxic liver disease with cholestasis |
| K71.10 |
Toxic liver disease with hepatic necrosis, without coma |
| K71.11 |
Toxic liver disease with hepatic necrosis, with coma |
| K71.2 |
Toxic liver disease with acute hepatitis |
| K71.3 |
Toxic liver disease with chronic persistent hepatitis |
| K71.4 |
Toxic liver disease with chronic lobular hepatitis |
| K71.50 |
Toxic liver disease with chronic active hepatitis without ascites |
| K71.51 |
Toxic liver disease with chronic active hepatitis with ascites |
| K71.6 |
Toxic liver disease with hepatitis, not elsewhere classified |
| K71.7 |
Toxic liver disease with fibrosis and cirrhosis of liver |
| K71.8 |
Toxic liver disease with other disorders of liver |
| K71.9 |
Toxic liver disease, unspecified |
| K72.00 |
Acute and subacute hepatic failure without coma |
| K72.01 |
Acute and subacute hepatic failure with coma |
| K72.10 |
Chronic hepatic failure without coma |
| K72.11 |
Chronic hepatic failure with coma |
| K72.90 |
Hepatic failure, unspecified without coma |
| K72.91 |
Hepatic failure, unspecified with coma |
| K73.0 |
Chronic persistent hepatitis, not elsewhere classified |
| K73.1 |
Chronic lobular hepatitis, not elsewhere classified |
| K73.2 |
Chronic active hepatitis, not elsewhere classified |
| K73.8 |
Other chronic hepatitis, not elsewhere classified |
| K73.9 |
Chronic hepatitis, unspecified |
| K74.00 |
Hepatic fibrosis, unspecified |
| K74.01 |
Hepatic fibrosis, early fibrosis |
| K74.02 |
Hepatic fibrosis, advanced fibrosis |
| K74.1 |
Hepatic sclerosis |
| K74.2 |
Hepatic fibrosis with hepatic sclerosis |
| K74.3 |
Primary biliary cirrhosis |
| K74.4 |
Secondary biliary cirrhosis |
| K74.5 |
Biliary cirrhosis, unspecified |
| K74.60 |
Unspecified cirrhosis of liver |
| K74.69 |
Other cirrhosis of liver |
| K75.0 |
Abscess of liver |
| K75.1 |
Phlebitis of portal vein |
| K75.2 |
Nonspecific reactive hepatitis |
| K75.3 |
Granulomatous hepatitis, not elsewhere classified |
| K75.4 |
Autoimmune hepatitis |
| K75.81 |
Nonalcoholic steatohepatitis (NASH) |
| K75.89 |
Other specified inflammatory liver diseases |
| K75.9 |
Inflammatory liver disease, unspecified |
| K76.0 |
Fatty (change of) liver, not elsewhere classified |
| K76.1 |
Chronic passive congestion of liver |
| K76.2 |
Central hemorrhagic necrosis of liver |
| K76.3 |
Infarction of liver |
| K76.4 |
Peliosis hepatis |
| K76.5 |
Hepatic veno-occlusive disease |
| K76.6 |
Portal hypertension |
| K76.7 |
Hepatorenal syndrome |
| K76.81 |
Hepatopulmonary syndrome |
| K76.82 |
Hepatic encephalopathy |
| K76.89 |
Other specified diseases of liver |
| K76.9 |
Liver disease, unspecified |
| K77 |
Liver disorders in diseases classified elsewhere |
| K80.00 |
Calculus of gallbladder with acute cholecystitis without obstruction |
| K80.01 |
Calculus of gallbladder with acute cholecystitis with obstruction |
| K80.10 |
Calculus of gallbladder with chronic cholecystitis without obstruction |
| K80.11 |
Calculus of gallbladder with chronic cholecystitis with obstruction |
| K80.12 |
Calculus of gallbladder with acute and chronic cholecystitis without obstruction |
| K80.13 |
Calculus of gallbladder with acute and chronic cholecystitis with obstruction |
| K80.18 |
Calculus of gallbladder with other cholecystitis without obstruction |
| K80.19 |
Calculus of gallbladder with other cholecystitis with obstruction |
| K80.20 |
Calculus of gallbladder without cholecystitis without obstruction |
| K80.21 |
Calculus of gallbladder without cholecystitis with obstruction |
| K80.30 |
Calculus of bile duct with cholangitis, unspecified, without obstruction |
| K80.31 |
Calculus of bile duct with cholangitis, unspecified, with obstruction |
| K80.32 |
Calculus of bile duct with acute cholangitis without obstruction |
| K80.33 |
Calculus of bile duct with acute cholangitis with obstruction |
| K80.34 |
Calculus of bile duct with chronic cholangitis without obstruction |
| K80.35 |
Calculus of bile duct with chronic cholangitis with obstruction |
| K80.36 |
Calculus of bile duct with acute and chronic cholangitis without obstruction |
| K80.37 |
Calculus of bile duct with acute and chronic cholangitis with obstruction |
| K80.40 |
Calculus of bile duct with cholecystitis, unspecified, without obstruction |
| K80.41 |
Calculus of bile duct with cholecystitis, unspecified, with obstruction |
| K80.42 |
Calculus of bile duct with acute cholecystitis without obstruction |
| K80.43 |
Calculus of bile duct with acute cholecystitis with obstruction |
| K80.44 |
Calculus of bile duct with chronic cholecystitis without obstruction |
| K80.45 |
Calculus of bile duct with chronic cholecystitis with obstruction |
| K80.46 |
Calculus of bile duct with acute and chronic cholecystitis without obstruction |
| K80.47 |
Calculus of bile duct with acute and chronic cholecystitis with obstruction |
| K80.50 |
Calculus of bile duct without cholangitis or cholecystitis without obstruction |
| K80.51 |
Calculus of bile duct without cholangitis or cholecystitis with obstruction |
| K80.60 |
Calculus of gallbladder and bile duct with cholecystitis, unspecified, without obstruction |
| K80.61 |
Calculus of gallbladder and bile duct with cholecystitis, unspecified, with obstruction |
| K80.62 |
Calculus of gallbladder and bile duct with acute cholecystitis without obstruction |
| K80.63 |
Calculus of gallbladder and bile duct with acute cholecystitis with obstruction |
| K80.64 |
Calculus of gallbladder and bile duct with chronic cholecystitis without obstruction |
| K80.65 |
Calculus of gallbladder and bile duct with chronic cholecystitis with obstruction |
| K80.66 |
Calculus of gallbladder and bile duct with acute and chronic cholecystitis without obstruction |
| K80.67 |
Calculus of gallbladder and bile duct with acute and chronic cholecystitis with obstruction |
| K80.70 |
Calculus of gallbladder and bile duct without cholecystitis without obstruction |
| K80.71 |
Calculus of gallbladder and bile duct without cholecystitis with obstruction |
| K80.80 |
Other cholelithiasis without obstruction |
| K80.81 |
Other cholelithiasis with obstruction |
| K81.0 |
Acute cholecystitis |
| K81.1 |
Chronic cholecystitis |
| K81.2 |
Acute cholecystitis with chronic cholecystitis |
| K81.9 |
Cholecystitis, unspecified |
| K82.0 |
Obstruction of gallbladder |
| K82.1 |
Hydrops of gallbladder |
| K82.2 |
Perforation of gallbladder |
| K82.3 |
Fistula of gallbladder |
| K82.4 |
Cholesterolosis of gallbladder |
| K82.8 |
Other specified diseases of gallbladder |
| K82.9 |
Disease of gallbladder, unspecified |
| K82.A1 |
Gangrene of gallbladder in cholecystitis |
| K82.A2 |
Perforation of gallbladder in cholecystitis |
| K83.01 |
Primary sclerosing cholangitis |
| K83.09 |
Other cholangitis |
| K83.1 |
Obstruction of bile duct |
| K83.2 |
Perforation of bile duct |
| K83.3 |
Fistula of bile duct |
| K83.4 |
Spasm of sphincter of Oddi |
| K83.5 |
Biliary cyst |
| K83.8 |
Other specified diseases of biliary tract |
| K83.9 |
Disease of biliary tract, unspecified |
| K87 |
Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere |
| K91.5 |
Postcholecystectomy syndrome |
| M04.1 |
Periodic fever syndromes |
| M1A.10X0 |
Lead-induced chronic gout, unspecified site, without tophus (tophi) |
| M1A.10X1 |
Lead-induced chronic gout, unspecified site, with tophus (tophi) |
| M1A.1110 |
Lead-induced chronic gout, right shoulder, without tophus (tophi) |
| M1A.1111 |
Lead-induced chronic gout, right shoulder, with tophus (tophi) |
| M1A.1120 |
Lead-induced chronic gout, left shoulder, without tophus (tophi) |
| M1A.1121 |
Lead-induced chronic gout, left shoulder, with tophus (tophi) |
| M1A.1190 |
Lead-induced chronic gout, unspecified shoulder, without tophus (tophi) |
| M1A.1191 |
Lead-induced chronic gout, unspecified shoulder, with tophus (tophi) |
| M1A.1210 |
Lead-induced chronic gout, right elbow, without tophus (tophi) |
| M1A.1211 |
Lead-induced chronic gout, right elbow, with tophus (tophi) |
| M1A.1220 |
Lead-induced chronic gout, left elbow, without tophus (tophi) |
| M1A.1221 |
Lead-induced chronic gout, left elbow, with tophus (tophi) |
| M1A.1290 |
Lead-induced chronic gout, unspecified elbow, without tophus (tophi) |
| M1A.1291 |
Lead-induced chronic gout, unspecified elbow, with tophus (tophi) |
| M1A.1310 |
Lead-induced chronic gout, right wrist, without tophus (tophi) |
| M1A.1311 |
Lead-induced chronic gout, right wrist, with tophus (tophi) |
| M1A.1320 |
Lead-induced chronic gout, left wrist, without tophus (tophi) |
| M1A.1321 |
Lead-induced chronic gout, left wrist, with tophus (tophi) |
| M1A.1390 |
Lead-induced chronic gout, unspecified wrist, without tophus (tophi) |
| M1A.1391 |
Lead-induced chronic gout, unspecified wrist, with tophus (tophi) |
| M1A.1410 |
Lead-induced chronic gout, right hand, without tophus (tophi) |
| M1A.1411 |
Lead-induced chronic gout, right hand, with tophus (tophi) |
| M1A.1420 |
Lead-induced chronic gout, left hand, without tophus (tophi) |
| M1A.1421 |
Lead-induced chronic gout, left hand, with tophus (tophi) |
| M1A.1490 |
Lead-induced chronic gout, unspecified hand, without tophus (tophi) |
| M1A.1491 |
Lead-induced chronic gout, unspecified hand, with tophus (tophi) |
| M1A.1510 |
Lead-induced chronic gout, right hip, without tophus (tophi) |
| M1A.1511 |
Lead-induced chronic gout, right hip, with tophus (tophi) |
| M1A.1520 |
Lead-induced chronic gout, left hip, without tophus (tophi) |
| M1A.1521 |
Lead-induced chronic gout, left hip, with tophus (tophi) |
| M1A.1590 |
Lead-induced chronic gout, unspecified hip, without tophus (tophi) |
| M1A.1591 |
Lead-induced chronic gout, unspecified hip, with tophus (tophi) |
| M1A.1610 |
Lead-induced chronic gout, right knee, without tophus (tophi) |
| M1A.1611 |
Lead-induced chronic gout, right knee, with tophus (tophi) |
| M1A.1620 |
Lead-induced chronic gout, left knee, without tophus (tophi) |
| M1A.1621 |
Lead-induced chronic gout, left knee, with tophus (tophi) |
| M1A.1690 |
Lead-induced chronic gout, unspecified knee, without tophus (tophi) |
| M1A.1691 |
Lead-induced chronic gout, unspecified knee, with tophus (tophi) |
| M1A.1710 |
Lead-induced chronic gout, right ankle and foot, without tophus (tophi) |
| M1A.1711 |
Lead-induced chronic gout, right ankle and foot, with tophus (tophi) |
| M1A.1720 |
Lead-induced chronic gout, left ankle and foot, without tophus (tophi) |
| M1A.1721 |
Lead-induced chronic gout, left ankle and foot, with tophus (tophi) |
| M1A.1790 |
Lead-induced chronic gout, unspecified ankle and foot, without tophus (tophi) |
| M1A.1791 |
Lead-induced chronic gout, unspecified ankle and foot, with tophus (tophi) |
| M1A.18X0 |
Lead-induced chronic gout, vertebrae, without tophus (tophi) |
| M1A.18X1 |
Lead-induced chronic gout, vertebrae, with tophus (tophi) |
| M1A.19X0 |
Lead-induced chronic gout, multiple sites, without tophus (tophi) |
| M1A.19X1 |
Lead-induced chronic gout, multiple sites, with tophus (tophi) |
| M32.14 |
Glomerular disease in systemic lupus erythematosus |
| M32.15 |
Tubulo-interstitial nephropathy in systemic lupus erythematosus |
| M35.04 |
Sjogren syndrome with tubulo-interstitial nephropathy |
| M83.0 |
Puerperal osteomalacia |
| M83.1 |
Senile osteomalacia |
| M83.2 |
Adult osteomalacia due to malabsorption |
| M83.3 |
Adult osteomalacia due to malnutrition |
| M83.4 |
Aluminum bone disease |
| M83.5 |
Other drug-induced osteomalacia in adults |
| M83.8 |
Other adult osteomalacia |
| M83.9 |
Adult osteomalacia, unspecified |
| N00.A |
Acute nephritic syndrome with C3 glomerulonephritis |
| N01.A |
Rapidly progressive nephritic syndrome with C3 glomerulonephritis |
| N02.0 |
Recurrent and persistent hematuria with minor glomerular abnormality |
| N02.1 |
Recurrent and persistent hematuria with focal and segmental glomerular lesions |
| N02.2 |
Recurrent and persistent hematuria with diffuse membranous glomerulonephritis |
| N02.3 |
Recurrent and persistent hematuria with diffuse mesangial proliferative glomerulonephritis |
| N02.4 |
Recurrent and persistent hematuria with diffuse endocapillary proliferative glomerulonephritis |
| N02.5 |
Recurrent and persistent hematuria with diffuse mesangiocapillary glomerulonephritis |
| N02.6 |
Recurrent and persistent hematuria with dense deposit disease |
| N02.7 |
Recurrent and persistent hematuria with diffuse crescentic glomerulonephritis |
| N02.8 |
Recurrent and persistent hematuria with other morphologic changes |
| N02.9 |
Recurrent and persistent hematuria with unspecified morphologic changes |
| N02.A |
Recurrent and persistent hematuria with C3 glomerulonephritis |
| N03.0 |
Chronic nephritic syndrome with minor glomerular abnormality |
| N03.1 |
Chronic nephritic syndrome with focal and segmental glomerular lesions |
| N03.2 |
Chronic nephritic syndrome with diffuse membranous glomerulonephritis |
| N03.3 |
Chronic nephritic syndrome with diffuse mesangial proliferative glomerulonephritis |
| N03.4 |
Chronic nephritic syndrome with diffuse endocapillary proliferative glomerulonephritis |
| N03.5 |
Chronic nephritic syndrome with diffuse mesangiocapillary glomerulonephritis |
| N03.6 |
Chronic nephritic syndrome with dense deposit disease |
| N03.7 |
Chronic nephritic syndrome with diffuse crescentic glomerulonephritis |
| N03.8 |
Chronic nephritic syndrome with other morphologic changes |
| N03.9 |
Chronic nephritic syndrome with unspecified morphologic changes |
| N03.A |
Chronic nephritic syndrome with C3 glomerulonephritis |
| N04.0 |
Nephrotic syndrome with minor glomerular abnormality |
| N04.1 |
Nephrotic syndrome with focal and segmental glomerular lesions |
| N04.20 |
Nephrotic syndrome with diffuse membranous glomerulonephritis, unspecified |
| N04.21 |
Primary membranous nephropathy with nephrotic syndrome |
| N04.22 |
Secondary membranous nephropathy with nephrotic syndrome |
| N04.29 |
Other nephrotic syndrome with diffuse membranous glomerulonephritis |
| N04.3 |
Nephrotic syndrome with diffuse mesangial proliferative glomerulonephritis |
| N04.4 |
Nephrotic syndrome with diffuse endocapillary proliferative glomerulonephritis |
| N04.5 |
Nephrotic syndrome with diffuse mesangiocapillary glomerulonephritis |
| N04.6 |
Nephrotic syndrome with dense deposit disease |
| N04.7 |
Nephrotic syndrome with diffuse crescentic glomerulonephritis |
| N04.8 |
Nephrotic syndrome with other morphologic changes |
| N04.9 |
Nephrotic syndrome with unspecified morphologic changes |
| N04.A |
Nephrotic syndrome with C3 glomerulonephritis |
| N05.0 |
Unspecified nephritic syndrome with minor glomerular abnormality |
| N05.1 |
Unspecified nephritic syndrome with focal and segmental glomerular lesions |
| N05.2 |
Unspecified nephritic syndrome with diffuse membranous glomerulonephritis |
| N05.3 |
Unspecified nephritic syndrome with diffuse mesangial proliferative glomerulonephritis |
| N05.4 |
Unspecified nephritic syndrome with diffuse endocapillary proliferative glomerulonephritis |
| N05.5 |
Unspecified nephritic syndrome with diffuse mesangiocapillary glomerulonephritis |
| N05.6 |
Unspecified nephritic syndrome with dense deposit disease |
| N05.7 |
Unspecified nephritic syndrome with diffuse crescentic glomerulonephritis |
| N05.8 |
Unspecified nephritic syndrome with other morphologic changes |
| N05.9 |
Unspecified nephritic syndrome with unspecified morphologic changes |
| N05.A |
Unspecified nephritic syndrome with C3 glomerulonephritis |
| N06.0 |
Isolated proteinuria with minor glomerular abnormality |
| N06.1 |
Isolated proteinuria with focal and segmental glomerular lesions |
| N06.20 |
Isolated proteinuria with diffuse membranous glomerulonephritis, unspecified |
| N06.21 |
Primary membranous nephropathy with isolated proteinuria |
| N06.22 |
Secondary membranous nephropathy with isolated proteinuria |
| N06.29 |
Other isolated proteinuria with diffuse membranous glomerulonephritis |
| N06.3 |
Isolated proteinuria with diffuse mesangial proliferative glomerulonephritis |
| N06.4 |
Isolated proteinuria with diffuse endocapillary proliferative glomerulonephritis |
| N06.5 |
Isolated proteinuria with diffuse mesangiocapillary glomerulonephritis |
| N06.6 |
Isolated proteinuria with dense deposit disease |
| N06.7 |
Isolated proteinuria with diffuse crescentic glomerulonephritis |
| N06.8 |
Isolated proteinuria with other morphologic lesion |
| N06.9 |
Isolated proteinuria with unspecified morphologic lesion |
| N06.A |
Isolated proteinuria with C3 glomerulonephritis |
| N07.0 |
Hereditary nephropathy, not elsewhere classified with minor glomerular abnormality |
| N07.1 |
Hereditary nephropathy, not elsewhere classified with focal and segmental glomerular lesions |
| N07.2 |
Hereditary nephropathy, not elsewhere classified with diffuse membranous glomerulonephritis |
| N07.3 |
Hereditary nephropathy, not elsewhere classified with diffuse mesangial proliferative glomerulonephritis |
| N07.4 |
Hereditary nephropathy, not elsewhere classified with diffuse endocapillary proliferative glomerulonephritis |
| N07.5 |
Hereditary nephropathy, not elsewhere classified with diffuse mesangiocapillary glomerulonephritis |
| N07.6 |
Hereditary nephropathy, not elsewhere classified with dense deposit disease |
| N07.7 |
Hereditary nephropathy, not elsewhere classified with diffuse crescentic glomerulonephritis |
| N07.8 |
Hereditary nephropathy, not elsewhere classified with other morphologic lesions |
| N07.9 |
Hereditary nephropathy, not elsewhere classified with unspecified morphologic lesions |
| N07.A |
Hereditary nephropathy, not elsewhere classified with C3 glomerulonephritis |
| N08 |
Glomerular disorders in diseases classified elsewhere |
| N10 |
Acute pyelonephritis |
| N11.0 |
Nonobstructive reflux-associated chronic pyelonephritis |
| N11.1 |
Chronic obstructive pyelonephritis |
| N11.8 |
Other chronic tubulo-interstitial nephritis |
| N11.9 |
Chronic tubulo-interstitial nephritis, unspecified |
| N12 |
Tubulo-interstitial nephritis, not specified as acute or chronic |
| N13.6 |
Pyonephrosis |
| N14.0 |
Analgesic nephropathy |
| N14.11 |
Contrast-induced nephropathy |
| N14.19 |
Nephropathy induced by other drugs, medicaments and biological substances |
| N14.2 |
Nephropathy induced by unspecified drug, medicament or biological substance |
| N14.3 |
Nephropathy induced by heavy metals |
| N14.4 |
Toxic nephropathy, not elsewhere classified |
| N15.0 |
Balkan nephropathy |
| N15.1 |
Renal and perinephric abscess |
| N15.8 |
Other specified renal tubulo-interstitial diseases |
| N15.9 |
Renal tubulo-interstitial disease, unspecified |
| N16 |
Renal tubulo-interstitial disorders in diseases classified elsewhere |
| N17.0 |
Acute kidney failure with tubular necrosis |
| N17.1 |
Acute kidney failure with acute cortical necrosis |
| N17.2 |
Acute kidney failure with medullary necrosis |
| N17.8 |
Other acute kidney failure |
| N17.9 |
Acute kidney failure, unspecified |
| N18.6 |
End stage renal disease |
| N19 |
Unspecified kidney failure |
| N25.0 |
Renal osteodystrophy |
| N25.1 |
Nephrogenic diabetes insipidus |
| N25.81 |
Secondary hyperparathyroidism of renal origin |
| N25.89 |
Other disorders resulting from impaired renal tubular function |
| N25.9 |
Disorder resulting from impaired renal tubular function, unspecified |
| N26.1 |
Atrophy of kidney (terminal) |
| N26.9 |
Renal sclerosis, unspecified |
| N28.84 |
Pyelitis cystica |
| N28.85 |
Pyeloureteritis cystica |
| N28.86 |
Ureteritis cystica |
| N61.20 |
Granulomatous mastitis, unspecified breast |
| N61.21 |
Granulomatous mastitis, right breast |
| N61.22 |
Granulomatous mastitis, left breast |
| N61.23 |
Granulomatous mastitis, bilateral breast |
| O14.10 |
Severe pre-eclampsia, unspecified trimester |
| O14.12 |
Severe pre-eclampsia, second trimester |
| O14.13 |
Severe pre-eclampsia, third trimester |
| O14.20 |
HELLP syndrome (HELLP), unspecified trimester |
| O14.22 |
HELLP syndrome (HELLP), second trimester |
| O14.23 |
HELLP syndrome (HELLP), third trimester |
| O26.611 |
Liver and biliary tract disorders in pregnancy, first trimester |
| O26.612 |
Liver and biliary tract disorders in pregnancy, second trimester |
| O26.613 |
Liver and biliary tract disorders in pregnancy, third trimester |
| O26.619 |
Liver and biliary tract disorders in pregnancy, unspecified trimester |
| O26.62 |
Liver and biliary tract disorders in childbirth |
| O30.131 |
Triplet pregnancy, trichorionic/triamniotic, first trimester |
| O30.132 |
Triplet pregnancy, trichorionic/triamniotic, second trimester |
| O30.133 |
Triplet pregnancy, trichorionic/triamniotic, third trimester |
| O30.139 |
Triplet pregnancy, trichorionic/triamniotic, unspecified trimester |
| O30.231 |
Quadruplet pregnancy, quadrachorionic/quadra-amniotic, first trimester |
| O30.232 |
Quadruplet pregnancy, quadrachorionic/quadra-amniotic, second trimester |
| O30.233 |
Quadruplet pregnancy, quadrachorionic/quadra-amniotic, third trimester |
| O30.239 |
Quadruplet pregnancy, quadrachorionic/quadra-amniotic, unspecified trimester |
| O30.831 |
Other specified multiple gestation, number of chorions and amnions are both equal to the number of fetuses, first trimester |
| O30.832 |
Other specified multiple gestation, number of chorions and amnions are both equal to the number of fetuses, second trimester |
| O30.833 |
Other specified multiple gestation, number of chorions and amnions are both equal to the number of fetuses, third trimester |
| O30.839 |
Other specified multiple gestation, number of chorions and amnions are both equal to the number of fetuses, unspecified trimester |
| P78.84 |
Gestational alloimmune liver disease |
| Q85.00 |
Neurofibromatosis, unspecified |
| Q85.01 |
Neurofibromatosis, type 1 |
| Q85.02 |
Neurofibromatosis, type 2 |
| Q85.03 |
Schwannomatosis |
| Q85.09 |
Other neurofibromatosis |
| R11.13 |
Vomiting of fecal matter |
| R11.15 |
Cyclical vomiting syndrome unrelated to migraine |
| R16.0 |
Hepatomegaly, not elsewhere classified |
| R16.2 |
Hepatomegaly with splenomegaly, not elsewhere classified |
| R17 |
Unspecified jaundice |
| R40.2410 |
Glasgow coma scale score 13-15, unspecified time |
| R40.2411 |
Glasgow coma scale score 13-15, in the field [EMT or ambulance] |
| R40.2412 |
Glasgow coma scale score 13-15, at arrival to emergency department |
| R40.2413 |
Glasgow coma scale score 13-15, at hospital admission |
| R40.2414 |
Glasgow coma scale score 13-15, 24 hours or more after hospital admission |
| R40.2420 |
Glasgow coma scale score 9-12, unspecified time |
| R40.2421 |
Glasgow coma scale score 9-12, in the field [EMT or ambulance] |
| R40.2422 |
Glasgow coma scale score 9-12, at arrival to emergency department |
| R40.2423 |
Glasgow coma scale score 9-12, at hospital admission |
| R40.2424 |
Glasgow coma scale score 9-12, 24 hours or more after hospital admission |
| R40.2430 |
Glasgow coma scale score 3-8, unspecified time |
| R40.2431 |
Glasgow coma scale score 3-8, in the field [EMT or ambulance] |
| R40.2432 |
Glasgow coma scale score 3-8, at arrival to emergency department |
| R40.2433 |
Glasgow coma scale score 3-8, at hospital admission |
| R40.2434 |
Glasgow coma scale score 3-8, 24 hours or more after hospital admission |
| R40.2440 |
Other coma, without documented Glasgow coma scale score, or with partial score reported, unspecified time |
| R40.2441 |
Other coma, without documented Glasgow coma scale score, or with partial score reported, in the field [EMT or ambulance] |
| R40.2442 |
Other coma, without documented Glasgow coma scale score, or with partial score reported, at arrival to emergency department |
| R40.2443 |
Other coma, without documented Glasgow coma scale score, or with partial score reported, at hospital admission |
| R40.2444 |
Other coma, without documented Glasgow coma scale score, or with partial score reported, 24 hours or more after hospital admission |
| R74.01 |
Elevation of levels of liver transaminase levels |
| R74.02 |
Elevation of levels of lactic acid dehydrogenase [LDH] |
| R74.8 |
Abnormal levels of other serum enzymes |
| R74.9 |
Abnormal serum enzyme level, unspecified |
| T36.0X1A |
Poisoning by penicillins, accidental (unintentional), initial encounter |
| T36.0X2A |
Poisoning by penicillins, intentional self-harm, initial encounter |
| T36.0X3A |
Poisoning by penicillins, assault, initial encounter |
| T36.0X4A |
Poisoning by penicillins, undetermined, initial encounter |
| T36.1X1A |
Poisoning by cephalosporins and other beta-lactam antibiotics, accidental (unintentional), initial encounter |
| T36.1X2A |
Poisoning by cephalosporins and other beta-lactam antibiotics, intentional self-harm, initial encounter |
| T36.1X3A |
Poisoning by cephalosporins and other beta-lactam antibiotics, assault, initial encounter |
| T36.1X4A |
Poisoning by cephalosporins and other beta-lactam antibiotics, undetermined, initial encounter |
| T36.2X1A |
Poisoning by chloramphenicol group, accidental (unintentional), initial encounter |
| T36.2X2A |
Poisoning by chloramphenicol group, intentional self-harm, initial encounter |
| T36.2X3A |
Poisoning by chloramphenicol group, assault, initial encounter |
| T36.2X4A |
Poisoning by chloramphenicol group, undetermined, initial encounter |
| T36.3X1A |
Poisoning by macrolides, accidental (unintentional), initial encounter |
| T36.3X2A |
Poisoning by macrolides, intentional self-harm, initial encounter |
| T36.3X3A |
Poisoning by macrolides, assault, initial encounter |
| T36.3X4A |
Poisoning by macrolides, undetermined, initial encounter |
| T36.4X1A |
Poisoning by tetracyclines, accidental (unintentional), initial encounter |
| T36.4X2A |
Poisoning by tetracyclines, intentional self-harm, initial encounter |
| T36.4X3A |
Poisoning by tetracyclines, assault, initial encounter |
| T36.4X4A |
Poisoning by tetracyclines, undetermined, initial encounter |
| T36.5X1A |
Poisoning by aminoglycosides, accidental (unintentional), initial encounter |
| T36.5X2A |
Poisoning by aminoglycosides, intentional self-harm, initial encounter |
| T36.5X3A |
Poisoning by aminoglycosides, assault, initial encounter |
| T36.5X4A |
Poisoning by aminoglycosides, undetermined, initial encounter |
| T36.6X1A |
Poisoning by rifampicins, accidental (unintentional), initial encounter |
| T36.6X2A |
Poisoning by rifampicins, intentional self-harm, initial encounter |
| T36.6X3A |
Poisoning by rifampicins, assault, initial encounter |
| T36.6X4A |
Poisoning by rifampicins, undetermined, initial encounter |
| T36.7X1A |
Poisoning by antifungal antibiotics, systemically used, accidental (unintentional), initial encounter |
| T36.7X2A |
Poisoning by antifungal antibiotics, systemically used, intentional self-harm, initial encounter |
| T36.7X3A |
Poisoning by antifungal antibiotics, systemically used, assault, initial encounter |
| T36.7X4A |
Poisoning by antifungal antibiotics, systemically used, undetermined, initial encounter |
| T36.8X1A |
Poisoning by other systemic antibiotics, accidental (unintentional), initial encounter |
| T36.8X2A |
Poisoning by other systemic antibiotics, intentional self-harm, initial encounter |
| T36.8X3A |
Poisoning by other systemic antibiotics, assault, initial encounter |
| T36.8X4A |
Poisoning by other systemic antibiotics, undetermined, initial encounter |
| T36.91XA |
Poisoning by unspecified systemic antibiotic, accidental (unintentional), initial encounter |
| T36.92XA |
Poisoning by unspecified systemic antibiotic, intentional self-harm, initial encounter |
| T36.93XA |
Poisoning by unspecified systemic antibiotic, assault, initial encounter |
| T36.94XA |
Poisoning by unspecified systemic antibiotic, undetermined, initial encounter |
| T37.0X1A |
Poisoning by sulfonamides, accidental (unintentional), initial encounter |
| T37.0X2A |
Poisoning by sulfonamides, intentional self-harm, initial encounter |
| T37.0X3A |
Poisoning by sulfonamides, assault, initial encounter |
| T37.0X4A |
Poisoning by sulfonamides, undetermined, initial encounter |
| T37.1X1A |
Poisoning by antimycobacterial drugs, accidental (unintentional), initial encounter |
| T37.1X2A |
Poisoning by antimycobacterial drugs, intentional self-harm, initial encounter |
| T37.1X3A |
Poisoning by antimycobacterial drugs, assault, initial encounter |
| T37.1X4A |
Poisoning by antimycobacterial drugs, undetermined, initial encounter |
| T37.2X1A |
Poisoning by antimalarials and drugs acting on other blood protozoa, accidental (unintentional), initial encounter |
| T37.2X2A |
Poisoning by antimalarials and drugs acting on other blood protozoa, intentional self-harm, initial encounter |
| T37.2X3A |
Poisoning by antimalarials and drugs acting on other blood protozoa, assault, initial encounter |
| T37.2X4A |
Poisoning by antimalarials and drugs acting on other blood protozoa, undetermined, initial encounter |
| T37.3X1A |
Poisoning by other antiprotozoal drugs, accidental (unintentional), initial encounter |
| T37.3X2A |
Poisoning by other antiprotozoal drugs, intentional self-harm, initial encounter |
| T37.3X3A |
Poisoning by other antiprotozoal drugs, assault, initial encounter |
| T37.3X4A |
Poisoning by other antiprotozoal drugs, undetermined, initial encounter |
| T37.4X1A |
Poisoning by anthelminthics, accidental (unintentional), initial encounter |
| T37.4X2A |
Poisoning by anthelminthics, intentional self-harm, initial encounter |
| T37.4X3A |
Poisoning by anthelminthics, assault, initial encounter |
| T37.4X4A |
Poisoning by anthelminthics, undetermined, initial encounter |
| T37.5X1A |
Poisoning by antiviral drugs, accidental (unintentional), initial encounter |
| T37.5X2A |
Poisoning by antiviral drugs, intentional self-harm, initial encounter |
| T37.5X3A |
Poisoning by antiviral drugs, assault, initial encounter |
| T37.5X4A |
Poisoning by antiviral drugs, undetermined, initial encounter |
| T37.8X1A |
Poisoning by other specified systemic anti-infectives and antiparasitics, accidental (unintentional), initial encounter |
| T37.8X2A |
Poisoning by other specified systemic anti-infectives and antiparasitics, intentional self-harm, initial encounter |
| T37.8X3A |
Poisoning by other specified systemic anti-infectives and antiparasitics, assault, initial encounter |
| T37.8X4A |
Poisoning by other specified systemic anti-infectives and antiparasitics, undetermined, initial encounter |
| T37.91XA |
Poisoning by unspecified systemic anti-infective and antiparasitics, accidental (unintentional), initial encounter |
| T37.92XA |
Poisoning by unspecified systemic anti-infective and antiparasitics, intentional self-harm, initial encounter |
| T37.93XA |
Poisoning by unspecified systemic anti-infective and antiparasitics, assault, initial encounter |
| T37.94XA |
Poisoning by unspecified systemic anti-infective and antiparasitics, undetermined, initial encounter |
| T38.0X1A |
Poisoning by glucocorticoids and synthetic analogues, accidental (unintentional), initial encounter |
| T38.0X2A |
Poisoning by glucocorticoids and synthetic analogues, intentional self-harm, initial encounter |
| T38.0X3A |
Poisoning by glucocorticoids and synthetic analogues, assault, initial encounter |
| T38.0X4A |
Poisoning by glucocorticoids and synthetic analogues, undetermined, initial encounter |
| T38.1X1A |
Poisoning by thyroid hormones and substitutes, accidental (unintentional), initial encounter |
| T38.1X2A |
Poisoning by thyroid hormones and substitutes, intentional self-harm, initial encounter |
| T38.1X3A |
Poisoning by thyroid hormones and substitutes, assault, initial encounter |
| T38.1X4A |
Poisoning by thyroid hormones and substitutes, undetermined, initial encounter |
| T38.2X1A |
Poisoning by antithyroid drugs, accidental (unintentional), initial encounter |
| T38.2X2A |
Poisoning by antithyroid drugs, intentional self-harm, initial encounter |
| T38.2X3A |
Poisoning by antithyroid drugs, assault, initial encounter |
| T38.2X4A |
Poisoning by antithyroid drugs, undetermined, initial encounter |
| T38.3X1A |
Poisoning by insulin and oral hypoglycemic [antidiabetic] drugs, accidental (unintentional), initial encounter |
| T38.3X2A |
Poisoning by insulin and oral hypoglycemic [antidiabetic] drugs, intentional self-harm, initial encounter |
| T38.3X3A |
Poisoning by insulin and oral hypoglycemic [antidiabetic] drugs, assault, initial encounter |
| T38.3X4A |
Poisoning by insulin and oral hypoglycemic [antidiabetic] drugs, undetermined, initial encounter |
| T38.4X1A |
Poisoning by oral contraceptives, accidental (unintentional), initial encounter |
| T38.4X2A |
Poisoning by oral contraceptives, intentional self-harm, initial encounter |
| T38.4X3A |
Poisoning by oral contraceptives, assault, initial encounter |
| T38.4X4A |
Poisoning by oral contraceptives, undetermined, initial encounter |
| T38.5X1A |
Poisoning by other estrogens and progestogens, accidental (unintentional), initial encounter |
| T38.5X2A |
Poisoning by other estrogens and progestogens, intentional self-harm, initial encounter |
| T38.5X3A |
Poisoning by other estrogens and progestogens, assault, initial encounter |
| T38.5X4A |
Poisoning by other estrogens and progestogens, undetermined, initial encounter |
| T38.6X1A |
Poisoning by antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, accidental (unintentional), initial encounter |
| T38.6X2A |
Poisoning by antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, intentional self-harm, initial encounter |
| T38.6X3A |
Poisoning by antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, assault, initial encounter |
| T38.6X4A |
Poisoning by antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, undetermined, initial encounter |
| T38.7X1A |
Poisoning by androgens and anabolic congeners, accidental (unintentional), initial encounter |
| T38.7X2A |
Poisoning by androgens and anabolic congeners, intentional self-harm, initial encounter |
| T38.7X3A |
Poisoning by androgens and anabolic congeners, assault, initial encounter |
| T38.7X4A |
Poisoning by androgens and anabolic congeners, undetermined, initial encounter |
| T38.801A |
Poisoning by unspecified hormones and synthetic substitutes, accidental (unintentional), initial encounter |
| T38.802A |
Poisoning by unspecified hormones and synthetic substitutes, intentional self-harm, initial encounter |
| T38.803A |
Poisoning by unspecified hormones and synthetic substitutes, assault, initial encounter |
| T38.804A |
Poisoning by unspecified hormones and synthetic substitutes, undetermined, initial encounter |
| T38.811A |
Poisoning by anterior pituitary [adenohypophyseal] hormones, accidental (unintentional), initial encounter |
| T38.812A |
Poisoning by anterior pituitary [adenohypophyseal] hormones, intentional self-harm, initial encounter |
| T38.813A |
Poisoning by anterior pituitary [adenohypophyseal] hormones, assault, initial encounter |
| T38.814A |
Poisoning by anterior pituitary [adenohypophyseal] hormones, undetermined, initial encounter |
| T38.891A |
Poisoning by other hormones and synthetic substitutes, accidental (unintentional), initial encounter |
| T38.892A |
Poisoning by other hormones and synthetic substitutes, intentional self-harm, initial encounter |
| T38.893A |
Poisoning by other hormones and synthetic substitutes, assault, initial encounter |
| T38.894A |
Poisoning by other hormones and synthetic substitutes, undetermined, initial encounter |
| T38.901A |
Poisoning by unspecified hormone antagonists, accidental (unintentional), initial encounter |
| T38.902A |
Poisoning by unspecified hormone antagonists, intentional self-harm, initial encounter |
| T38.903A |
Poisoning by unspecified hormone antagonists, assault, initial encounter |
| T38.904A |
Poisoning by unspecified hormone antagonists, undetermined, initial encounter |
| T38.991A |
Poisoning by other hormone antagonists, accidental (unintentional), initial encounter |
| T38.992A |
Poisoning by other hormone antagonists, intentional self-harm, initial encounter |
| T38.993A |
Poisoning by other hormone antagonists, assault, initial encounter |
| T38.994A |
Poisoning by other hormone antagonists, undetermined, initial encounter |
| T39.011A |
Poisoning by aspirin, accidental (unintentional), initial encounter |
| T39.012A |
Poisoning by aspirin, intentional self-harm, initial encounter |
| T39.013A |
Poisoning by aspirin, assault, initial encounter |
| T39.014A |
Poisoning by aspirin, undetermined, initial encounter |
| T39.091A |
Poisoning by salicylates, accidental (unintentional), initial encounter |
| T39.092A |
Poisoning by salicylates, intentional self-harm, initial encounter |
| T39.093A |
Poisoning by salicylates, assault, initial encounter |
| T39.094A |
Poisoning by salicylates, undetermined, initial encounter |
| T39.1X1A |
Poisoning by 4-Aminophenol derivatives, accidental (unintentional), initial encounter |
| T39.1X2A |
Poisoning by 4-Aminophenol derivatives, intentional self-harm, initial encounter |
| T39.1X3A |
Poisoning by 4-Aminophenol derivatives, assault, initial encounter |
| T39.1X4A |
Poisoning by 4-Aminophenol derivatives, undetermined, initial encounter |
| T39.2X1A |
Poisoning by pyrazolone derivatives, accidental (unintentional), initial encounter |
| T39.2X2A |
Poisoning by pyrazolone derivatives, intentional self-harm, initial encounter |
| T39.2X3A |
Poisoning by pyrazolone derivatives, assault, initial encounter |
| T39.2X4A |
Poisoning by pyrazolone derivatives, undetermined, initial encounter |
| T39.311A |
Poisoning by propionic acid derivatives, accidental (unintentional), initial encounter |
| T39.312A |
Poisoning by propionic acid derivatives, intentional self-harm, initial encounter |
| T39.313A |
Poisoning by propionic acid derivatives, assault, initial encounter |
| T39.314A |
Poisoning by propionic acid derivatives, undetermined, initial encounter |
| T39.391A |
Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], accidental (unintentional), initial encounter |
| T39.392A |
Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], intentional self-harm, initial encounter |
| T39.393A |
Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], assault, initial encounter |
| T39.394A |
Poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], undetermined, initial encounter |
| T39.4X1A |
Poisoning by antirheumatics, not elsewhere classified, accidental (unintentional), initial encounter |
| T39.4X2A |
Poisoning by antirheumatics, not elsewhere classified, intentional self-harm, initial encounter |
| T39.4X3A |
Poisoning by antirheumatics, not elsewhere classified, assault, initial encounter |
| T39.4X4A |
Poisoning by antirheumatics, not elsewhere classified, undetermined, initial encounter |
| T39.8X1A |
Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, accidental (unintentional), initial encounter |
| T39.8X2A |
Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, intentional self-harm, initial encounter |
| T39.8X3A |
Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, assault, initial encounter |
| T39.8X4A |
Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, undetermined, initial encounter |
| T39.91XA |
Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, accidental (unintentional), initial encounter |
| T39.92XA |
Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, intentional self-harm, initial encounter |
| T39.93XA |
Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, assault, initial encounter |
| T39.94XA |
Poisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, undetermined, initial encounter |
| T40.0X1A |
Poisoning by opium, accidental (unintentional), initial encounter |
| T40.0X2A |
Poisoning by opium, intentional self-harm, initial encounter |
| T40.0X3A |
Poisoning by opium, assault, initial encounter |
| T40.0X4A |
Poisoning by opium, undetermined, initial encounter |
| T40.1X1A |
Poisoning by heroin, accidental (unintentional), initial encounter |
| T40.1X2A |
Poisoning by heroin, intentional self-harm, initial encounter |
| T40.1X3A |
Poisoning by heroin, assault, initial encounter |
| T40.1X4A |
Poisoning by heroin, undetermined, initial encounter |
| T40.2X1A |
Poisoning by other opioids, accidental (unintentional), initial encounter |
| T40.2X2A |
Poisoning by other opioids, intentional self-harm, initial encounter |
| T40.2X3A |
Poisoning by other opioids, assault, initial encounter |
| T40.2X4A |
Poisoning by other opioids, undetermined, initial encounter |
| T40.3X1A |
Poisoning by methadone, accidental (unintentional), initial encounter |
| T40.3X2A |
Poisoning by methadone, intentional self-harm, initial encounter |
| T40.3X3A |
Poisoning by methadone, assault, initial encounter |
| T40.3X4A |
Poisoning by methadone, undetermined, initial encounter |
| T40.411A |
Poisoning by fentanyl or fentanyl analogs, accidental (unintentional), initial encounter |
| T40.411D |
Poisoning by fentanyl or fentanyl analogs, accidental (unintentional), subsequent encounter |
| T40.411S |
Poisoning by fentanyl or fentanyl analogs, accidental (unintentional), sequela |
| T40.412A |
Poisoning by fentanyl or fentanyl analogs, intentional self-harm, initial encounter |
| T40.412D |
Poisoning by fentanyl or fentanyl analogs, intentional self-harm, subsequent encounter |
| T40.412S |
Poisoning by fentanyl or fentanyl analogs, intentional self-harm, sequela |
| T40.413A |
Poisoning by fentanyl or fentanyl analogs, assault, initial encounter |
| T40.413D |
Poisoning by fentanyl or fentanyl analogs, assault, subsequent encounter |
| T40.413S |
Poisoning by fentanyl or fentanyl analogs, assault, sequela |
| T40.414A |
Poisoning by fentanyl or fentanyl analogs, undetermined, initial encounter |
| T40.414D |
Poisoning by fentanyl or fentanyl analogs, undetermined, subsequent encounter |
| T40.414S |
Poisoning by fentanyl or fentanyl analogs, undetermined, sequela |
| T40.415A |
Adverse effect of fentanyl or fentanyl analogs, initial encounter |
| T40.415D |
Adverse effect of fentanyl or fentanyl analogs, subsequent encounter |
| T40.415S |
Adverse effect of fentanyl or fentanyl analogs, sequela |
| T40.416A |
Underdosing of fentanyl or fentanyl analogs, initial encounter |
| T40.416D |
Underdosing of fentanyl or fentanyl analogs, subsequent encounter |
| T40.416S |
Underdosing of fentanyl or fentanyl analogs, sequela |
| T40.421A |
Poisoning by tramadol, accidental (unintentional), initial encounter |
| T40.421D |
Poisoning by tramadol, accidental (unintentional), subsequent encounter |
| T40.421S |
Poisoning by tramadol, accidental (unintentional), sequela |
| T40.422A |
Poisoning by tramadol, intentional self-harm, initial encounter |
| T40.422D |
Poisoning by tramadol, intentional self-harm, subsequent encounter |
| T40.422S |
Poisoning by tramadol, intentional self-harm, sequela |
| T40.423A |
Poisoning by tramadol, assault, initial encounter |
| T40.423D |
Poisoning by tramadol, assault, subsequent encounter |
| T40.423S |
Poisoning by tramadol, assault, sequela |
| T40.424A |
Poisoning by tramadol, undetermined, initial encounter |
| T40.424D |
Poisoning by tramadol, undetermined, subsequent encounter |
| T40.424S |
Poisoning by tramadol, undetermined, sequela |
| T40.425A |
Adverse effect of tramadol, initial encounter |
| T40.425D |
Adverse effect of tramadol, subsequent encounter |
| T40.425S |
Adverse effect of tramadol, sequela |
| T40.426A |
Underdosing of tramadol, initial encounter |
| T40.426D |
Underdosing of tramadol, subsequent encounter |
| T40.426S |
Underdosing of tramadol, sequela |
| T40.491A |
Poisoning by other synthetic narcotics, accidental (unintentional), initial encounter |
| T40.491D |
Poisoning by other synthetic narcotics, accidental (unintentional), subsequent encounter |
| T40.491S |
Poisoning by other synthetic narcotics, accidental (unintentional), sequela |
| T40.492A |
Poisoning by other synthetic narcotics, intentional self-harm, initial encounter |
| T40.492D |
Poisoning by other synthetic narcotics, intentional self-harm, subsequent encounter |
| T40.492S |
Poisoning by other synthetic narcotics, intentional self-harm, sequela |
| T40.493A |
Poisoning by other synthetic narcotics, assault, initial encounter |
| T40.493D |
Poisoning by other synthetic narcotics, assault, subsequent encounter |
| T40.493S |
Poisoning by other synthetic narcotics, assault, sequela |
| T40.494A |
Poisoning by other synthetic narcotics, undetermined, initial encounter |
| T40.494D |
Poisoning by other synthetic narcotics, undetermined, subsequent encounter |
| T40.494S |
Poisoning by other synthetic narcotics, undetermined, sequela |
| T40.495A |
Adverse effect of other synthetic narcotics, initial encounter |
| T40.495D |
Adverse effect of other synthetic narcotics, subsequent encounter |
| T40.495S |
Adverse effect of other synthetic narcotics, sequela |
| T40.496A |
Underdosing of other synthetic narcotics, initial encounter |
| T40.496D |
Underdosing of other synthetic narcotics, subsequent encounter |
| T40.496S |
Underdosing of other synthetic narcotics, sequela |
| T40.5X1A |
Poisoning by cocaine, accidental (unintentional), initial encounter |
| T40.5X2A |
Poisoning by cocaine, intentional self-harm, initial encounter |
| T40.5X3A |
Poisoning by cocaine, assault, initial encounter |
| T40.5X4A |
Poisoning by cocaine, undetermined, initial encounter |
| T40.601A |
Poisoning by unspecified narcotics, accidental (unintentional), initial encounter |
| T40.602A |
Poisoning by unspecified narcotics, intentional self-harm, initial encounter |
| T40.603A |
Poisoning by unspecified narcotics, assault, initial encounter |
| T40.604A |
Poisoning by unspecified narcotics, undetermined, initial encounter |
| T40.691A |
Poisoning by other narcotics, accidental (unintentional), initial encounter |
| T40.692A |
Poisoning by other narcotics, intentional self-harm, initial encounter |
| T40.693A |
Poisoning by other narcotics, assault, initial encounter |
| T40.694A |
Poisoning by other narcotics, undetermined, initial encounter |
| T40.711A |
Poisoning by cannabis, accidental (unintentional), initial encounter |
| T40.712A |
Poisoning by cannabis, intentional self-harm, initial encounter |
| T40.713A |
Poisoning by cannabis, assault, initial encounter |
| T40.714A |
Poisoning by cannabis, undetermined, initial encounter |
| T40.721A |
Poisoning by synthetic cannabinoids, accidental (unintentional), initial encounter |
| T40.722A |
Poisoning by synthetic cannabinoids, intentional self-harm, initial encounter |
| T40.723A |
Poisoning by synthetic cannabinoids, assault, initial encounter |
| T40.724A |
Poisoning by synthetic cannabinoids, undetermined, initial encounter |
| T40.8X1A |
Poisoning by lysergide [LSD], accidental (unintentional), initial encounter |
| T40.8X2A |
Poisoning by lysergide [LSD], intentional self-harm, initial encounter |
| T40.8X3A |
Poisoning by lysergide [LSD], assault, initial encounter |
| T40.8X4A |
Poisoning by lysergide [LSD], undetermined, initial encounter |
| T40.901A |
Poisoning by unspecified psychodysleptics [hallucinogens], accidental (unintentional), initial encounter |
| T40.902A |
Poisoning by unspecified psychodysleptics [hallucinogens], intentional self-harm, initial encounter |
| T40.903A |
Poisoning by unspecified psychodysleptics [hallucinogens], assault, initial encounter |
| T40.904A |
Poisoning by unspecified psychodysleptics [hallucinogens], undetermined, initial encounter |
| T40.991A |
Poisoning by other psychodysleptics [hallucinogens], accidental (unintentional), initial encounter |
| T40.992A |
Poisoning by other psychodysleptics [hallucinogens], intentional self-harm, initial encounter |
| T40.993A |
Poisoning by other psychodysleptics [hallucinogens], assault, initial encounter |
| T40.994A |
Poisoning by other psychodysleptics [hallucinogens], undetermined, initial encounter |
| T41.0X1A |
Poisoning by inhaled anesthetics, accidental (unintentional), initial encounter |
| T41.0X2A |
Poisoning by inhaled anesthetics, intentional self-harm, initial encounter |
| T41.0X3A |
Poisoning by inhaled anesthetics, assault, initial encounter |
| T41.0X4A |
Poisoning by inhaled anesthetics, undetermined, initial encounter |
| T41.1X1A |
Poisoning by intravenous anesthetics, accidental (unintentional), initial encounter |
| T41.1X2A |
Poisoning by intravenous anesthetics, intentional self-harm, initial encounter |
| T41.1X3A |
Poisoning by intravenous anesthetics, assault, initial encounter |
| T41.1X4A |
Poisoning by intravenous anesthetics, undetermined, initial encounter |
| T41.201A |
Poisoning by unspecified general anesthetics, accidental (unintentional), initial encounter |
| T41.202A |
Poisoning by unspecified general anesthetics, intentional self-harm, initial encounter |
| T41.203A |
Poisoning by unspecified general anesthetics, assault, initial encounter |
| T41.204A |
Poisoning by unspecified general anesthetics, undetermined, initial encounter |
| T41.291A |
Poisoning by other general anesthetics, accidental (unintentional), initial encounter |
| T41.292A |
Poisoning by other general anesthetics, intentional self-harm, initial encounter |
| T41.293A |
Poisoning by other general anesthetics, assault, initial encounter |
| T41.294A |
Poisoning by other general anesthetics, undetermined, initial encounter |
| T41.3X1A |
Poisoning by local anesthetics, accidental (unintentional), initial encounter |
| T41.3X2A |
Poisoning by local anesthetics, intentional self-harm, initial encounter |
| T41.3X3A |
Poisoning by local anesthetics, assault, initial encounter |
| T41.3X4A |
Poisoning by local anesthetics, undetermined, initial encounter |
| T41.41XA |
Poisoning by unspecified anesthetic, accidental (unintentional), initial encounter |
| T41.42XA |
Poisoning by unspecified anesthetic, intentional self-harm, initial encounter |
| T41.43XA |
Poisoning by unspecified anesthetic, assault, initial encounter |
| T41.44XA |
Poisoning by unspecified anesthetic, undetermined, initial encounter |
| T41.5X1A |
Poisoning by therapeutic gases, accidental (unintentional), initial encounter |
| T41.5X2A |
Poisoning by therapeutic gases, intentional self-harm, initial encounter |
| T41.5X3A |
Poisoning by therapeutic gases, assault, initial encounter |
| T41.5X4A |
Poisoning by therapeutic gases, undetermined, initial encounter |
| T42.0X1A |
Poisoning by hydantoin derivatives, accidental (unintentional), initial encounter |
| T42.0X2A |
Poisoning by hydantoin derivatives, intentional self-harm, initial encounter |
| T42.0X3A |
Poisoning by hydantoin derivatives, assault, initial encounter |
| T42.0X4A |
Poisoning by hydantoin derivatives, undetermined, initial encounter |
| T42.1X1A |
Poisoning by iminostilbenes, accidental (unintentional), initial encounter |
| T42.1X2A |
Poisoning by iminostilbenes, intentional self-harm, initial encounter |
| T42.1X3A |
Poisoning by iminostilbenes, assault, initial encounter |
| T42.1X4A |
Poisoning by iminostilbenes, undetermined, initial encounter |
| T42.2X1A |
Poisoning by succinimides and oxazolidinediones, accidental (unintentional), initial encounter |
| T42.2X2A |
Poisoning by succinimides and oxazolidinediones, intentional self-harm, initial encounter |
| T42.2X3A |
Poisoning by succinimides and oxazolidinediones, assault, initial encounter |
| T42.2X4A |
Poisoning by succinimides and oxazolidinediones, undetermined, initial encounter |
| T42.3X1A |
Poisoning by barbiturates, accidental (unintentional), initial encounter |
| T42.3X2A |
Poisoning by barbiturates, intentional self-harm, initial encounter |
| T42.3X3A |
Poisoning by barbiturates, assault, initial encounter |
| T42.3X4A |
Poisoning by barbiturates, undetermined, initial encounter |
| T42.4X1A |
Poisoning by benzodiazepines, accidental (unintentional), initial encounter |
| T42.4X2A |
Poisoning by benzodiazepines, intentional self-harm, initial encounter |
| T42.4X3A |
Poisoning by benzodiazepines, assault, initial encounter |
| T42.4X4A |
Poisoning by benzodiazepines, undetermined, initial encounter |
| T42.5X1A |
Poisoning by mixed antiepileptics, accidental (unintentional), initial encounter |
| T42.5X2A |
Poisoning by mixed antiepileptics, intentional self-harm, initial encounter |
| T42.5X3A |
Poisoning by mixed antiepileptics, assault, initial encounter |
| T42.5X4A |
Poisoning by mixed antiepileptics, undetermined, initial encounter |
| T42.6X1A |
Poisoning by other antiepileptic and sedative-hypnotic drugs, accidental (unintentional), initial encounter |
| T42.6X2A |
Poisoning by other antiepileptic and sedative-hypnotic drugs, intentional self-harm, initial encounter |
| T42.6X3A |
Poisoning by other antiepileptic and sedative-hypnotic drugs, assault, initial encounter |
| T42.6X4A |
Poisoning by other antiepileptic and sedative-hypnotic drugs, undetermined, initial encounter |
| T42.71XA |
Poisoning by unspecified antiepileptic and sedative-hypnotic drugs, accidental (unintentional), initial encounter |
| T42.72XA |
Poisoning by unspecified antiepileptic and sedative-hypnotic drugs, intentional self-harm, initial encounter |
| T42.73XA |
Poisoning by unspecified antiepileptic and sedative-hypnotic drugs, assault, initial encounter |
| T42.74XA |
Poisoning by unspecified antiepileptic and sedative-hypnotic drugs, undetermined, initial encounter |
| T42.8X1A |
Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, accidental (unintentional), initial encounter |
| T42.8X2A |
Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, intentional self-harm, initial encounter |
| T42.8X3A |
Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, assault, initial encounter |
| T42.8X4A |
Poisoning by antiparkinsonism drugs and other central muscle-tone depressants, undetermined, initial encounter |
| T43.011A |
Poisoning by tricyclic antidepressants, accidental (unintentional), initial encounter |
| T43.012A |
Poisoning by tricyclic antidepressants, intentional self-harm, initial encounter |
| T43.013A |
Poisoning by tricyclic antidepressants, assault, initial encounter |
| T43.014A |
Poisoning by tricyclic antidepressants, undetermined, initial encounter |
| T43.021A |
Poisoning by tetracyclic antidepressants, accidental (unintentional), initial encounter |
| T43.022A |
Poisoning by tetracyclic antidepressants, intentional self-harm, initial encounter |
| T43.023A |
Poisoning by tetracyclic antidepressants, assault, initial encounter |
| T43.024A |
Poisoning by tetracyclic antidepressants, undetermined, initial encounter |
| T43.1X1A |
Poisoning by monoamine-oxidase-inhibitor antidepressants, accidental (unintentional), initial encounter |
| T43.1X2A |
Poisoning by monoamine-oxidase-inhibitor antidepressants, intentional self-harm, initial encounter |
| T43.1X3A |
Poisoning by monoamine-oxidase-inhibitor antidepressants, assault, initial encounter |
| T43.1X4A |
Poisoning by monoamine-oxidase-inhibitor antidepressants, undetermined, initial encounter |
| T43.201A |
Poisoning by unspecified antidepressants, accidental (unintentional), initial encounter |
| T43.202A |
Poisoning by unspecified antidepressants, intentional self-harm, initial encounter |
| T43.203A |
Poisoning by unspecified antidepressants, assault, initial encounter |
| T43.204A |
Poisoning by unspecified antidepressants, undetermined, initial encounter |
| T43.211A |
Poisoning by selective serotonin and norepinephrine reuptake inhibitors, accidental (unintentional), initial encounter |
| T43.212A |
Poisoning by selective serotonin and norepinephrine reuptake inhibitors, intentional self-harm, initial encounter |
| T43.213A |
Poisoning by selective serotonin and norepinephrine reuptake inhibitors, assault, initial encounter |
| T43.214A |
Poisoning by selective serotonin and norepinephrine reuptake inhibitors, undetermined, initial encounter |
| T43.221A |
Poisoning by selective serotonin reuptake inhibitors, accidental (unintentional), initial encounter |
| T43.222A |
Poisoning by selective serotonin reuptake inhibitors, intentional self-harm, initial encounter |
| T43.223A |
Poisoning by selective serotonin reuptake inhibitors, assault, initial encounter |
| T43.224A |
Poisoning by selective serotonin reuptake inhibitors, undetermined, initial encounter |
| T43.291A |
Poisoning by other antidepressants, accidental (unintentional), initial encounter |
| T43.292A |
Poisoning by other antidepressants, intentional self-harm, initial encounter |
| T43.293A |
Poisoning by other antidepressants, assault, initial encounter |
| T43.294A |
Poisoning by other antidepressants, undetermined, initial encounter |
| T43.3X1A |
Poisoning by phenothiazine antipsychotics and neuroleptics, accidental (unintentional), initial encounter |
| T43.3X2A |
Poisoning by phenothiazine antipsychotics and neuroleptics, intentional self-harm, initial encounter |
| T43.3X3A |
Poisoning by phenothiazine antipsychotics and neuroleptics, assault, initial encounter |
| T43.3X4A |
Poisoning by phenothiazine antipsychotics and neuroleptics, undetermined, initial encounter |
| T43.4X1A |
Poisoning by butyrophenone and thiothixene neuroleptics, accidental (unintentional), initial encounter |
| T43.4X2A |
Poisoning by butyrophenone and thiothixene neuroleptics, intentional self-harm, initial encounter |
| T43.4X3A |
Poisoning by butyrophenone and thiothixene neuroleptics, assault, initial encounter |
| T43.4X4A |
Poisoning by butyrophenone and thiothixene neuroleptics, undetermined, initial encounter |
| T43.501A |
Poisoning by unspecified antipsychotics and neuroleptics, accidental (unintentional), initial encounter |
| T43.502A |
Poisoning by unspecified antipsychotics and neuroleptics, intentional self-harm, initial encounter |
| T43.503A |
Poisoning by unspecified antipsychotics and neuroleptics, assault, initial encounter |
| T43.504A |
Poisoning by unspecified antipsychotics and neuroleptics, undetermined, initial encounter |
| T43.591A |
Poisoning by other antipsychotics and neuroleptics, accidental (unintentional), initial encounter |
| T43.592A |
Poisoning by other antipsychotics and neuroleptics, intentional self-harm, initial encounter |
| T43.593A |
Poisoning by other antipsychotics and neuroleptics, assault, initial encounter |
| T43.594A |
Poisoning by other antipsychotics and neuroleptics, undetermined, initial encounter |
| T43.601A |
Poisoning by unspecified psychostimulants, accidental (unintentional), initial encounter |
| T43.602A |
Poisoning by unspecified psychostimulants, intentional self-harm, initial encounter |
| T43.603A |
Poisoning by unspecified psychostimulants, assault, initial encounter |
| T43.604A |
Poisoning by unspecified psychostimulants, undetermined, initial encounter |
| T43.611A |
Poisoning by caffeine, accidental (unintentional), initial encounter |
| T43.612A |
Poisoning by caffeine, intentional self-harm, initial encounter |
| T43.613A |
Poisoning by caffeine, assault, initial encounter |
| T43.614A |
Poisoning by caffeine, undetermined, initial encounter |
| T43.621A |
Poisoning by amphetamines, accidental (unintentional), initial encounter |
| T43.622A |
Poisoning by amphetamines, intentional self-harm, initial encounter |
| T43.623A |
Poisoning by amphetamines, assault, initial encounter |
| T43.624A |
Poisoning by amphetamines, undetermined, initial encounter |
| T43.631A |
Poisoning by methylphenidate, accidental (unintentional), initial encounter |
| T43.632A |
Poisoning by methylphenidate, intentional self-harm, initial encounter |
| T43.633A |
Poisoning by methylphenidate, assault, initial encounter |
| T43.634A |
Poisoning by methylphenidate, undetermined, initial encounter |
| T43.641A |
Poisoning by ecstasy, accidental (unintentional), initial encounter |
| T43.641D |
Poisoning by ecstasy, accidental (unintentional), subsequent encounter |
| T43.641S |
Poisoning by ecstasy, accidental (unintentional), sequela |
| T43.642A |
Poisoning by ecstasy, intentional self-harm, initial encounter |
| T43.642D |
Poisoning by ecstasy, intentional self-harm, subsequent encounter |
| T43.642S |
Poisoning by ecstasy, intentional self-harm, sequela |
| T43.643A |
Poisoning by ecstasy, assault, initial encounter |
| T43.643D |
Poisoning by ecstasy, assault, subsequent encounter |
| T43.643S |
Poisoning by ecstasy, assault, sequela |
| T43.644A |
Poisoning by ecstasy, undetermined, initial encounter |
| T43.644D |
Poisoning by ecstasy, undetermined, subsequent encounter |
| T43.644S |
Poisoning by ecstasy, undetermined, sequela |
| T43.651A |
Poisoning by methamphetamines accidental (unintentional), initial encounter |
| T43.652A |
Poisoning by methamphetamines intentional self-harm, initial encounter |
| T43.653A |
Poisoning by methamphetamines, assault, initial encounter |
| T43.654A |
Poisoning by methamphetamines, undetermined, initial encounter |
| T43.655A |
Adverse effect of methamphetamines, initial encounter |
| T43.691A |
Poisoning by other psychostimulants, accidental (unintentional), initial encounter |
| T43.692A |
Poisoning by other psychostimulants, intentional self-harm, initial encounter |
| T43.693A |
Poisoning by other psychostimulants, assault, initial encounter |
| T43.694A |
Poisoning by other psychostimulants, undetermined, initial encounter |
| T43.8X1A |
Poisoning by other psychotropic drugs, accidental (unintentional), initial encounter |
| T43.8X2A |
Poisoning by other psychotropic drugs, intentional self-harm, initial encounter |
| T43.8X3A |
Poisoning by other psychotropic drugs, assault, initial encounter |
| T43.8X4A |
Poisoning by other psychotropic drugs, undetermined, initial encounter |
| T43.91XA |
Poisoning by unspecified psychotropic drug, accidental (unintentional), initial encounter |
| T43.92XA |
Poisoning by unspecified psychotropic drug, intentional self-harm, initial encounter |
| T43.93XA |
Poisoning by unspecified psychotropic drug, assault, initial encounter |
| T43.94XA |
Poisoning by unspecified psychotropic drug, undetermined, initial encounter |
| T44.0X1A |
Poisoning by anticholinesterase agents, accidental (unintentional), initial encounter |
| T44.0X2A |
Poisoning by anticholinesterase agents, intentional self-harm, initial encounter |
| T44.0X3A |
Poisoning by anticholinesterase agents, assault, initial encounter |
| T44.0X4A |
Poisoning by anticholinesterase agents, undetermined, initial encounter |
| T44.1X1A |
Poisoning by other parasympathomimetics [cholinergics], accidental (unintentional), initial encounter |
| T44.1X2A |
Poisoning by other parasympathomimetics [cholinergics], intentional self-harm, initial encounter |
| T44.1X3A |
Poisoning by other parasympathomimetics [cholinergics], assault, initial encounter |
| T44.1X4A |
Poisoning by other parasympathomimetics [cholinergics], undetermined, initial encounter |
| T44.2X1A |
Poisoning by ganglionic blocking drugs, accidental (unintentional), initial encounter |
| T44.2X2A |
Poisoning by ganglionic blocking drugs, intentional self-harm, initial encounter |
| T44.2X3A |
Poisoning by ganglionic blocking drugs, assault, initial encounter |
| T44.2X4A |
Poisoning by ganglionic blocking drugs, undetermined, initial encounter |
| T44.3X1A |
Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, accidental (unintentional), initial encounter |
| T44.3X2A |
Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, intentional self-harm, initial encounter |
| T44.3X3A |
Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, assault, initial encounter |
| T44.3X4A |
Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, undetermined, initial encounter |
| T44.4X1A |
Poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), initial encounter |
| T44.4X2A |
Poisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm, initial encounter |
| T44.4X3A |
Poisoning by predominantly alpha-adrenoreceptor agonists, assault, initial encounter |
| T44.4X4A |
Poisoning by predominantly alpha-adrenoreceptor agonists, undetermined, initial encounter |
| T44.5X1A |
Poisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional), initial encounter |
| T44.5X2A |
Poisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm, initial encounter |
| T44.5X3A |
Poisoning by predominantly beta-adrenoreceptor agonists, assault, initial encounter |
| T44.5X4A |
Poisoning by predominantly beta-adrenoreceptor agonists, undetermined, initial encounter |
| T44.6X1A |
Poisoning by alpha-adrenoreceptor antagonists, accidental (unintentional), initial encounter |
| T44.6X2A |
Poisoning by alpha-adrenoreceptor antagonists, intentional self-harm, initial encounter |
| T44.6X3A |
Poisoning by alpha-adrenoreceptor antagonists, assault, initial encounter |
| T44.6X4A |
Poisoning by alpha-adrenoreceptor antagonists, undetermined, initial encounter |
| T44.7X1A |
Poisoning by beta-adrenoreceptor antagonists, accidental (unintentional), initial encounter |
| T44.7X2A |
Poisoning by beta-adrenoreceptor antagonists, intentional self-harm, initial encounter |
| T44.7X3A |
Poisoning by beta-adrenoreceptor antagonists, assault, initial encounter |
| T44.7X4A |
Poisoning by beta-adrenoreceptor antagonists, undetermined, initial encounter |
| T44.8X1A |
Poisoning by centrally-acting and adrenergic-neuron-blocking agents, accidental (unintentional), initial encounter |
| T44.8X2A |
Poisoning by centrally-acting and adrenergic-neuron-blocking agents, intentional self-harm, initial encounter |
| T44.8X3A |
Poisoning by centrally-acting and adrenergic-neuron-blocking agents, assault, initial encounter |
| T44.8X4A |
Poisoning by centrally-acting and adrenergic-neuron-blocking agents, undetermined, initial encounter |
| T44.901A |
Poisoning by unspecified drugs primarily affecting the autonomic nervous system, accidental (unintentional), initial encounter |
| T44.902A |
Poisoning by unspecified drugs primarily affecting the autonomic nervous system, intentional self-harm, initial encounter |
| T44.903A |
Poisoning by unspecified drugs primarily affecting the autonomic nervous system, assault, initial encounter |
| T44.904A |
Poisoning by unspecified drugs primarily affecting the autonomic nervous system, undetermined, initial encounter |
| T44.991A |
Poisoning by other drug primarily affecting the autonomic nervous system, accidental (unintentional), initial encounter |
| T44.992A |
Poisoning by other drug primarily affecting the autonomic nervous system, intentional self-harm, initial encounter |
| T44.993A |
Poisoning by other drug primarily affecting the autonomic nervous system, assault, initial encounter |
| T44.994A |
Poisoning by other drug primarily affecting the autonomic nervous system, undetermined, initial encounter |
| T45.0X1A |
Poisoning by antiallergic and antiemetic drugs, accidental (unintentional), initial encounter |
| T45.0X2A |
Poisoning by antiallergic and antiemetic drugs, intentional self-harm, initial encounter |
| T45.0X3A |
Poisoning by antiallergic and antiemetic drugs, assault, initial encounter |
| T45.0X4A |
Poisoning by antiallergic and antiemetic drugs, undetermined, initial encounter |
| T45.1X1A |
Poisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional), initial encounter |
| T45.1X2A |
Poisoning by antineoplastic and immunosuppressive drugs, intentional self-harm, initial encounter |
| T45.1X3A |
Poisoning by antineoplastic and immunosuppressive drugs, assault, initial encounter |
| T45.1X4A |
Poisoning by antineoplastic and immunosuppressive drugs, undetermined, initial encounter |
| T45.2X1A |
Poisoning by vitamins, accidental (unintentional), initial encounter |
| T45.2X2A |
Poisoning by vitamins, intentional self-harm, initial encounter |
| T45.2X3A |
Poisoning by vitamins, assault, initial encounter |
| T45.2X4A |
Poisoning by vitamins, undetermined, initial encounter |
| T45.3X1A |
Poisoning by enzymes, accidental (unintentional), initial encounter |
| T45.3X2A |
Poisoning by enzymes, intentional self-harm, initial encounter |
| T45.3X3A |
Poisoning by enzymes, assault, initial encounter |
| T45.3X4A |
Poisoning by enzymes, undetermined, initial encounter |
| T45.4X1A |
Poisoning by iron and its compounds, accidental (unintentional), initial encounter |
| T45.4X2A |
Poisoning by iron and its compounds, intentional self-harm, initial encounter |
| T45.4X3A |
Poisoning by iron and its compounds, assault, initial encounter |
| T45.4X4A |
Poisoning by iron and its compounds, undetermined, initial encounter |
| T45.511A |
Poisoning by anticoagulants, accidental (unintentional), initial encounter |
| T45.512A |
Poisoning by anticoagulants, intentional self-harm, initial encounter |
| T45.513A |
Poisoning by anticoagulants, assault, initial encounter |
| T45.514A |
Poisoning by anticoagulants, undetermined, initial encounter |
| T45.521A |
Poisoning by antithrombotic drugs, accidental (unintentional), initial encounter |
| T45.522A |
Poisoning by antithrombotic drugs, intentional self-harm, initial encounter |
| T45.523A |
Poisoning by antithrombotic drugs, assault, initial encounter |
| T45.524A |
Poisoning by antithrombotic drugs, undetermined, initial encounter |
| T45.601A |
Poisoning by unspecified fibrinolysis-affecting drugs, accidental (unintentional), initial encounter |
| T45.602A |
Poisoning by unspecified fibrinolysis-affecting drugs, intentional self-harm, initial encounter |
| T45.603A |
Poisoning by unspecified fibrinolysis-affecting drugs, assault, initial encounter |
| T45.604A |
Poisoning by unspecified fibrinolysis-affecting drugs, undetermined, initial encounter |
| T45.611A |
Poisoning by thrombolytic drug, accidental (unintentional), initial encounter |
| T45.612A |
Poisoning by thrombolytic drug, intentional self-harm, initial encounter |
| T45.613A |
Poisoning by thrombolytic drug, assault, initial encounter |
| T45.614A |
Poisoning by thrombolytic drug, undetermined, initial encounter |
| T45.621A |
Poisoning by hemostatic drug, accidental (unintentional), initial encounter |
| T45.622A |
Poisoning by hemostatic drug, intentional self-harm, initial encounter |
| T45.623A |
Poisoning by hemostatic drug, assault, initial encounter |
| T45.624A |
Poisoning by hemostatic drug, undetermined, initial encounter |
| T45.691A |
Poisoning by other fibrinolysis-affecting drugs, accidental (unintentional), initial encounter |
| T45.692A |
Poisoning by other fibrinolysis-affecting drugs, intentional self-harm, initial encounter |
| T45.693A |
Poisoning by other fibrinolysis-affecting drugs, assault, initial encounter |
| T45.694A |
Poisoning by other fibrinolysis-affecting drugs, undetermined, initial encounter |
| T45.7X1A |
Poisoning by anticoagulant antagonists, vitamin K and other coagulants, accidental (unintentional), initial encounter |
| T45.7X2A |
Poisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm, initial encounter |
| T45.7X3A |
Poisoning by anticoagulant antagonists, vitamin K and other coagulants, assault, initial encounter |
| T45.7X4A |
Poisoning by anticoagulant antagonists, vitamin K and other coagulants, undetermined, initial encounter |
| T45.8X1A |
Poisoning by other primarily systemic and hematological agents, accidental (unintentional), initial encounter |
| T45.8X2A |
Poisoning by other primarily systemic and hematological agents, intentional self-harm, initial encounter |
| T45.8X3A |
Poisoning by other primarily systemic and hematological agents, assault, initial encounter |
| T45.8X4A |
Poisoning by other primarily systemic and hematological agents, undetermined, initial encounter |
| T45.91XA |
Poisoning by unspecified primarily systemic and hematological agent, accidental (unintentional), initial encounter |
| T45.92XA |
Poisoning by unspecified primarily systemic and hematological agent, intentional self-harm, initial encounter |
| T45.93XA |
Poisoning by unspecified primarily systemic and hematological agent, assault, initial encounter |
| T45.94XA |
Poisoning by unspecified primarily systemic and hematological agent, undetermined, initial encounter |
| T46.0X1A |
Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), initial encounter |
| T46.0X2A |
Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, initial encounter |
| T46.0X3A |
Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, initial encounter |
| T46.0X4A |
Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, initial encounter |
| T46.1X1A |
Poisoning by calcium-channel blockers, accidental (unintentional), initial encounter |
| T46.1X2A |
Poisoning by calcium-channel blockers, intentional self-harm, initial encounter |
| T46.1X3A |
Poisoning by calcium-channel blockers, assault, initial encounter |
| T46.1X4A |
Poisoning by calcium-channel blockers, undetermined, initial encounter |
| T46.2X1A |
Poisoning by other antidysrhythmic drugs, accidental (unintentional), initial encounter |
| T46.2X2A |
Poisoning by other antidysrhythmic drugs, intentional self-harm, initial encounter |
| T46.2X3A |
Poisoning by other antidysrhythmic drugs, assault, initial encounter |
| T46.2X4A |
Poisoning by other antidysrhythmic drugs, undetermined, initial encounter |
| T46.3X1A |
Poisoning by coronary vasodilators, accidental (unintentional), initial encounter |
| T46.3X2A |
Poisoning by coronary vasodilators, intentional self-harm, initial encounter |
| T46.3X3A |
Poisoning by coronary vasodilators, assault, initial encounter |
| T46.3X4A |
Poisoning by coronary vasodilators, undetermined, initial encounter |
| T46.4X1A |
Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), initial encounter |
| T46.4X2A |
Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, initial encounter |
| T46.4X3A |
Poisoning by angiotensin-converting-enzyme inhibitors, assault, initial encounter |
| T46.4X4A |
Poisoning by angiotensin-converting-enzyme inhibitors, undetermined, initial encounter |
| T46.5X1A |
Poisoning by other antihypertensive drugs, accidental (unintentional), initial encounter |
| T46.5X2A |
Poisoning by other antihypertensive drugs, intentional self-harm, initial encounter |
| T46.5X3A |
Poisoning by other antihypertensive drugs, assault, initial encounter |
| T46.5X4A |
Poisoning by other antihypertensive drugs, undetermined, initial encounter |
| T46.6X1A |
Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), initial encounter |
| T46.6X2A |
Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, initial encounter |
| T46.6X3A |
Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault, initial encounter |
| T46.6X4A |
Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined, initial encounter |
| T46.7X1A |
Poisoning by peripheral vasodilators, accidental (unintentional), initial encounter |
| T46.7X2A |
Poisoning by peripheral vasodilators, intentional self-harm, initial encounter |
| T46.7X3A |
Poisoning by peripheral vasodilators, assault, initial encounter |
| T46.7X4A |
Poisoning by peripheral vasodilators, undetermined, initial encounter |
| T46.8X1A |
Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), initial encounter |
| T46.8X2A |
Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, initial encounter |
| T46.8X3A |
Poisoning by antivaricose drugs, including sclerosing agents, assault, initial encounter |
| T46.8X4A |
Poisoning by antivaricose drugs, including sclerosing agents, undetermined, initial encounter |
| T46.901A |
Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), initial encounter |
| T46.902A |
Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, initial encounter |
| T46.903A |
Poisoning by unspecified agents primarily affecting the cardiovascular system, assault, initial encounter |
| T46.904A |
Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, initial encounter |
| T46.991A |
Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), initial encounter |
| T46.992A |
Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, initial encounter |
| T46.993A |
Poisoning by other agents primarily affecting the cardiovascular system, assault, initial encounter |
| T46.994A |
Poisoning by other agents primarily affecting the cardiovascular system, undetermined, initial encounter |
| T47.0X1A |
Poisoning by histamine H2-receptor blockers, accidental (unintentional), initial encounter |
| T47.0X2A |
Poisoning by histamine H2-receptor blockers, intentional self-harm, initial encounter |
| T47.0X3A |
Poisoning by histamine H2-receptor blockers, assault, initial encounter |
| T47.0X4A |
Poisoning by histamine H2-receptor blockers, undetermined, initial encounter |
| T47.1X1A |
Poisoning by other antacids and anti-gastric-secretion drugs, accidental (unintentional), initial encounter |
| T47.1X2A |
Poisoning by other antacids and anti-gastric-secretion drugs, intentional self-harm, initial encounter |
| T47.1X3A |
Poisoning by other antacids and anti-gastric-secretion drugs, assault, initial encounter |
| T47.1X4A |
Poisoning by other antacids and anti-gastric-secretion drugs, undetermined, initial encounter |
| T47.2X1A |
Poisoning by stimulant laxatives, accidental (unintentional), initial encounter |
| T47.2X2A |
Poisoning by stimulant laxatives, intentional self-harm, initial encounter |
| T47.2X3A |
Poisoning by stimulant laxatives, assault, initial encounter |
| T47.2X4A |
Poisoning by stimulant laxatives, undetermined, initial encounter |
| T47.3X1A |
Poisoning by saline and osmotic laxatives, accidental (unintentional), initial encounter |
| T47.3X2A |
Poisoning by saline and osmotic laxatives, intentional self-harm, initial encounter |
| T47.3X3A |
Poisoning by saline and osmotic laxatives, assault, initial encounter |
| T47.3X4A |
Poisoning by saline and osmotic laxatives, undetermined, initial encounter |
| T47.4X1A |
Poisoning by other laxatives, accidental (unintentional), initial encounter |
| T47.4X2A |
Poisoning by other laxatives, intentional self-harm, initial encounter |
| T47.4X3A |
Poisoning by other laxatives, assault, initial encounter |
| T47.4X4A |
Poisoning by other laxatives, undetermined, initial encounter |
| T47.5X1A |
Poisoning by digestants, accidental (unintentional), initial encounter |
| T47.5X2A |
Poisoning by digestants, intentional self-harm, initial encounter |
| T47.5X3A |
Poisoning by digestants, assault, initial encounter |
| T47.5X4A |
Poisoning by digestants, undetermined, initial encounter |
| T47.6X1A |
Poisoning by antidiarrheal drugs, accidental (unintentional), initial encounter |
| T47.6X2A |
Poisoning by antidiarrheal drugs, intentional self-harm, initial encounter |
| T47.6X3A |
Poisoning by antidiarrheal drugs, assault, initial encounter |
| T47.6X4A |
Poisoning by antidiarrheal drugs, undetermined, initial encounter |
| T47.7X1A |
Poisoning by emetics, accidental (unintentional), initial encounter |
| T47.7X2A |
Poisoning by emetics, intentional self-harm, initial encounter |
| T47.7X3A |
Poisoning by emetics, assault, initial encounter |
| T47.7X4A |
Poisoning by emetics, undetermined, initial encounter |
| T47.8X1A |
Poisoning by other agents primarily affecting gastrointestinal system, accidental (unintentional), initial encounter |
| T47.8X2A |
Poisoning by other agents primarily affecting gastrointestinal system, intentional self-harm, initial encounter |
| T47.8X3A |
Poisoning by other agents primarily affecting gastrointestinal system, assault, initial encounter |
| T47.8X4A |
Poisoning by other agents primarily affecting gastrointestinal system, undetermined, initial encounter |
| T47.91XA |
Poisoning by unspecified agents primarily affecting the gastrointestinal system, accidental (unintentional), initial encounter |
| T47.92XA |
Poisoning by unspecified agents primarily affecting the gastrointestinal system, intentional self-harm, initial encounter |
| T47.93XA |
Poisoning by unspecified agents primarily affecting the gastrointestinal system, assault, initial encounter |
| T47.94XA |
Poisoning by unspecified agents primarily affecting the gastrointestinal system, undetermined, initial encounter |
| T48.0X1A |
Poisoning by oxytocic drugs, accidental (unintentional), initial encounter |
| T48.0X2A |
Poisoning by oxytocic drugs, intentional self-harm, initial encounter |
| T48.0X3A |
Poisoning by oxytocic drugs, assault, initial encounter |
| T48.0X4A |
Poisoning by oxytocic drugs, undetermined, initial encounter |
| T48.1X1A |
Poisoning by skeletal muscle relaxants [neuromuscular blocking agents], accidental (unintentional), initial encounter |
| T48.1X2A |
Poisoning by skeletal muscle relaxants [neuromuscular blocking agents], intentional self-harm, initial encounter |
| T48.1X3A |
Poisoning by skeletal muscle relaxants [neuromuscular blocking agents], assault, initial encounter |
| T48.1X4A |
Poisoning by skeletal muscle relaxants [neuromuscular blocking agents], undetermined, initial encounter |
| T48.201A |
Poisoning by unspecified drugs acting on muscles, accidental (unintentional), initial encounter |
| T48.202A |
Poisoning by unspecified drugs acting on muscles, intentional self-harm, initial encounter |
| T48.203A |
Poisoning by unspecified drugs acting on muscles, assault, initial encounter |
| T48.204A |
Poisoning by unspecified drugs acting on muscles, undetermined, initial encounter |
| T48.291A |
Poisoning by other drugs acting on muscles, accidental (unintentional), initial encounter |
| T48.292A |
Poisoning by other drugs acting on muscles, intentional self-harm, initial encounter |
| T48.293A |
Poisoning by other drugs acting on muscles, assault, initial encounter |
| T48.294A |
Poisoning by other drugs acting on muscles, undetermined, initial encounter |
| T48.3X1A |
Poisoning by antitussives, accidental (unintentional), initial encounter |
| T48.3X2A |
Poisoning by antitussives, intentional self-harm, initial encounter |
| T48.3X3A |
Poisoning by antitussives, assault, initial encounter |
| T48.3X4A |
Poisoning by antitussives, undetermined, initial encounter |
| T48.4X1A |
Poisoning by expectorants, accidental (unintentional), initial encounter |
| T48.4X2A |
Poisoning by expectorants, intentional self-harm, initial encounter |
| T48.4X3A |
Poisoning by expectorants, assault, initial encounter |
| T48.4X4A |
Poisoning by expectorants, undetermined, initial encounter |
| T48.5X1A |
Poisoning by other anti-common-cold drugs, accidental (unintentional), initial encounter |
| T48.5X2A |
Poisoning by other anti-common-cold drugs, intentional self-harm, initial encounter |
| T48.5X3A |
Poisoning by other anti-common-cold drugs, assault, initial encounter |
| T48.5X4A |
Poisoning by other anti-common-cold drugs, undetermined, initial encounter |
| T48.6X1A |
Poisoning by antiasthmatics, accidental (unintentional), initial encounter |
| T48.6X2A |
Poisoning by antiasthmatics, intentional self-harm, initial encounter |
| T48.6X3A |
Poisoning by antiasthmatics, assault, initial encounter |
| T48.6X4A |
Poisoning by antiasthmatics, undetermined, initial encounter |
| T48.901A |
Poisoning by unspecified agents primarily acting on the respiratory system, accidental (unintentional), initial encounter |
| T48.902A |
Poisoning by unspecified agents primarily acting on the respiratory system, intentional self-harm, initial encounter |
| T48.903A |
Poisoning by unspecified agents primarily acting on the respiratory system, assault, initial encounter |
| T48.904A |
Poisoning by unspecified agents primarily acting on the respiratory system, undetermined, initial encounter |
| T48.991A |
Poisoning by other agents primarily acting on the respiratory system, accidental (unintentional), initial encounter |
| T48.992A |
Poisoning by other agents primarily acting on the respiratory system, intentional self-harm, initial encounter |
| T48.993A |
Poisoning by other agents primarily acting on the respiratory system, assault, initial encounter |
| T48.994A |
Poisoning by other agents primarily acting on the respiratory system, undetermined, initial encounter |
| T49.0X1A |
Poisoning by local antifungal, anti-infective and anti-inflammatory drugs, accidental (unintentional), initial encounter |
| T49.0X2A |
Poisoning by local antifungal, anti-infective and anti-inflammatory drugs, intentional self-harm, initial encounter |
| T49.0X3A |
Poisoning by local antifungal, anti-infective and anti-inflammatory drugs, assault, initial encounter |
| T49.0X4A |
Poisoning by local antifungal, anti-infective and anti-inflammatory drugs, undetermined, initial encounter |
| T49.1X1A |
Poisoning by antipruritics, accidental (unintentional), initial encounter |
| T49.1X2A |
Poisoning by antipruritics, intentional self-harm, initial encounter |
| T49.1X3A |
Poisoning by antipruritics, assault, initial encounter |
| T49.1X4A |
Poisoning by antipruritics, undetermined, initial encounter |
| T49.2X1A |
Poisoning by local astringents and local detergents, accidental (unintentional), initial encounter |
| T49.2X2A |
Poisoning by local astringents and local detergents, intentional self-harm, initial encounter |
| T49.2X3A |
Poisoning by local astringents and local detergents, assault, initial encounter |
| T49.2X4A |
Poisoning by local astringents and local detergents, undetermined, initial encounter |
| T49.3X1A |
Poisoning by emollients, demulcents and protectants, accidental (unintentional), initial encounter |
| T49.3X2A |
Poisoning by emollients, demulcents and protectants, intentional self-harm, initial encounter |
| T49.3X3A |
Poisoning by emollients, demulcents and protectants, assault, initial encounter |
| T49.3X4A |
Poisoning by emollients, demulcents and protectants, undetermined, initial encounter |
| T49.4X1A |
Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, accidental (unintentional), initial encounter |
| T49.4X2A |
Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, intentional self-harm, initial encounter |
| T49.4X3A |
Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, assault, initial encounter |
| T49.4X4A |
Poisoning by keratolytics, keratoplastics, and other hair treatment drugs and preparations, undetermined, initial encounter |
| T49.5X1A |
Poisoning by ophthalmological drugs and preparations, accidental (unintentional), initial encounter |
| T49.5X2A |
Poisoning by ophthalmological drugs and preparations, intentional self-harm, initial encounter |
| T49.5X3A |
Poisoning by ophthalmological drugs and preparations, assault, initial encounter |
| T49.5X4A |
Poisoning by ophthalmological drugs and preparations, undetermined, initial encounter |
| T49.6X1A |
Poisoning by otorhinolaryngological drugs and preparations, accidental (unintentional), initial encounter |
| T49.6X2A |
Poisoning by otorhinolaryngological drugs and preparations, intentional self-harm, initial encounter |
| T49.6X3A |
Poisoning by otorhinolaryngological drugs and preparations, assault, initial encounter |
| T49.6X4A |
Poisoning by otorhinolaryngological drugs and preparations, undetermined, initial encounter |
| T49.7X1A |
Poisoning by dental drugs, topically applied, accidental (unintentional), initial encounter |
| T49.7X2A |
Poisoning by dental drugs, topically applied, intentional self-harm, initial encounter |
| T49.7X3A |
Poisoning by dental drugs, topically applied, assault, initial encounter |
| T49.7X4A |
Poisoning by dental drugs, topically applied, undetermined, initial encounter |
| T49.8X1A |
Poisoning by other topical agents, accidental (unintentional), initial encounter |
| T49.8X2A |
Poisoning by other topical agents, intentional self-harm, initial encounter |
| T49.8X3A |
Poisoning by other topical agents, assault, initial encounter |
| T49.8X4A |
Poisoning by other topical agents, undetermined, initial encounter |
| T49.91XA |
Poisoning by unspecified topical agent, accidental (unintentional), initial encounter |
| T49.92XA |
Poisoning by unspecified topical agent, intentional self-harm, initial encounter |
| T49.93XA |
Poisoning by unspecified topical agent, assault, initial encounter |
| T49.94XA |
Poisoning by unspecified topical agent, undetermined, initial encounter |
| T50.0X1A |
Poisoning by mineralocorticoids and their antagonists, accidental (unintentional), initial encounter |
| T50.0X2A |
Poisoning by mineralocorticoids and their antagonists, intentional self-harm, initial encounter |
| T50.0X3A |
Poisoning by mineralocorticoids and their antagonists, assault, initial encounter |
| T50.0X4A |
Poisoning by mineralocorticoids and their antagonists, undetermined, initial encounter |
| T50.1X1A |
Poisoning by loop [high-ceiling] diuretics, accidental (unintentional), initial encounter |
| T50.1X2A |
Poisoning by loop [high-ceiling] diuretics, intentional self-harm, initial encounter |
| T50.1X3A |
Poisoning by loop [high-ceiling] diuretics, assault, initial encounter |
| T50.1X4A |
Poisoning by loop [high-ceiling] diuretics, undetermined, initial encounter |
| T50.2X1A |
Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, accidental (unintentional), initial encounter |
| T50.2X2A |
Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, intentional self-harm, initial encounter |
| T50.2X3A |
Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, assault, initial encounter |
| T50.2X4A |
Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, undetermined, initial encounter |
| T50.3X1A |
Poisoning by electrolytic, caloric and water-balance agents, accidental (unintentional), initial encounter |
| T50.3X2A |
Poisoning by electrolytic, caloric and water-balance agents, intentional self-harm, initial encounter |
| T50.3X3A |
Poisoning by electrolytic, caloric and water-balance agents, assault, initial encounter |
| T50.3X4A |
Poisoning by electrolytic, caloric and water-balance agents, undetermined, initial encounter |
| T50.4X1A |
Poisoning by drugs affecting uric acid metabolism, accidental (unintentional), initial encounter |
| T50.4X2A |
Poisoning by drugs affecting uric acid metabolism, intentional self-harm, initial encounter |
| T50.4X3A |
Poisoning by drugs affecting uric acid metabolism, assault, initial encounter |
| T50.4X4A |
Poisoning by drugs affecting uric acid metabolism, undetermined, initial encounter |
| T50.5X1A |
Poisoning by appetite depressants, accidental (unintentional), initial encounter |
| T50.5X2A |
Poisoning by appetite depressants, intentional self-harm, initial encounter |
| T50.5X3A |
Poisoning by appetite depressants, assault, initial encounter |
| T50.5X4A |
Poisoning by appetite depressants, undetermined, initial encounter |
| T50.6X1A |
Poisoning by antidotes and chelating agents, accidental (unintentional), initial encounter |
| T50.6X2A |
Poisoning by antidotes and chelating agents, intentional self-harm, initial encounter |
| T50.6X3A |
Poisoning by antidotes and chelating agents, assault, initial encounter |
| T50.6X4A |
Poisoning by antidotes and chelating agents, undetermined, initial encounter |
| T50.7X1A |
Poisoning by analeptics and opioid receptor antagonists, accidental (unintentional), initial encounter |
| T50.7X2A |
Poisoning by analeptics and opioid receptor antagonists, intentional self-harm, initial encounter |
| T50.7X3A |
Poisoning by analeptics and opioid receptor antagonists, assault, initial encounter |
| T50.7X4A |
Poisoning by analeptics and opioid receptor antagonists, undetermined, initial encounter |
| T50.8X1A |
Poisoning by diagnostic agents, accidental (unintentional), initial encounter |
| T50.8X2A |
Poisoning by diagnostic agents, intentional self-harm, initial encounter |
| T50.8X3A |
Poisoning by diagnostic agents, assault, initial encounter |
| T50.8X4A |
Poisoning by diagnostic agents, undetermined, initial encounter |
| T50.901A |
Poisoning by unspecified drugs, medicaments and biological substances, accidental (unintentional), initial encounter |
| T50.902A |
Poisoning by unspecified drugs, medicaments and biological substances, intentional self-harm, initial encounter |
| T50.903A |
Poisoning by unspecified drugs, medicaments and biological substances, assault, initial encounter |
| T50.904A |
Poisoning by unspecified drugs, medicaments and biological substances, undetermined, initial encounter |
| T50.991A |
Poisoning by other drugs, medicaments and biological substances, accidental (unintentional), initial encounter |
| T50.992A |
Poisoning by other drugs, medicaments and biological substances, intentional self-harm, initial encounter |
| T50.993A |
Poisoning by other drugs, medicaments and biological substances, assault, initial encounter |
| T50.994A |
Poisoning by other drugs, medicaments and biological substances, undetermined, initial encounter |
| T50.A11A |
Poisoning by pertussis vaccine, including combinations with a pertussis component, accidental (unintentional), initial encounter |
| T50.A12A |
Poisoning by pertussis vaccine, including combinations with a pertussis component, intentional self-harm, initial encounter |
| T50.A13A |
Poisoning by pertussis vaccine, including combinations with a pertussis component, assault, initial encounter |
| T50.A14A |
Poisoning by pertussis vaccine, including combinations with a pertussis component, undetermined, initial encounter |
| T50.A21A |
Poisoning by mixed bacterial vaccines without a pertussis component, accidental (unintentional), initial encounter |
| T50.A22A |
Poisoning by mixed bacterial vaccines without a pertussis component, intentional self-harm, initial encounter |
| T50.A23A |
Poisoning by mixed bacterial vaccines without a pertussis component, assault, initial encounter |
| T50.A24A |
Poisoning by mixed bacterial vaccines without a pertussis component, undetermined, initial encounter |
| T50.A91A |
Poisoning by other bacterial vaccines, accidental (unintentional), initial encounter |
| T50.A92A |
Poisoning by other bacterial vaccines, intentional self-harm, initial encounter |
| T50.A93A |
Poisoning by other bacterial vaccines, assault, initial encounter |
| T50.A94A |
Poisoning by other bacterial vaccines, undetermined, initial encounter |
| T50.B11A |
Poisoning by smallpox vaccines, accidental (unintentional), initial encounter |
| T50.B12A |
Poisoning by smallpox vaccines, intentional self-harm, initial encounter |
| T50.B13A |
Poisoning by smallpox vaccines, assault, initial encounter |
| T50.B14A |
Poisoning by smallpox vaccines, undetermined, initial encounter |
| T50.B91A |
Poisoning by other viral vaccines, accidental (unintentional), initial encounter |
| T50.B92A |
Poisoning by other viral vaccines, intentional self-harm, initial encounter |
| T50.B93A |
Poisoning by other viral vaccines, assault, initial encounter |
| T50.B94A |
Poisoning by other viral vaccines, undetermined, initial encounter |
| T50.Z11A |
Poisoning by immunoglobulin, accidental (unintentional), initial encounter |
| T50.Z12A |
Poisoning by immunoglobulin, intentional self-harm, initial encounter |
| T50.Z13A |
Poisoning by immunoglobulin, assault, initial encounter |
| T50.Z14A |
Poisoning by immunoglobulin, undetermined, initial encounter |
| T50.Z91A |
Poisoning by other vaccines and biological substances, accidental (unintentional), initial encounter |
| T50.Z92A |
Poisoning by other vaccines and biological substances, intentional self-harm, initial encounter |
| T50.Z93A |
Poisoning by other vaccines and biological substances, assault, initial encounter |
| T50.Z94A |
Poisoning by other vaccines and biological substances, undetermined, initial encounter |
| T51.0X1A |
Toxic effect of ethanol, accidental (unintentional), initial encounter |
| T51.0X2A |
Toxic effect of ethanol, intentional self-harm, initial encounter |
| T51.0X3A |
Toxic effect of ethanol, assault, initial encounter |
| T51.0X4A |
Toxic effect of ethanol, undetermined, initial encounter |
| T51.1X1A |
Toxic effect of methanol, accidental (unintentional), initial encounter |
| T51.1X2A |
Toxic effect of methanol, intentional self-harm, initial encounter |
| T51.1X3A |
Toxic effect of methanol, assault, initial encounter |
| T51.1X4A |
Toxic effect of methanol, undetermined, initial encounter |
| T51.2X1A |
Toxic effect of 2-Propanol, accidental (unintentional), initial encounter |
| T51.2X2A |
Toxic effect of 2-Propanol, intentional self-harm, initial encounter |
| T51.2X3A |
Toxic effect of 2-Propanol, assault, initial encounter |
| T51.2X4A |
Toxic effect of 2-Propanol, undetermined, initial encounter |
| T51.3X1A |
Toxic effect of fusel oil, accidental (unintentional), initial encounter |
| T51.3X2A |
Toxic effect of fusel oil, intentional self-harm, initial encounter |
| T51.3X3A |
Toxic effect of fusel oil, assault, initial encounter |
| T51.3X4A |
Toxic effect of fusel oil, undetermined, initial encounter |
| T51.8X1A |
Toxic effect of other alcohols, accidental (unintentional), initial encounter |
| T51.8X2A |
Toxic effect of other alcohols, intentional self-harm, initial encounter |
| T51.8X3A |
Toxic effect of other alcohols, assault, initial encounter |
| T51.8X4A |
Toxic effect of other alcohols, undetermined, initial encounter |
| T51.91XA |
Toxic effect of unspecified alcohol, accidental (unintentional), initial encounter |
| T51.92XA |
Toxic effect of unspecified alcohol, intentional self-harm, initial encounter |
| T51.93XA |
Toxic effect of unspecified alcohol, assault, initial encounter |
| T51.94XA |
Toxic effect of unspecified alcohol, undetermined, initial encounter |
| T52.0X1A |
Toxic effect of petroleum products, accidental (unintentional), initial encounter |
| T52.0X2A |
Toxic effect of petroleum products, intentional self-harm, initial encounter |
| T52.0X3A |
Toxic effect of petroleum products, assault, initial encounter |
| T52.0X4A |
Toxic effect of petroleum products, undetermined, initial encounter |
| T52.1X1A |
Toxic effect of benzene, accidental (unintentional), initial encounter |
| T52.1X2A |
Toxic effect of benzene, intentional self-harm, initial encounter |
| T52.1X3A |
Toxic effect of benzene, assault, initial encounter |
| T52.1X4A |
Toxic effect of benzene, undetermined, initial encounter |
| T52.2X1A |
Toxic effect of homologues of benzene, accidental (unintentional), initial encounter |
| T52.2X2A |
Toxic effect of homologues of benzene, intentional self-harm, initial encounter |
| T52.2X3A |
Toxic effect of homologues of benzene, assault, initial encounter |
| T52.2X4A |
Toxic effect of homologues of benzene, undetermined, initial encounter |
| T52.3X1A |
Toxic effect of glycols, accidental (unintentional), initial encounter |
| T52.3X2A |
Toxic effect of glycols, intentional self-harm, initial encounter |
| T52.3X3A |
Toxic effect of glycols, assault, initial encounter |
| T52.3X4A |
Toxic effect of glycols, undetermined, initial encounter |
| T52.4X1A |
Toxic effect of ketones, accidental (unintentional), initial encounter |
| T52.4X2A |
Toxic effect of ketones, intentional self-harm, initial encounter |
| T52.4X3A |
Toxic effect of ketones, assault, initial encounter |
| T52.4X4A |
Toxic effect of ketones, undetermined, initial encounter |
| T52.8X1A |
Toxic effect of other organic solvents, accidental (unintentional), initial encounter |
| T52.8X2A |
Toxic effect of other organic solvents, intentional self-harm, initial encounter |
| T52.8X3A |
Toxic effect of other organic solvents, assault, initial encounter |
| T52.8X4A |
Toxic effect of other organic solvents, undetermined, initial encounter |
| T52.91XA |
Toxic effect of unspecified organic solvent, accidental (unintentional), initial encounter |
| T52.92XA |
Toxic effect of unspecified organic solvent, intentional self-harm, initial encounter |
| T52.93XA |
Toxic effect of unspecified organic solvent, assault, initial encounter |
| T52.94XA |
Toxic effect of unspecified organic solvent, undetermined, initial encounter |
| T53.0X1A |
Toxic effect of carbon tetrachloride, accidental (unintentional), initial encounter |
| T53.0X2A |
Toxic effect of carbon tetrachloride, intentional self-harm, initial encounter |
| T53.0X3A |
Toxic effect of carbon tetrachloride, assault, initial encounter |
| T53.0X4A |
Toxic effect of carbon tetrachloride, undetermined, initial encounter |
| T53.1X1A |
Toxic effect of chloroform, accidental (unintentional), initial encounter |
| T53.1X2A |
Toxic effect of chloroform, intentional self-harm, initial encounter |
| T53.1X3A |
Toxic effect of chloroform, assault, initial encounter |
| T53.1X4A |
Toxic effect of chloroform, undetermined, initial encounter |
| T53.2X1A |
Toxic effect of trichloroethylene, accidental (unintentional), initial encounter |
| T53.2X2A |
Toxic effect of trichloroethylene, intentional self-harm, initial encounter |
| T53.2X3A |
Toxic effect of trichloroethylene, assault, initial encounter |
| T53.2X4A |
Toxic effect of trichloroethylene, undetermined, initial encounter |
| T53.3X1A |
Toxic effect of tetrachloroethylene, accidental (unintentional), initial encounter |
| T53.3X2A |
Toxic effect of tetrachloroethylene, intentional self-harm, initial encounter |
| T53.3X3A |
Toxic effect of tetrachloroethylene, assault, initial encounter |
| T53.3X4A |
Toxic effect of tetrachloroethylene, undetermined, initial encounter |
| T53.4X1A |
Toxic effect of dichloromethane, accidental (unintentional), initial encounter |
| T53.4X2A |
Toxic effect of dichloromethane, intentional self-harm, initial encounter |
| T53.4X3A |
Toxic effect of dichloromethane, assault, initial encounter |
| T53.4X4A |
Toxic effect of dichloromethane, undetermined, initial encounter |
| T53.5X1A |
Toxic effect of chlorofluorocarbons, accidental (unintentional), initial encounter |
| T53.5X2A |
Toxic effect of chlorofluorocarbons, intentional self-harm, initial encounter |
| T53.5X3A |
Toxic effect of chlorofluorocarbons, assault, initial encounter |
| T53.5X4A |
Toxic effect of chlorofluorocarbons, undetermined, initial encounter |
| T53.6X1A |
Toxic effect of other halogen derivatives of aliphatic hydrocarbons, accidental (unintentional), initial encounter |
| T53.6X2A |
Toxic effect of other halogen derivatives of aliphatic hydrocarbons, intentional self-harm, initial encounter |
| T53.6X3A |
Toxic effect of other halogen derivatives of aliphatic hydrocarbons, assault, initial encounter |
| T53.6X4A |
Toxic effect of other halogen derivatives of aliphatic hydrocarbons, undetermined, initial encounter |
| T53.7X1A |
Toxic effect of other halogen derivatives of aromatic hydrocarbons, accidental (unintentional), initial encounter |
| T53.7X2A |
Toxic effect of other halogen derivatives of aromatic hydrocarbons, intentional self-harm, initial encounter |
| T53.7X3A |
Toxic effect of other halogen derivatives of aromatic hydrocarbons, assault, initial encounter |
| T53.7X4A |
Toxic effect of other halogen derivatives of aromatic hydrocarbons, undetermined, initial encounter |
| T53.91XA |
Toxic effect of unspecified halogen derivatives of aliphatic and aromatic hydrocarbons, accidental (unintentional), initial encounter |
| T53.92XA |
Toxic effect of unspecified halogen derivatives of aliphatic and aromatic hydrocarbons, intentional self-harm, initial encounter |
| T53.93XA |
Toxic effect of unspecified halogen derivatives of aliphatic and aromatic hydrocarbons, assault, initial encounter |
| T53.94XA |
Toxic effect of unspecified halogen derivatives of aliphatic and aromatic hydrocarbons, undetermined, initial encounter |
| T54.0X1A |
Toxic effect of phenol and phenol homologues, accidental (unintentional), initial encounter |
| T54.0X2A |
Toxic effect of phenol and phenol homologues, intentional self-harm, initial encounter |
| T54.0X3A |
Toxic effect of phenol and phenol homologues, assault, initial encounter |
| T54.0X4A |
Toxic effect of phenol and phenol homologues, undetermined, initial encounter |
| T54.1X1A |
Toxic effect of other corrosive organic compounds, accidental (unintentional), initial encounter |
| T54.1X2A |
Toxic effect of other corrosive organic compounds, intentional self-harm, initial encounter |
| T54.1X3A |
Toxic effect of other corrosive organic compounds, assault, initial encounter |
| T54.1X4A |
Toxic effect of other corrosive organic compounds, undetermined, initial encounter |
| T54.2X1A |
Toxic effect of corrosive acids and acid-like substances, accidental (unintentional), initial encounter |
| T54.2X2A |
Toxic effect of corrosive acids and acid-like substances, intentional self-harm, initial encounter |
| T54.2X3A |
Toxic effect of corrosive acids and acid-like substances, assault, initial encounter |
| T54.2X4A |
Toxic effect of corrosive acids and acid-like substances, undetermined, initial encounter |
| T54.3X1A |
Toxic effect of corrosive alkalis and alkali-like substances, accidental (unintentional), initial encounter |
| T54.3X2A |
Toxic effect of corrosive alkalis and alkali-like substances, intentional self-harm, initial encounter |
| T54.3X3A |
Toxic effect of corrosive alkalis and alkali-like substances, assault, initial encounter |
| T54.3X4A |
Toxic effect of corrosive alkalis and alkali-like substances, undetermined, initial encounter |
| T54.91XA |
Toxic effect of unspecified corrosive substance, accidental (unintentional), initial encounter |
| T54.92XA |
Toxic effect of unspecified corrosive substance, intentional self-harm, initial encounter |
| T54.93XA |
Toxic effect of unspecified corrosive substance, assault, initial encounter |
| T54.94XA |
Toxic effect of unspecified corrosive substance, undetermined, initial encounter |
| T55.0X1A |
Toxic effect of soaps, accidental (unintentional), initial encounter |
| T55.0X2A |
Toxic effect of soaps, intentional self-harm, initial encounter |
| T55.0X3A |
Toxic effect of soaps, assault, initial encounter |
| T55.0X4A |
Toxic effect of soaps, undetermined, initial encounter |
| T55.1X1A |
Toxic effect of detergents, accidental (unintentional), initial encounter |
| T55.1X2A |
Toxic effect of detergents, intentional self-harm, initial encounter |
| T55.1X3A |
Toxic effect of detergents, assault, initial encounter |
| T55.1X4A |
Toxic effect of detergents, undetermined, initial encounter |
| T56.0X1A |
Toxic effect of lead and its compounds, accidental (unintentional), initial encounter |
| T56.0X2A |
Toxic effect of lead and its compounds, intentional self-harm, initial encounter |
| T56.0X3A |
Toxic effect of lead and its compounds, assault, initial encounter |
| T56.0X4A |
Toxic effect of lead and its compounds, undetermined, initial encounter |
| T56.1X1A |
Toxic effect of mercury and its compounds, accidental (unintentional), initial encounter |
| T56.1X2A |
Toxic effect of mercury and its compounds, intentional self-harm, initial encounter |
| T56.1X3A |
Toxic effect of mercury and its compounds, assault, initial encounter |
| T56.1X4A |
Toxic effect of mercury and its compounds, undetermined, initial encounter |
| T56.2X1A |
Toxic effect of chromium and its compounds, accidental (unintentional), initial encounter |
| T56.2X2A |
Toxic effect of chromium and its compounds, intentional self-harm, initial encounter |
| T56.2X3A |
Toxic effect of chromium and its compounds, assault, initial encounter |
| T56.2X4A |
Toxic effect of chromium and its compounds, undetermined, initial encounter |
| T56.3X1A |
Toxic effect of cadmium and its compounds, accidental (unintentional), initial encounter |
| T56.3X2A |
Toxic effect of cadmium and its compounds, intentional self-harm, initial encounter |
| T56.3X3A |
Toxic effect of cadmium and its compounds, assault, initial encounter |
| T56.3X4A |
Toxic effect of cadmium and its compounds, undetermined, initial encounter |
| T56.4X1A |
Toxic effect of copper and its compounds, accidental (unintentional), initial encounter |
| T56.4X2A |
Toxic effect of copper and its compounds, intentional self-harm, initial encounter |
| T56.4X3A |
Toxic effect of copper and its compounds, assault, initial encounter |
| T56.4X4A |
Toxic effect of copper and its compounds, undetermined, initial encounter |
| T56.5X1A |
Toxic effect of zinc and its compounds, accidental (unintentional), initial encounter |
| T56.5X2A |
Toxic effect of zinc and its compounds, intentional self-harm, initial encounter |
| T56.5X3A |
Toxic effect of zinc and its compounds, assault, initial encounter |
| T56.5X4A |
Toxic effect of zinc and its compounds, undetermined, initial encounter |
| T56.6X1A |
Toxic effect of tin and its compounds, accidental (unintentional), initial encounter |
| T56.6X2A |
Toxic effect of tin and its compounds, intentional self-harm, initial encounter |
| T56.6X3A |
Toxic effect of tin and its compounds, assault, initial encounter |
| T56.6X4A |
Toxic effect of tin and its compounds, undetermined, initial encounter |
| T56.7X1A |
Toxic effect of beryllium and its compounds, accidental (unintentional), initial encounter |
| T56.7X2A |
Toxic effect of beryllium and its compounds, intentional self-harm, initial encounter |
| T56.7X3A |
Toxic effect of beryllium and its compounds, assault, initial encounter |
| T56.7X4A |
Toxic effect of beryllium and its compounds, undetermined, initial encounter |
| T56.811A |
Toxic effect of thallium, accidental (unintentional), initial encounter |
| T56.812A |
Toxic effect of thallium, intentional self-harm, initial encounter |
| T56.813A |
Toxic effect of thallium, assault, initial encounter |
| T56.814A |
Toxic effect of thallium, undetermined, initial encounter |
| T56.891A |
Toxic effect of other metals, accidental (unintentional), initial encounter |
| T56.892A |
Toxic effect of other metals, intentional self-harm, initial encounter |
| T56.893A |
Toxic effect of other metals, assault, initial encounter |
| T56.894A |
Toxic effect of other metals, undetermined, initial encounter |
| T56.91XA |
Toxic effect of unspecified metal, accidental (unintentional), initial encounter |
| T56.92XA |
Toxic effect of unspecified metal, intentional self-harm, initial encounter |
| T56.93XA |
Toxic effect of unspecified metal, assault, initial encounter |
| T56.94XA |
Toxic effect of unspecified metal, undetermined, initial encounter |
| T57.0X1A |
Toxic effect of arsenic and its compounds, accidental (unintentional), initial encounter |
| T57.0X2A |
Toxic effect of arsenic and its compounds, intentional self-harm, initial encounter |
| T57.0X3A |
Toxic effect of arsenic and its compounds, assault, initial encounter |
| T57.0X4A |
Toxic effect of arsenic and its compounds, undetermined, initial encounter |
| T57.1X1A |
Toxic effect of phosphorus and its compounds, accidental (unintentional), initial encounter |
| T57.1X2A |
Toxic effect of phosphorus and its compounds, intentional self-harm, initial encounter |
| T57.1X3A |
Toxic effect of phosphorus and its compounds, assault, initial encounter |
| T57.1X4A |
Toxic effect of phosphorus and its compounds, undetermined, initial encounter |
| T57.2X1A |
Toxic effect of manganese and its compounds, accidental (unintentional), initial encounter |
| T57.2X2A |
Toxic effect of manganese and its compounds, intentional self-harm, initial encounter |
| T57.2X3A |
Toxic effect of manganese and its compounds, assault, initial encounter |
| T57.2X4A |
Toxic effect of manganese and its compounds, undetermined, initial encounter |
| T57.3X1A |
Toxic effect of hydrogen cyanide, accidental (unintentional), initial encounter |
| T57.3X2A |
Toxic effect of hydrogen cyanide, intentional self-harm, initial encounter |
| T57.3X3A |
Toxic effect of hydrogen cyanide, assault, initial encounter |
| T57.3X4A |
Toxic effect of hydrogen cyanide, undetermined, initial encounter |
| T57.8X1A |
Toxic effect of other specified inorganic substances, accidental (unintentional), initial encounter |
| T57.8X2A |
Toxic effect of other specified inorganic substances, intentional self-harm, initial encounter |
| T57.8X3A |
Toxic effect of other specified inorganic substances, assault, initial encounter |
| T57.8X4A |
Toxic effect of other specified inorganic substances, undetermined, initial encounter |
| T58.01XA |
Toxic effect of carbon monoxide from motor vehicle exhaust, accidental (unintentional), initial encounter |
| T58.02XA |
Toxic effect of carbon monoxide from motor vehicle exhaust, intentional self-harm, initial encounter |
| T58.03XA |
Toxic effect of carbon monoxide from motor vehicle exhaust, assault, initial encounter |
| T58.04XA |
Toxic effect of carbon monoxide from motor vehicle exhaust, undetermined, initial encounter |
| T58.11XA |
Toxic effect of carbon monoxide from utility gas, accidental (unintentional), initial encounter |
| T58.12XA |
Toxic effect of carbon monoxide from utility gas, intentional self-harm, initial encounter |
| T58.13XA |
Toxic effect of carbon monoxide from utility gas, assault, initial encounter |
| T58.14XA |
Toxic effect of carbon monoxide from utility gas, undetermined, initial encounter |
| T58.2X1A |
Toxic effect of carbon monoxide from incomplete combustion of other domestic fuels, accidental (unintentional), initial encounter |
| T58.2X2A |
Toxic effect of carbon monoxide from incomplete combustion of other domestic fuels, intentional self-harm, initial encounter |
| T58.2X3A |
Toxic effect of carbon monoxide from incomplete combustion of other domestic fuels, assault, initial encounter |
| T58.2X4A |
Toxic effect of carbon monoxide from incomplete combustion of other domestic fuels, undetermined, initial encounter |
| T58.8X1A |
Toxic effect of carbon monoxide from other source, accidental (unintentional), initial encounter |
| T58.8X2A |
Toxic effect of carbon monoxide from other source, intentional self-harm, initial encounter |
| T58.8X3A |
Toxic effect of carbon monoxide from other source, assault, initial encounter |
| T58.8X4A |
Toxic effect of carbon monoxide from other source, undetermined, initial encounter |
| T58.91XA |
Toxic effect of carbon monoxide from unspecified source, accidental (unintentional), initial encounter |
| T58.92XA |
Toxic effect of carbon monoxide from unspecified source, intentional self-harm, initial encounter |
| T58.93XA |
Toxic effect of carbon monoxide from unspecified source, assault, initial encounter |
| T58.94XA |
Toxic effect of carbon monoxide from unspecified source, undetermined, initial encounter |
| T59.0X1A |
Toxic effect of nitrogen oxides, accidental (unintentional), initial encounter |
| T59.0X2A |
Toxic effect of nitrogen oxides, intentional self-harm, initial encounter |
| T59.0X3A |
Toxic effect of nitrogen oxides, assault, initial encounter |
| T59.0X4A |
Toxic effect of nitrogen oxides, undetermined, initial encounter |
| T59.1X1A |
Toxic effect of sulfur dioxide, accidental (unintentional), initial encounter |
| T59.1X2A |
Toxic effect of sulfur dioxide, intentional self-harm, initial encounter |
| T59.1X3A |
Toxic effect of sulfur dioxide, assault, initial encounter |
| T59.1X4A |
Toxic effect of sulfur dioxide, undetermined, initial encounter |
| T59.2X1A |
Toxic effect of formaldehyde, accidental (unintentional), initial encounter |
| T59.2X2A |
Toxic effect of formaldehyde, intentional self-harm, initial encounter |
| T59.2X3A |
Toxic effect of formaldehyde, assault, initial encounter |
| T59.2X4A |
Toxic effect of formaldehyde, undetermined, initial encounter |
| T59.3X1A |
Toxic effect of lacrimogenic gas, accidental (unintentional), initial encounter |
| T59.3X2A |
Toxic effect of lacrimogenic gas, intentional self-harm, initial encounter |
| T59.3X3A |
Toxic effect of lacrimogenic gas, assault, initial encounter |
| T59.3X4A |
Toxic effect of lacrimogenic gas, undetermined, initial encounter |
| T59.4X1A |
Toxic effect of chlorine gas, accidental (unintentional), initial encounter |
| T59.4X2A |
Toxic effect of chlorine gas, intentional self-harm, initial encounter |
| T59.4X3A |
Toxic effect of chlorine gas, assault, initial encounter |
| T59.4X4A |
Toxic effect of chlorine gas, undetermined, initial encounter |
| T59.5X1A |
Toxic effect of fluorine gas and hydrogen fluoride, accidental (unintentional), initial encounter |
| T59.5X2A |
Toxic effect of fluorine gas and hydrogen fluoride, intentional self-harm, initial encounter |
| T59.5X3A |
Toxic effect of fluorine gas and hydrogen fluoride, assault, initial encounter |
| T59.5X4A |
Toxic effect of fluorine gas and hydrogen fluoride, undetermined, initial encounter |
| T59.6X1A |
Toxic effect of hydrogen sulfide, accidental (unintentional), initial encounter |
| T59.6X2A |
Toxic effect of hydrogen sulfide, intentional self-harm, initial encounter |
| T59.6X3A |
Toxic effect of hydrogen sulfide, assault, initial encounter |
| T59.6X4A |
Toxic effect of hydrogen sulfide, undetermined, initial encounter |
| T59.7X1A |
Toxic effect of carbon dioxide, accidental (unintentional), initial encounter |
| T59.7X2A |
Toxic effect of carbon dioxide, intentional self-harm, initial encounter |
| T59.7X3A |
Toxic effect of carbon dioxide, assault, initial encounter |
| T59.7X4A |
Toxic effect of carbon dioxide, undetermined, initial encounter |
| T59.811A |
Toxic effect of smoke, accidental (unintentional), initial encounter |
| T59.812A |
Toxic effect of smoke, intentional self-harm, initial encounter |
| T59.813A |
Toxic effect of smoke, assault, initial encounter |
| T59.814A |
Toxic effect of smoke, undetermined, initial encounter |
| T59.891A |
Toxic effect of other specified gases, fumes and vapors, accidental (unintentional), initial encounter |
| T59.892A |
Toxic effect of other specified gases, fumes and vapors, intentional self-harm, initial encounter |
| T59.893A |
Toxic effect of other specified gases, fumes and vapors, assault, initial encounter |
| T59.894A |
Toxic effect of other specified gases, fumes and vapors, undetermined, initial encounter |
| T59.91XA |
Toxic effect of unspecified gases, fumes and vapors, accidental (unintentional), initial encounter |
| T59.92XA |
Toxic effect of unspecified gases, fumes and vapors, intentional self-harm, initial encounter |
| T59.93XA |
Toxic effect of unspecified gases, fumes and vapors, assault, initial encounter |
| T59.94XA |
Toxic effect of unspecified gases, fumes and vapors, undetermined, initial encounter |
| T60.0X1A |
Toxic effect of organophosphate and carbamate insecticides, accidental (unintentional), initial encounter |
| T60.0X2A |
Toxic effect of organophosphate and carbamate insecticides, intentional self-harm, initial encounter |
| T60.0X3A |
Toxic effect of organophosphate and carbamate insecticides, assault, initial encounter |
| T60.0X4A |
Toxic effect of organophosphate and carbamate insecticides, undetermined, initial encounter |
| T60.1X1A |
Toxic effect of halogenated insecticides, accidental (unintentional), initial encounter |
| T60.1X2A |
Toxic effect of halogenated insecticides, intentional self-harm, initial encounter |
| T60.1X3A |
Toxic effect of halogenated insecticides, assault, initial encounter |
| T60.1X4A |
Toxic effect of halogenated insecticides, undetermined, initial encounter |
| T60.2X1A |
Toxic effect of other insecticides, accidental (unintentional), initial encounter |
| T60.2X2A |
Toxic effect of other insecticides, intentional self-harm, initial encounter |
| T60.2X3A |
Toxic effect of other insecticides, assault, initial encounter |
| T60.2X4A |
Toxic effect of other insecticides, undetermined, initial encounter |
| T60.3X1A |
Toxic effect of herbicides and fungicides, accidental (unintentional), initial encounter |
| T60.3X2A |
Toxic effect of herbicides and fungicides, intentional self-harm, initial encounter |
| T60.3X3A |
Toxic effect of herbicides and fungicides, assault, initial encounter |
| T60.3X4A |
Toxic effect of herbicides and fungicides, undetermined, initial encounter |
| T60.4X1A |
Toxic effect of rodenticides, accidental (unintentional), initial encounter |
| T60.4X2A |
Toxic effect of rodenticides, intentional self-harm, initial encounter |
| T60.4X3A |
Toxic effect of rodenticides, assault, initial encounter |
| T60.4X4A |
Toxic effect of rodenticides, undetermined, initial encounter |
| T60.8X1A |
Toxic effect of other pesticides, accidental (unintentional), initial encounter |
| T60.8X2A |
Toxic effect of other pesticides, intentional self-harm, initial encounter |
| T60.8X3A |
Toxic effect of other pesticides, assault, initial encounter |
| T60.8X4A |
Toxic effect of other pesticides, undetermined, initial encounter |
| T60.91XA |
Toxic effect of unspecified pesticide, accidental (unintentional), initial encounter |
| T60.92XA |
Toxic effect of unspecified pesticide, intentional self-harm, initial encounter |
| T60.93XA |
Toxic effect of unspecified pesticide, assault, initial encounter |
| T60.94XA |
Toxic effect of unspecified pesticide, undetermined, initial encounter |
| T61.01XA |
Ciguatera fish poisoning, accidental (unintentional), initial encounter |
| T61.02XA |
Ciguatera fish poisoning, intentional self-harm, initial encounter |
| T61.03XA |
Ciguatera fish poisoning, assault, initial encounter |
| T61.04XA |
Ciguatera fish poisoning, undetermined, initial encounter |
| T61.11XA |
Scombroid fish poisoning, accidental (unintentional), initial encounter |
| T61.12XA |
Scombroid fish poisoning, intentional self-harm, initial encounter |
| T61.13XA |
Scombroid fish poisoning, assault, initial encounter |
| T61.14XA |
Scombroid fish poisoning, undetermined, initial encounter |
| T61.771A |
Other fish poisoning, accidental (unintentional), initial encounter |
| T61.772A |
Other fish poisoning, intentional self-harm, initial encounter |
| T61.773A |
Other fish poisoning, assault, initial encounter |
| T61.774A |
Other fish poisoning, undetermined, initial encounter |
| T61.781A |
Other shellfish poisoning, accidental (unintentional), initial encounter |
| T61.782A |
Other shellfish poisoning, intentional self-harm, initial encounter |
| T61.783A |
Other shellfish poisoning, assault, initial encounter |
| T61.784A |
Other shellfish poisoning, undetermined, initial encounter |
| T61.8X1A |
Toxic effect of other seafood, accidental (unintentional), initial encounter |
| T61.8X2A |
Toxic effect of other seafood, intentional self-harm, initial encounter |
| T61.8X3A |
Toxic effect of other seafood, assault, initial encounter |
| T61.8X4A |
Toxic effect of other seafood, undetermined, initial encounter |
| T61.91XA |
Toxic effect of unspecified seafood, accidental (unintentional), initial encounter |
| T61.92XA |
Toxic effect of unspecified seafood, intentional self-harm, initial encounter |
| T61.93XA |
Toxic effect of unspecified seafood, assault, initial encounter |
| T61.94XA |
Toxic effect of unspecified seafood, undetermined, initial encounter |
| T62.0X1A |
Toxic effect of ingested mushrooms, accidental (unintentional), initial encounter |
| T62.0X2A |
Toxic effect of ingested mushrooms, intentional self-harm, initial encounter |
| T62.0X3A |
Toxic effect of ingested mushrooms, assault, initial encounter |
| T62.0X4A |
Toxic effect of ingested mushrooms, undetermined, initial encounter |
| T62.1X1A |
Toxic effect of ingested berries, accidental (unintentional), initial encounter |
| T62.1X2A |
Toxic effect of ingested berries, intentional self-harm, initial encounter |
| T62.1X3A |
Toxic effect of ingested berries, assault, initial encounter |
| T62.1X4A |
Toxic effect of ingested berries, undetermined, initial encounter |
| T62.2X1A |
Toxic effect of other ingested (parts of) plant(s), accidental (unintentional), initial encounter |
| T62.2X2A |
Toxic effect of other ingested (parts of) plant(s), intentional self-harm, initial encounter |
| T62.2X3A |
Toxic effect of other ingested (parts of) plant(s), assault, initial encounter |
| T62.2X4A |
Toxic effect of other ingested (parts of) plant(s), undetermined, initial encounter |
| T62.8X1A |
Toxic effect of other specified noxious substances eaten as food, accidental (unintentional), initial encounter |
| T62.8X2A |
Toxic effect of other specified noxious substances eaten as food, intentional self-harm, initial encounter |
| T62.8X3A |
Toxic effect of other specified noxious substances eaten as food, assault, initial encounter |
| T62.8X4A |
Toxic effect of other specified noxious substances eaten as food, undetermined, initial encounter |
| T62.91XA |
Toxic effect of unspecified noxious substance eaten as food, accidental (unintentional), initial encounter |
| T62.92XA |
Toxic effect of unspecified noxious substance eaten as food, intentional self-harm, initial encounter |
| T62.93XA |
Toxic effect of unspecified noxious substance eaten as food, assault, initial encounter |
| T62.94XA |
Toxic effect of unspecified noxious substance eaten as food, undetermined, initial encounter |
| T63.001A |
Toxic effect of unspecified snake venom, accidental (unintentional), initial encounter |
| T63.002A |
Toxic effect of unspecified snake venom, intentional self-harm, initial encounter |
| T63.003A |
Toxic effect of unspecified snake venom, assault, initial encounter |
| T63.004A |
Toxic effect of unspecified snake venom, undetermined, initial encounter |
| T63.011A |
Toxic effect of rattlesnake venom, accidental (unintentional), initial encounter |
| T63.012A |
Toxic effect of rattlesnake venom, intentional self-harm, initial encounter |
| T63.013A |
Toxic effect of rattlesnake venom, assault, initial encounter |
| T63.014A |
Toxic effect of rattlesnake venom, undetermined, initial encounter |
| T63.021A |
Toxic effect of coral snake venom, accidental (unintentional), initial encounter |
| T63.022A |
Toxic effect of coral snake venom, intentional self-harm, initial encounter |
| T63.023A |
Toxic effect of coral snake venom, assault, initial encounter |
| T63.024A |
Toxic effect of coral snake venom, undetermined, initial encounter |
| T63.031A |
Toxic effect of taipan venom, accidental (unintentional), initial encounter |
| T63.032A |
Toxic effect of taipan venom, intentional self-harm, initial encounter |
| T63.033A |
Toxic effect of taipan venom, assault, initial encounter |
| T63.034A |
Toxic effect of taipan venom, undetermined, initial encounter |
| T63.041A |
Toxic effect of cobra venom, accidental (unintentional), initial encounter |
| T63.042A |
Toxic effect of cobra venom, intentional self-harm, initial encounter |
| T63.043A |
Toxic effect of cobra venom, assault, initial encounter |
| T63.044A |
Toxic effect of cobra venom, undetermined, initial encounter |
| T63.061A |
Toxic effect of venom of other North and South American snake, accidental (unintentional), initial encounter |
| T63.062A |
Toxic effect of venom of other North and South American snake, intentional self-harm, initial encounter |
| T63.063A |
Toxic effect of venom of other North and South American snake, assault, initial encounter |
| T63.064A |
Toxic effect of venom of other North and South American snake, undetermined, initial encounter |
| T63.071A |
Toxic effect of venom of other Australian snake, accidental (unintentional), initial encounter |
| T63.072A |
Toxic effect of venom of other Australian snake, intentional self-harm, initial encounter |
| T63.073A |
Toxic effect of venom of other Australian snake, assault, initial encounter |
| T63.074A |
Toxic effect of venom of other Australian snake, undetermined, initial encounter |
| T63.081A |
Toxic effect of venom of other African and Asian snake, accidental (unintentional), initial encounter |
| T63.082A |
Toxic effect of venom of other African and Asian snake, intentional self-harm, initial encounter |
| T63.083A |
Toxic effect of venom of other African and Asian snake, assault, initial encounter |
| T63.084A |
Toxic effect of venom of other African and Asian snake, undetermined, initial encounter |
| T63.091A |
Toxic effect of venom of other snake, accidental (unintentional), initial encounter |
| T63.092A |
Toxic effect of venom of other snake, intentional self-harm, initial encounter |
| T63.093A |
Toxic effect of venom of other snake, assault, initial encounter |
| T63.094A |
Toxic effect of venom of other snake, undetermined, initial encounter |
| T63.111A |
Toxic effect of venom of gila monster, accidental (unintentional), initial encounter |
| T63.112A |
Toxic effect of venom of gila monster, intentional self-harm, initial encounter |
| T63.113A |
Toxic effect of venom of gila monster, assault, initial encounter |
| T63.114A |
Toxic effect of venom of gila monster, undetermined, initial encounter |
| T63.121A |
Toxic effect of venom of other venomous lizard, accidental (unintentional), initial encounter |
| T63.122A |
Toxic effect of venom of other venomous lizard, intentional self-harm, initial encounter |
| T63.123A |
Toxic effect of venom of other venomous lizard, assault, initial encounter |
| T63.124A |
Toxic effect of venom of other venomous lizard, undetermined, initial encounter |
| T63.191A |
Toxic effect of venom of other reptiles, accidental (unintentional), initial encounter |
| T63.192A |
Toxic effect of venom of other reptiles, intentional self-harm, initial encounter |
| T63.193A |
Toxic effect of venom of other reptiles, assault, initial encounter |
| T63.194A |
Toxic effect of venom of other reptiles, undetermined, initial encounter |
| T63.2X1A |
Toxic effect of venom of scorpion, accidental (unintentional), initial encounter |
| T63.2X2A |
Toxic effect of venom of scorpion, intentional self-harm, initial encounter |
| T63.2X3A |
Toxic effect of venom of scorpion, assault, initial encounter |
| T63.2X4A |
Toxic effect of venom of scorpion, undetermined, initial encounter |
| T63.301A |
Toxic effect of unspecified spider venom, accidental (unintentional), initial encounter |
| T63.302A |
Toxic effect of unspecified spider venom, intentional self-harm, initial encounter |
| T63.303A |
Toxic effect of unspecified spider venom, assault, initial encounter |
| T63.304A |
Toxic effect of unspecified spider venom, undetermined, initial encounter |
| T63.311A |
Toxic effect of venom of black widow spider, accidental (unintentional), initial encounter |
| T63.312A |
Toxic effect of venom of black widow spider, intentional self-harm, initial encounter |
| T63.313A |
Toxic effect of venom of black widow spider, assault, initial encounter |
| T63.314A |
Toxic effect of venom of black widow spider, undetermined, initial encounter |
| T63.321A |
Toxic effect of venom of tarantula, accidental (unintentional), initial encounter |
| T63.322A |
Toxic effect of venom of tarantula, intentional self-harm, initial encounter |
| T63.323A |
Toxic effect of venom of tarantula, assault, initial encounter |
| T63.324A |
Toxic effect of venom of tarantula, undetermined, initial encounter |
| T63.331A |
Toxic effect of venom of brown recluse spider, accidental (unintentional), initial encounter |
| T63.332A |
Toxic effect of venom of brown recluse spider, intentional self-harm, initial encounter |
| T63.333A |
Toxic effect of venom of brown recluse spider, assault, initial encounter |
| T63.334A |
Toxic effect of venom of brown recluse spider, undetermined, initial encounter |
| T63.391A |
Toxic effect of venom of other spider, accidental (unintentional), initial encounter |
| T63.392A |
Toxic effect of venom of other spider, intentional self-harm, initial encounter |
| T63.393A |
Toxic effect of venom of other spider, assault, initial encounter |
| T63.394A |
Toxic effect of venom of other spider, undetermined, initial encounter |
| T63.411A |
Toxic effect of venom of centipedes and venomous millipedes, accidental (unintentional), initial encounter |
| T63.412A |
Toxic effect of venom of centipedes and venomous millipedes, intentional self-harm, initial encounter |
| T63.413A |
Toxic effect of venom of centipedes and venomous millipedes, assault, initial encounter |
| T63.414A |
Toxic effect of venom of centipedes and venomous millipedes, undetermined, initial encounter |
| T63.421A |
Toxic effect of venom of ants, accidental (unintentional), initial encounter |
| T63.422A |
Toxic effect of venom of ants, intentional self-harm, initial encounter |
| T63.423A |
Toxic effect of venom of ants, assault, initial encounter |
| T63.424A |
Toxic effect of venom of ants, undetermined, initial encounter |
| T63.431A |
Toxic effect of venom of caterpillars, accidental (unintentional), initial encounter |
| T63.432A |
Toxic effect of venom of caterpillars, intentional self-harm, initial encounter |
| T63.433A |
Toxic effect of venom of caterpillars, assault, initial encounter |
| T63.434A |
Toxic effect of venom of caterpillars, undetermined, initial encounter |
| T63.441A |
Toxic effect of venom of bees, accidental (unintentional), initial encounter |
| T63.442A |
Toxic effect of venom of bees, intentional self-harm, initial encounter |
| T63.443A |
Toxic effect of venom of bees, assault, initial encounter |
| T63.444A |
Toxic effect of venom of bees, undetermined, initial encounter |
| T63.451A |
Toxic effect of venom of hornets, accidental (unintentional), initial encounter |
| T63.452A |
Toxic effect of venom of hornets, intentional self-harm, initial encounter |
| T63.453A |
Toxic effect of venom of hornets, assault, initial encounter |
| T63.454A |
Toxic effect of venom of hornets, undetermined, initial encounter |
| T63.461A |
Toxic effect of venom of wasps, accidental (unintentional), initial encounter |
| T63.462A |
Toxic effect of venom of wasps, intentional self-harm, initial encounter |
| T63.463A |
Toxic effect of venom of wasps, assault, initial encounter |
| T63.464A |
Toxic effect of venom of wasps, undetermined, initial encounter |
| T63.481A |
Toxic effect of venom of other arthropod, accidental (unintentional), initial encounter |
| T63.482A |
Toxic effect of venom of other arthropod, intentional self-harm, initial encounter |
| T63.483A |
Toxic effect of venom of other arthropod, assault, initial encounter |
| T63.484A |
Toxic effect of venom of other arthropod, undetermined, initial encounter |
| T63.511A |
Toxic effect of contact with stingray, accidental (unintentional), initial encounter |
| T63.512A |
Toxic effect of contact with stingray, intentional self-harm, initial encounter |
| T63.513A |
Toxic effect of contact with stingray, assault, initial encounter |
| T63.514A |
Toxic effect of contact with stingray, undetermined, initial encounter |
| T63.591A |
Toxic effect of contact with other venomous fish, accidental (unintentional), initial encounter |
| T63.592A |
Toxic effect of contact with other venomous fish, intentional self-harm, initial encounter |
| T63.593A |
Toxic effect of contact with other venomous fish, assault, initial encounter |
| T63.594A |
Toxic effect of contact with other venomous fish, undetermined, initial encounter |
| T63.611A |
Toxic effect of contact with Portuguese Man-o-war, accidental (unintentional), initial encounter |
| T63.612A |
Toxic effect of contact with Portuguese Man-o-war, intentional self-harm, initial encounter |
| T63.613A |
Toxic effect of contact with Portuguese Man-o-war, assault, initial encounter |
| T63.614A |
Toxic effect of contact with Portuguese Man-o-war, undetermined, initial encounter |
| T63.621A |
Toxic effect of contact with other jellyfish, accidental (unintentional), initial encounter |
| T63.622A |
Toxic effect of contact with other jellyfish, intentional self-harm, initial encounter |
| T63.623A |
Toxic effect of contact with other jellyfish, assault, initial encounter |
| T63.624A |
Toxic effect of contact with other jellyfish, undetermined, initial encounter |
| T63.631A |
Toxic effect of contact with sea anemone, accidental (unintentional), initial encounter |
| T63.632A |
Toxic effect of contact with sea anemone, intentional self-harm, initial encounter |
| T63.633A |
Toxic effect of contact with sea anemone, assault, initial encounter |
| T63.634A |
Toxic effect of contact with sea anemone, undetermined, initial encounter |
| T63.691A |
Toxic effect of contact with other venomous marine animals, accidental (unintentional), initial encounter |
| T63.692A |
Toxic effect of contact with other venomous marine animals, intentional self-harm, initial encounter |
| T63.693A |
Toxic effect of contact with other venomous marine animals, assault, initial encounter |
| T63.694A |
Toxic effect of contact with other venomous marine animals, undetermined, initial encounter |
| T63.711A |
Toxic effect of contact with venomous marine plant, accidental (unintentional), initial encounter |
| T63.712A |
Toxic effect of contact with venomous marine plant, intentional self-harm, initial encounter |
| T63.713A |
Toxic effect of contact with venomous marine plant, assault, initial encounter |
| T63.714A |
Toxic effect of contact with venomous marine plant, undetermined, initial encounter |
| T63.791A |
Toxic effect of contact with other venomous plant, accidental (unintentional), initial encounter |
| T63.792A |
Toxic effect of contact with other venomous plant, intentional self-harm, initial encounter |
| T63.793A |
Toxic effect of contact with other venomous plant, assault, initial encounter |
| T63.794A |
Toxic effect of contact with other venomous plant, undetermined, initial encounter |
| T63.811A |
Toxic effect of contact with venomous frog, accidental (unintentional), initial encounter |
| T63.812A |
Toxic effect of contact with venomous frog, intentional self-harm, initial encounter |
| T63.813A |
Toxic effect of contact with venomous frog, assault, initial encounter |
| T63.814A |
Toxic effect of contact with venomous frog, undetermined, initial encounter |
| T63.821A |
Toxic effect of contact with venomous toad, accidental (unintentional), initial encounter |
| T63.822A |
Toxic effect of contact with venomous toad, intentional self-harm, initial encounter |
| T63.823A |
Toxic effect of contact with venomous toad, assault, initial encounter |
| T63.824A |
Toxic effect of contact with venomous toad, undetermined, initial encounter |
| T63.831A |
Toxic effect of contact with other venomous amphibian, accidental (unintentional), initial encounter |
| T63.832A |
Toxic effect of contact with other venomous amphibian, intentional self-harm, initial encounter |
| T63.833A |
Toxic effect of contact with other venomous amphibian, assault, initial encounter |
| T63.834A |
Toxic effect of contact with other venomous amphibian, undetermined, initial encounter |
| T63.891A |
Toxic effect of contact with other venomous animals, accidental (unintentional), initial encounter |
| T63.892A |
Toxic effect of contact with other venomous animals, intentional self-harm, initial encounter |
| T63.893A |
Toxic effect of contact with other venomous animals, assault, initial encounter |
| T63.894A |
Toxic effect of contact with other venomous animals, undetermined, initial encounter |
| T63.91XA |
Toxic effect of contact with unspecified venomous animal, accidental (unintentional), initial encounter |
| T63.92XA |
Toxic effect of contact with unspecified venomous animal, intentional self-harm, initial encounter |
| T63.93XA |
Toxic effect of contact with unspecified venomous animal, assault, initial encounter |
| T63.94XA |
Toxic effect of contact with unspecified venomous animal, undetermined, initial encounter |
| T64.01XA |
Toxic effect of aflatoxin, accidental (unintentional), initial encounter |
| T64.02XA |
Toxic effect of aflatoxin, intentional self-harm, initial encounter |
| T64.03XA |
Toxic effect of aflatoxin, assault, initial encounter |
| T64.04XA |
Toxic effect of aflatoxin, undetermined, initial encounter |
| T64.81XA |
Toxic effect of other mycotoxin food contaminants, accidental (unintentional), initial encounter |
| T64.82XA |
Toxic effect of other mycotoxin food contaminants, intentional self-harm, initial encounter |
| T64.83XA |
Toxic effect of other mycotoxin food contaminants, assault, initial encounter |
| T64.84XA |
Toxic effect of other mycotoxin food contaminants, undetermined, initial encounter |
| T65.0X1A |
Toxic effect of cyanides, accidental (unintentional), initial encounter |
| T65.0X2A |
Toxic effect of cyanides, intentional self-harm, initial encounter |
| T65.0X3A |
Toxic effect of cyanides, assault, initial encounter |
| T65.0X4A |
Toxic effect of cyanides, undetermined, initial encounter |
| T65.1X1A |
Toxic effect of strychnine and its salts, accidental (unintentional), initial encounter |
| T65.1X2A |
Toxic effect of strychnine and its salts, intentional self-harm, initial encounter |
| T65.1X3A |
Toxic effect of strychnine and its salts, assault, initial encounter |
| T65.1X4A |
Toxic effect of strychnine and its salts, undetermined, initial encounter |
| T65.211A |
Toxic effect of chewing tobacco, accidental (unintentional), initial encounter |
| T65.212A |
Toxic effect of chewing tobacco, intentional self-harm, initial encounter |
| T65.213A |
Toxic effect of chewing tobacco, assault, initial encounter |
| T65.214A |
Toxic effect of chewing tobacco, undetermined, initial encounter |
| T65.221A |
Toxic effect of tobacco cigarettes, accidental (unintentional), initial encounter |
| T65.222A |
Toxic effect of tobacco cigarettes, intentional self-harm, initial encounter |
| T65.223A |
Toxic effect of tobacco cigarettes, assault, initial encounter |
| T65.224A |
Toxic effect of tobacco cigarettes, undetermined, initial encounter |
| T65.291A |
Toxic effect of other tobacco and nicotine, accidental (unintentional), initial encounter |
| T65.292A |
Toxic effect of other tobacco and nicotine, intentional self-harm, initial encounter |
| T65.293A |
Toxic effect of other tobacco and nicotine, assault, initial encounter |
| T65.294A |
Toxic effect of other tobacco and nicotine, undetermined, initial encounter |
| T65.3X1A |
Toxic effect of nitroderivatives and aminoderivatives of benzene and its homologues, accidental (unintentional), initial encounter |
| T65.3X2A |
Toxic effect of nitroderivatives and aminoderivatives of benzene and its homologues, intentional self-harm, initial encounter |
| T65.3X3A |
Toxic effect of nitroderivatives and aminoderivatives of benzene and its homologues, assault, initial encounter |
| T65.3X4A |
Toxic effect of nitroderivatives and aminoderivatives of benzene and its homologues, undetermined, initial encounter |
| T65.4X1A |
Toxic effect of carbon disulfide, accidental (unintentional), initial encounter |
| T65.4X2A |
Toxic effect of carbon disulfide, intentional self-harm, initial encounter |
| T65.4X3A |
Toxic effect of carbon disulfide, assault, initial encounter |
| T65.4X4A |
Toxic effect of carbon disulfide, undetermined, initial encounter |
| T65.5X1A |
Toxic effect of nitroglycerin and other nitric acids and esters, accidental (unintentional), initial encounter |
| T65.5X2A |
Toxic effect of nitroglycerin and other nitric acids and esters, intentional self-harm, initial encounter |
| T65.5X3A |
Toxic effect of nitroglycerin and other nitric acids and esters, assault, initial encounter |
| T65.5X4A |
Toxic effect of nitroglycerin and other nitric acids and esters, undetermined, initial encounter |
| T65.6X1A |
Toxic effect of paints and dyes, not elsewhere classified, accidental (unintentional), initial encounter |
| T65.6X2A |
Toxic effect of paints and dyes, not elsewhere classified, intentional self-harm, initial encounter |
| T65.6X3A |
Toxic effect of paints and dyes, not elsewhere classified, assault, initial encounter |
| T65.6X4A |
Toxic effect of paints and dyes, not elsewhere classified, undetermined, initial encounter |
| T65.811A |
Toxic effect of latex, accidental (unintentional), initial encounter |
| T65.812A |
Toxic effect of latex, intentional self-harm, initial encounter |
| T65.813A |
Toxic effect of latex, assault, initial encounter |
| T65.814A |
Toxic effect of latex, undetermined, initial encounter |
| T65.821A |
Toxic effect of harmful algae and algae toxins, accidental (unintentional), initial encounter |
| T65.822A |
Toxic effect of harmful algae and algae toxins, intentional self-harm, initial encounter |
| T65.823A |
Toxic effect of harmful algae and algae toxins, assault, initial encounter |
| T65.824A |
Toxic effect of harmful algae and algae toxins, undetermined, initial encounter |
| T65.831A |
Toxic effect of fiberglass, accidental (unintentional), initial encounter |
| T65.832A |
Toxic effect of fiberglass, intentional self-harm, initial encounter |
| T65.833A |
Toxic effect of fiberglass, assault, initial encounter |
| T65.834A |
Toxic effect of fiberglass, undetermined, initial encounter |
| T65.891A |
Toxic effect of other specified substances, accidental (unintentional), initial encounter |
| T65.892A |
Toxic effect of other specified substances, intentional self-harm, initial encounter |
| T65.893A |
Toxic effect of other specified substances, assault, initial encounter |
| T65.894A |
Toxic effect of other specified substances, undetermined, initial encounter |
| T78.1XXA |
Other adverse food reactions, not elsewhere classified, initial encounter |
| Z05.0 |
Observation and evaluation of newborn for suspected cardiac condition ruled out |
| Z05.1 |
Observation and evaluation of newborn for suspected infectious condition ruled out |
| Z05.2 |
Observation and evaluation of newborn for suspected neurological condition ruled out |
| Z05.3 |
Observation and evaluation of newborn for suspected respiratory condition ruled out |
| Z05.41 |
Observation and evaluation of newborn for suspected genetic condition ruled out |
| Z05.42 |
Observation and evaluation of newborn for suspected metabolic condition ruled out |
| Z05.43 |
Observation and evaluation of newborn for suspected immunologic condition ruled out |
| Z05.5 |
Observation and evaluation of newborn for suspected gastrointestinal condition ruled out |
| Z05.6 |
Observation and evaluation of newborn for suspected genitourinary condition ruled out |
| Z05.71 |
Observation and evaluation of newborn for suspected skin and subcutaneous tissue condition ruled out |
| Z05.72 |
Observation and evaluation of newborn for suspected musculoskeletal condition ruled out |
| Z05.73 |
Observation and evaluation of newborn for suspected connective tissue condition ruled out |
| Z05.81 |
Observation and evaluation of newborn for suspected condition related to home physiologic monitoring device ruled out |
| Z05.89 |
Observation and evaluation of newborn for other specified suspected condition ruled out |
| Z05.9 |
Observation and evaluation of newborn for unspecified suspected condition ruled out |
| Z08 |
Encounter for follow-up examination after completed treatment for malignant neoplasm |
| Z09 |
Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm |
| Z19.1 |
Hormone sensitive malignancy status |
| Z19.2 |
Hormone resistant malignancy status |
| Z22.7 |
Latent tuberculosis |
| Z29.11 |
Encounter for prophylactic immunotherapy for respiratory syncytial virus (RSV) |
| Z48.23 |
Encounter for aftercare following liver transplant |
| Z79.01 |
Long term (current) use of anticoagulants |
| Z79.02 |
Long term (current) use of antithrombotics/antiplatelets |
| Z79.1 |
Long term (current) use of non-steroidal anti-inflammatories (NSAID) |
| Z79.2 |
Long term (current) use of antibiotics |
| Z79.3 |
Long term (current) use of hormonal contraceptives |
| Z79.60 |
Long term (current) use of unspecified immunomodulators and immunosuppressants |
| Z79.61 |
Long term (current) use of immunomodulator |
| Z79.620 |
Long term (current) use of immunosuppressive biologic |
| Z79.621 |
Long term (current) use of calcineurin inhibitor |
| Z79.622 |
Long term (current) use of Janus kinase inhibitor |
| Z79.623 |
Long term (current) use of mammalian target of rapamycin (mTOR) inhibitor |
| Z79.624 |
Long term (current) use of inhibitors of nucleotide synthesis |
| Z79.630 |
Long term (current) use of alkylating agent |
| Z79.631 |
Long term (current) use of antimetabolite agent |
| Z79.632 |
Long term (current) use of antitumor antibiotic |
| Z79.633 |
Long term (current) use of mitotic inhibitor |
| Z79.634 |
Long term (current) use of topoisomerase inhibitor |
| Z79.64 |
Long term (current) use of myelosuppressive agent |
| Z79.69 |
Long term (current) use of other immunomodulators and immunosuppressants |
| Z79.84 |
Long term (current) use of oral hypoglycemic drugs |
| Z79.85 |
Long-term (current) use of injectable non-insulin antidiabetic drugs |
| Z79.891 |
Long term (current) use of opiate analgesic |
| Z79.899 |
Other long term (current) drug therapy |
| Z86.002 |
Personal history of in-situ neoplasm of other and unspecified genital organs |
| Z86.003 |
Personal history of in-situ neoplasm of oral cavity, esophagus and stomach |
| Z86.004 |
Personal history of in-situ neoplasm of other and unspecified digestive organs |
| Z86.005 |
Personal history of in-situ neoplasm of middle ear and respiratory system |
| Z86.006 |
Personal history of melanoma in-situ |
| Z86.007 |
Personal history of in-situ neoplasm of skin |
| Z86.15 |
Personal history of latent tuberculosis infection |
| Z94.4 |
Liver transplant status |
